data_1waz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1waz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.503 -0.614 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.63 -34.63 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.345 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -36.79 75.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 110.273 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.78 -42.72 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.447 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.3 -37.65 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.1 mt -61.82 -43.53 98.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 0.0 110.426 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.1 -42.96 99.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.46 95.68 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.38 -45.29 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -1.108 . . . . 0.0 110.34 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.09 -40.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.55 -40.58 96.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -59.72 -38.54 81.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.238 . . . . 0.0 110.521 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 t -58.13 -47.93 81.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.9 61.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 110.314 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.13 106.71 17.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 t -142.46 37.37 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.16 143.77 15.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.61 173.92 3.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -1.154 . . . . 0.0 110.469 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -174.98 129.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.87 . . . . 0.0 109.97 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.08 -178.21 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.929 . . . . 0.0 110.314 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.52 127.09 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.12 -145.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -57.95 -38.0 75.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.892 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 120.56 3.36 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.22 65.02 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.869 1.457 . . . . 0.0 110.137 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.06 -32.3 67.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -67.2 -49.38 64.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.0 77.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.305 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.41 -44.07 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 110.348 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.61 -45.47 73.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.485 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.82 -43.74 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 110.425 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.85 -50.52 57.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -37.66 88.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.4 m -64.87 -49.83 68.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.48 -42.79 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.869 . . . . 0.0 110.969 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -60.1 -49.1 78.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.91 -1.119 . . . . 0.0 109.856 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.24 93.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 111.019 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.99 -45.31 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.78 -51.68 57.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.074 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -57.17 -47.99 79.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 110.122 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -56.1 -39.79 72.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 109.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.37 145.81 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 110.463 -179.583 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.484 0.968 0 N-CA-C 110.432 -0.642 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.8 p -64.87 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 110.399 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.408 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 27.0 tp -58.79 -37.04 75.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.86 -43.22 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.474 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.97 -38.27 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.345 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 3.1 mm? -63.39 -43.77 96.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 110.478 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.4 -43.29 97.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.05 -38.96 96.02 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.41 -45.72 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -1.06 . . . . 0.0 110.327 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.54 -40.94 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 110.658 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.26 97.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.0 tp -60.04 -38.55 83.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -1.223 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -58.34 -47.92 82.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.168 -0.957 . . . . 0.0 110.736 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.19 64.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.103 -0.998 . . . . 0.0 110.355 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.74 107.56 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.7 p -147.94 38.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.674 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 -147.69 18.31 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -132.69 140.93 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -1.099 . . . . 0.0 110.487 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 tt -163.61 133.96 4.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.017 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.05 -167.27 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.579 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.8 p90 -85.02 124.31 31.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.134 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 4.2 m -103.87 -147.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.407 ' N ' ' CG2' ' A' ' 46' ' ' VAL . 28.6 tp -54.11 -39.97 66.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.04 137.08 6.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.675 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.92 67.43 3.99 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.912 1.48 . . . . 0.0 110.159 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -38.49 65.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.128 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -49.9 61.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.274 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.87 -44.25 77.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.2 -44.35 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -54.17 -44.86 71.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 110.452 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.26 -44.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.166 -0.959 . . . . 0.0 110.406 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -54.16 -50.49 55.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.79 -36.68 83.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 110.453 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.9 m -64.77 -49.83 69.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.403 HD12 HG22 ' A' ' 59' ' ' ILE . 91.3 mt -66.05 -42.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 111.008 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 6.5 m-85 -59.73 -49.56 77.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 0.0 109.859 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.931 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.33 -46.09 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 110.854 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.66 -39.74 89.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.65 -51.42 56.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -57.48 -49.48 76.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.104 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.43 -38.98 78.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.96 149.76 23.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.474 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.483 0.878 0 N-CA-C 110.432 -0.641 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.79 -33.12 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -38.22 73.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.53 -44.03 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.422 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 ' CD1' ' CZ ' ' A' ' 66' ' ' ARG . 94.7 mt -66.28 -37.97 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.364 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 tt -63.21 -43.4 98.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.467 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 tt -62.87 -43.56 98.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -38.3 95.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.19 -45.81 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -1.067 . . . . 0.0 110.297 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.6 t -59.77 -40.44 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -0.808 . . . . 0.0 110.705 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.02 98.21 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.58 -38.98 82.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.093 -1.239 . . . . 0.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.4 t -59.07 -48.85 80.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.773 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.78 64.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.405 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -107.84 102.43 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.0 p -137.73 36.47 2.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.643 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.78 148.09 19.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.43 170.27 3.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.1 tp -174.73 129.96 0.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.973 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.96 -178.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 19.6 p90 -100.99 127.2 47.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 1.1 p -91.98 -157.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.504 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 80.2 mt -61.36 -44.61 96.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.349 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.06 110.79 20.01 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.4 65.27 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.924 1.486 . . . . 0.0 110.117 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.86 71.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.216 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.14 -50.02 65.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.62 80.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 0.0 110.327 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.2 -44.07 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -54.81 -46.09 74.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -63.55 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.359 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.95 -50.71 57.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.84 -38.0 89.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.411 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.1 m -64.97 -50.02 68.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 110.521 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mm -66.63 -42.71 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.975 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 66.3 t80 -59.18 -48.55 81.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.908 -1.12 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.82 -39.72 78.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.337 -0.852 . . . . 0.0 110.983 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -58.38 -39.57 79.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 110.334 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 77.8 mtp180 -66.44 -49.19 67.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -56.88 -51.06 70.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.079 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 86.3 mtt180 -55.79 -35.28 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -172.73 138.28 0.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.827 . . . . 0.0 109.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 110.553 -179.782 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' HG21 ' A' ' 28' ' ' VAL . 40.0 Cg_endo . . . . . 0 N--CA 1.483 0.909 0 N-CA-C 110.507 -0.613 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.55 -30.04 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.92 -35.85 67.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.193 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 25' ' ' PRO . 3.4 m -58.92 -35.37 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.438 -0.788 . . . . 0.0 110.489 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 89.6 mt -65.28 -37.71 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.352 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.82 -43.71 98.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.06 -43.23 96.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.42 96.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.4 -45.43 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -1.111 . . . . 0.0 110.33 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.53 -40.83 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.8 . . . . 0.0 110.698 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.0 97.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.15 -37.7 80.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.276 . . . . 0.0 110.536 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 t -57.93 -47.5 82.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.727 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.56 61.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.9 tt -107.47 110.95 23.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.565 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -148.86 38.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.705 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.74 -148.42 20.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.97 142.71 47.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tt -162.0 132.57 4.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.001 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.55 -164.26 0.68 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 110.331 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 14.3 p90 -91.96 122.96 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.69 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.73 -39.07 67.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 110.318 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.76 136.36 7.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.655 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.06 63.61 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.962 1.506 . . . . 0.0 110.127 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.51 66.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -49.71 62.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.86 77.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -65.05 -43.97 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -54.54 -44.76 73.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.28 -43.76 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.452 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' TYR . . . -54.55 -50.23 57.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.94 -38.36 90.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.255 . . . . 0.0 110.416 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -64.63 -50.1 68.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.5 -43.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.849 . . . . 0.0 110.958 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 5.6 m-85 -60.2 -49.22 78.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.848 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.34 88.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.877 . . . . 0.0 111.039 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.05 -45.19 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.849 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -61.29 -39.19 89.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.037 -1.039 . . . . 0.0 110.289 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.6 mtp-105 -66.2 -51.33 58.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.059 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -57.35 -48.64 78.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.132 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.27 -40.35 74.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 109.815 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -157.65 151.0 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.858 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.503 -179.863 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 110.517 -0.609 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.1 p -60.09 -34.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -58.05 -37.83 75.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.23 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -60.9 -43.83 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 110.566 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 29' ' ' ILE . 90.5 mt -65.64 -38.37 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.323 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.41 -43.63 98.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 110.435 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.32 -43.65 97.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.84 96.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.02 -45.41 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 110.346 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.32 -40.76 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.852 . . . . 0.0 110.678 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.23 -41.22 98.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.9 -38.86 83.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.125 -1.221 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.2 m -58.78 -48.08 82.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.741 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -34.08 63.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.085 -1.01 . . . . 0.0 110.381 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.47 103.65 13.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 p -139.73 36.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.182 -0.949 . . . . 0.0 110.644 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.25 145.81 17.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.96 170.27 3.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -1.138 . . . . 0.0 110.483 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -173.45 127.65 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 109.996 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -68.87 -178.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 21.3 p90 -104.21 129.42 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 m -98.14 -146.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.0 -35.0 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 110.324 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.88 119.13 5.24 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.648 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.42 64.64 2.19 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.022 1.538 . . . . 0.0 110.153 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.08 -31.9 53.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.191 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 2.3 pp -69.37 -46.24 67.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.561 ' H ' ' HG ' ' A' ' 51' ' ' LEU . . . -55.78 -45.09 78.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.368 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.16 -43.84 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.865 . . . . 0.0 110.344 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.27 -47.03 76.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.459 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.4 -44.42 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.361 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.21 -51.32 54.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.17 -38.09 87.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.241 . . . . 0.0 110.452 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.7 m -65.05 -50.14 67.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.476 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.29 -43.07 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.955 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.3 t80 -59.64 -49.13 78.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.122 . . . . 0.0 109.811 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.77 80.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.991 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG2' ' NE ' ' A' ' 66' ' ' ARG . 78.9 mt -63.24 -44.81 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.25 -40.58 86.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.3 mtm180 -66.56 -49.57 65.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -51.93 67.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 110.057 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' CG2' ' A' ' 62' ' ' ILE . 96.7 mtt180 -55.81 -40.21 72.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.792 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -162.15 165.66 26.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.89 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 -179.711 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.521 -0.607 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.7 -36.24 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.83 -37.23 75.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -43.29 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 110.479 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.53 -38.35 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tt -62.89 -43.73 98.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.476 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.63 -43.29 97.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.397 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -39.19 95.94 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.8 t -58.55 -46.03 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.394 -1.062 . . . . 0.0 110.365 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.79 -41.06 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.384 -0.822 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.51 97.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.24 -38.55 83.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.239 . . . . 0.0 110.527 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 t -58.61 -47.89 82.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.768 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.25 -33.76 63.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.393 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.9 tp -106.43 109.98 22.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 39.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 110.716 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.0 -150.28 24.0 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.32 143.97 48.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -1.106 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.8 tp -167.14 137.47 3.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 109.953 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.23 -165.78 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.237 -0.915 . . . . 0.0 110.24 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 15.4 p90 -88.75 123.39 33.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.153 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.31 -146.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -55.71 -38.7 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.4 tp -154.97 136.27 9.16 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.634 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.59 63.73 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.893 1.47 . . . . 0.0 110.168 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.77 68.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.0 -50.17 63.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.75 76.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.1 mp -65.12 -44.33 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.38 -44.77 72.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.495 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.49 -43.92 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.42 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.94 -50.24 55.58 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.49 -37.07 85.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -1.207 . . . . 0.0 110.421 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -64.99 -49.85 68.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.09 -43.28 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.955 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 5.7 m-85 -59.96 -49.23 78.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.963 -1.085 . . . . 0.0 109.837 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.91 88.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.062 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.83 -46.12 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.857 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.47 -39.8 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.075 -1.015 . . . . 0.0 110.221 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -66.7 -51.35 57.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.065 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -57.27 -49.89 74.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -57.63 -38.7 75.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.739 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -160.59 141.76 12.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.497 -179.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 110.438 -0.639 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.86 -40.19 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -56.3 -44.32 79.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.159 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.82 -46.49 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.79 -38.94 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.355 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.28 -43.7 93.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.487 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.71 -44.4 93.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.16 96.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.54 -46.83 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.364 -1.08 . . . . 0.0 110.316 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.12 -41.56 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.815 . . . . 0.0 110.729 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.04 99.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.5 tp -60.2 -41.19 92.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -1.233 . . . . 0.0 110.499 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 p -59.47 -48.84 80.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.816 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.86 65.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.099 -1.0 . . . . 0.0 110.347 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -107.19 105.71 15.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 110.601 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.09 37.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 110.725 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.4 145.14 16.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.22 173.03 5.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -1.116 . . . . 0.0 110.491 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.7 tp -175.54 128.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.937 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.86 -175.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 25.3 p90 -109.16 130.6 55.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.212 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.91 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.269 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.78 112.21 8.26 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 110.661 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.14 62.82 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.972 1.512 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -30.79 70.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.4 mt -67.1 -49.32 65.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.98 79.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 mm -65.76 -44.19 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.255 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -54.45 -45.27 73.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.468 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.9 mm -63.88 -43.96 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 0.0 110.385 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.37 -51.01 57.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 4.5 mm? -63.24 -38.58 91.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -1.197 . . . . 0.0 110.37 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.1 m -64.95 -49.81 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.3 -43.7 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.859 . . . . 0.0 111.013 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -60.41 -48.97 79.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.812 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.7 87.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -64.22 -45.29 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.863 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -62.42 -42.07 99.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.088 -1.007 . . . . 0.0 110.275 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -66.46 -51.22 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.075 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -58.36 -49.99 75.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 110.077 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -57.59 -39.84 77.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.938 . . . . 0.0 109.782 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.65 157.04 31.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 110.48 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.484 0.951 0 N-CA-C 110.436 -0.64 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.27 -34.34 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.359 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.33 -37.65 75.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.872 . . . . 0.0 110.176 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.26 -43.64 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 110.402 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.35 -38.12 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.356 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.69 -43.35 97.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.453 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.425 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.24 95.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.1 t -57.55 -45.13 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -1.112 . . . . 0.0 110.315 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.81 -39.47 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.437 -0.79 . . . . 0.0 110.788 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.04 95.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 26.7 tp -57.01 -37.17 71.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -1.214 . . . . 0.0 110.471 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 t -58.64 -49.6 76.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.22 64.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.093 -1.004 . . . . 0.0 110.367 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 39' ' ' LEU . 1.3 pp -107.6 103.07 12.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.564 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m -140.22 37.56 1.91 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.715 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.43 147.5 19.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 63.3 t80 -63.71 169.01 4.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.479 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 28.8 tp -174.26 128.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.959 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.29 179.95 0.89 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.552 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.3 p90 -99.23 127.15 45.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 110.199 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 1.4 p -93.15 -155.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 4.4 mm? -61.72 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.298 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.05 111.09 20.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.588 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 65.47 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.886 1.466 . . . . 0.0 110.168 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.58 -32.02 71.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.02 -50.18 65.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.8 80.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.294 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.65 -43.96 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -55.35 -46.56 76.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 110.485 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.62 -44.7 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.955 . . . . 0.0 110.443 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.23 -50.96 57.33 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.69 92.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -1.21 . . . . 0.0 110.451 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.9 m -64.82 -50.11 68.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.547 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.35 -43.62 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.369 -0.832 . . . . 0.0 110.959 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.4 t80 -59.39 -48.88 79.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.934 -1.104 . . . . 0.0 109.871 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 111.088 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mm -62.45 -45.36 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -59.35 -40.65 87.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 110.235 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.4 mtm180 -67.42 -49.93 61.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -51.37 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -58.69 -35.48 72.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -162.63 138.98 7.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.141 -0.974 . . . . 0.0 110.547 -179.718 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 N--CA 1.484 0.931 0 N-CA-C 110.47 -0.627 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.81 -33.73 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.328 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -34.88 75.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.205 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.12 -40.78 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 110.507 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -38.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.255 -0.903 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.78 -43.47 98.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.397 -0.814 . . . . 0.0 110.443 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.45 -42.46 98.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.89 96.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.59 -44.91 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.086 . . . . 0.0 110.324 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.01 -40.89 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.467 -0.771 . . . . 0.0 110.777 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.54 -40.0 95.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.49 -38.18 83.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.08 -1.247 . . . . 0.0 110.54 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 p -58.07 -47.21 83.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.17 60.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.411 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.4 mm? -107.65 108.55 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 110.557 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.2 p -147.04 38.35 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.933 . . . . 0.0 110.696 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.97 -146.38 13.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.56 138.71 48.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -1.141 . . . . 0.0 110.521 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 tp -176.14 142.88 0.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -105.17 164.64 11.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.323 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -57.84 140.55 51.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.196 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -105.17 -135.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -34.13 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.937 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.1 tp -144.45 133.49 11.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.685 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.77 55.01 4.71 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.863 1.454 . . . . 0.0 110.171 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.67 -42.9 65.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -67.49 -49.13 64.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.41 -44.3 76.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 -43.55 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -55.62 -46.1 77.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.3 mm -64.09 -44.12 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.38 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 -50.19 57.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.02 -38.79 92.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.119 -1.224 . . . . 0.0 110.468 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -64.85 -50.25 67.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.93 -43.41 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.94 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.99 -48.43 81.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.842 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.97 89.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.016 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.41 -45.57 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.852 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -62.66 -39.85 95.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -65.41 -51.9 57.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 110.076 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -57.77 -48.02 80.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 20.5 mtp180 -59.81 -38.97 83.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.798 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 67.2 mt-30 -155.26 148.89 25.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -0.786 . . . . 0.0 109.842 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 110.514 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.483 0.884 0 N-CA-C 110.489 -0.62 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.0 p -61.85 -34.28 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.862 . . . . 0.0 110.299 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -58.49 -36.8 74.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.07 -43.63 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.507 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.72 -38.11 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.337 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.33 -43.56 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.436 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tt -62.81 -43.31 99.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.5 -44.81 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.381 -1.07 . . . . 0.0 110.289 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.72 -40.18 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.734 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.66 97.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 -38.73 82.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.24 . . . . 0.0 110.528 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.4 t -59.05 -48.46 81.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.765 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.13 64.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.995 . . . . 0.0 110.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.2 mt -107.25 100.23 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.535 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -133.38 35.66 3.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 110.708 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.85 146.51 17.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.93 174.71 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.89 131.15 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.968 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.06 136.66 33.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -62.07 139.15 58.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.49 -138.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.0 tp -65.27 -35.33 80.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.315 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.58 107.73 6.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.624 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.16 61.62 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.0 1.526 . . . . 0.0 110.12 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.03 70.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.191 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -66.3 -50.43 63.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -0.832 . . . . 0.0 110.242 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.08 76.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.18 -44.53 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.272 -0.892 . . . . 0.0 110.315 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -54.29 -44.43 71.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.514 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.67 -44.34 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.436 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.77 57.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -38.01 89.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -1.192 . . . . 0.0 110.419 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.7 m -64.03 -50.29 69.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.57 -42.87 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.828 . . . . 0.0 110.959 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -59.28 -49.02 79.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 109.845 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.45 92.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.45 -45.96 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.823 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.09 -40.18 96.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.035 -1.041 . . . . 0.0 110.282 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.15 -51.9 53.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.091 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -57.37 -47.89 80.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -57.84 -41.03 81.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.77 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -158.67 157.85 32.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 109.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 110.47 -179.824 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.484 0.94 0 N-CA-C 110.518 -0.608 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.3 -34.6 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 110.315 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.81 -37.63 74.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.236 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.35 -43.79 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.477 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 33' ' ' VAL . 94.1 mt -65.67 -38.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.306 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.58 ' O ' HG21 ' A' ' 33' ' ' VAL . 26.0 tp -60.68 -42.25 96.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 110.408 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 tp -69.47 -45.76 68.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.75 -47.84 82.64 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 30' ' ' LEU . 34.2 m -59.42 -42.68 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -1.102 . . . . 0.0 110.346 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 33' ' ' VAL . 55.1 t -61.76 -40.06 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 0.0 110.742 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.06 94.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.13 -38.63 80.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.163 -1.198 . . . . 0.0 110.587 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.1 p -57.85 -47.91 81.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.77 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.55 -34.75 64.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.6 mt -107.58 104.19 13.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -140.91 37.6 1.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.678 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.54 146.07 17.22 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -65.55 172.06 3.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.528 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -173.81 127.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.28 -176.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.118 -0.989 . . . . 0.0 110.296 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 24.7 p90 -109.11 131.22 55.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.07 -145.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.213 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.2 tp -57.89 -36.63 72.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 110.247 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.05 118.53 4.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.19 64.64 2.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.199 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.36 69.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.146 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 3.2 mm? -67.2 -49.34 64.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.74 80.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 53' ' ' ILE . 30.6 mm -66.1 -43.83 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.285 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.84 -45.57 74.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.6 mm -63.71 -44.29 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.224 -0.923 . . . . 0.0 110.385 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.9 -50.7 57.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.31 -37.85 88.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -1.22 . . . . 0.0 110.36 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.3 m -64.61 -50.14 68.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.74 -42.76 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 0.0 110.941 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.78 -48.77 80.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.92 -1.113 . . . . 0.0 109.869 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.75 90.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.034 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.86 -45.39 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.03 -40.12 94.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.235 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -65.18 -51.6 60.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 110.112 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -57.59 -48.49 79.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -60.7 -36.29 78.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -157.44 141.8 16.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.483 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 110.482 -0.622 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -65.69 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.357 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -37.38 77.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 110.247 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.96 -43.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.85 -38.15 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.316 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.57 -43.32 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.37 -42.18 98.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.4 -38.79 96.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.07 -44.73 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 110.379 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.8 -40.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.375 -0.828 . . . . 0.0 110.74 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.59 -40.22 96.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.03 -37.97 81.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -1.201 . . . . 0.0 110.53 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -57.6 -47.53 81.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 110.761 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.54 60.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 110.364 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 mt -108.12 107.08 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 t -143.74 37.68 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.05 146.32 17.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.54 169.17 5.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.137 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -175.41 130.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -68.66 -175.98 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.327 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -104.07 128.41 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.158 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 1.4 p -92.36 -155.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.176 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 27.4 tp -61.29 -44.0 97.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.306 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 tp -129.89 110.33 17.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.672 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.18 65.26 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.936 1.493 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.92 -31.93 73.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.298 -0.877 . . . . 0.0 110.148 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.11 -50.28 64.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.87 84.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.34 -44.79 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.288 -0.883 . . . . 0.0 110.303 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.88 -45.27 74.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.503 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.7 -44.85 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.168 -0.958 . . . . 0.0 110.375 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.41 -50.59 59.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.65 -38.06 89.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.081 -1.246 . . . . 0.0 110.451 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -64.74 -50.05 68.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.505 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.01 -43.45 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.961 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.87 -48.86 79.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.823 -1.173 . . . . 0.0 109.84 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.54 92.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 111.046 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.5 -45.58 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.871 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -63.15 -42.34 99.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 110.25 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -65.98 -51.55 57.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.054 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -57.87 -48.92 78.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -56.06 -40.51 73.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -158.39 152.3 23.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.448 -179.856 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.432 ' O ' HG21 ' A' ' 28' ' ' VAL . 57.2 Cg_endo . . . . . 0 N--CA 1.483 0.894 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.62 -31.46 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.386 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -34.04 69.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 25' ' ' PRO . 3.0 m -58.24 -33.82 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.399 -0.813 . . . . 0.0 110.525 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.418 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 40.7 mm -64.39 -38.24 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.7 tp -61.86 -43.18 99.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.471 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -43.11 98.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.336 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.71 -38.37 95.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.49 -44.99 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.1 . . . . 0.0 110.276 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.73 -40.43 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.696 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.82 98.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.67 -38.68 82.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.199 -1.177 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.4 t -58.3 -48.08 81.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.763 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.42 64.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.112 -0.993 . . . . 0.0 110.387 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.77 100.43 9.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.551 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.0 p -132.52 35.2 3.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.665 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.1 144.06 15.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -62.8 173.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -1.131 . . . . 0.0 110.472 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.2 tp -173.69 130.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 109.952 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -72.58 -177.63 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.357 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.52 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -102.2 129.54 48.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.205 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.35 -143.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.9 -35.9 71.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.269 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 121.67 3.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.601 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.64 65.69 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.893 1.47 . . . . 0.0 110.084 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.39 66.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.188 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 tp -67.65 -49.55 62.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.321 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.1 77.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.1 mm -65.62 -44.52 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -54.44 -45.4 73.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.443 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.44 -44.2 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.447 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.26 -49.96 57.9 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.333 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -64.71 -50.24 67.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.462 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.84 -43.85 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 0.0 110.875 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.48 -49.48 77.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.868 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.92 87.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 111.047 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 mp -64.46 -45.63 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.87 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -62.12 -40.48 96.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 0.0 110.294 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -66.05 -51.61 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -56.59 -47.94 78.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -62.19 -35.77 79.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 109.754 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -160.43 134.59 7.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.837 . . . . 0.0 109.815 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.516 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.484 0.917 0 N-CA-C 110.409 -0.65 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 6.4 p -67.97 -33.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 28.0 tp -60.29 -34.67 74.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.84 -40.99 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 110.496 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.59 -37.07 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.374 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 110.412 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.26 -43.47 97.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.67 96.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.7 -45.42 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -1.138 . . . . 0.0 110.317 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.98 -41.48 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 0.0 110.68 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.86 -40.66 98.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.29 -41.52 93.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.102 -1.234 . . . . 0.0 110.572 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -59.12 -48.72 80.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.13 62.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.352 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.22 101.7 10.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -135.57 36.08 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.671 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.26 147.73 19.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.85 174.89 3.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.123 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 tp -175.33 129.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.57 131.89 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -60.98 141.41 57.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -0.969 . . . . 0.0 110.133 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 19.1 m -103.45 -136.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.24 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.404 ' N ' ' CG2' ' A' ' 46' ' ' VAL . 9.3 tt -62.67 -35.18 78.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.98 108.28 15.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.685 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.85 62.16 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.962 1.506 . . . . 0.0 110.126 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.25 -50.66 64.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.294 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.73 78.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 110.332 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.57 -44.56 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.311 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -54.98 -45.44 75.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.487 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.7 -44.93 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.07 -50.5 58.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.6 tt -63.56 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -1.201 . . . . 0.0 110.454 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.1 m -64.8 -50.13 67.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.51 -43.46 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 111.036 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 25.8 t80 -59.23 -48.56 81.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.969 -1.082 . . . . 0.0 109.806 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.4 -39.8 84.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 111.077 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.94 -45.15 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.23 -40.93 95.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.02 -1.05 . . . . 0.0 110.241 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 55.8 mtp180 -66.34 -50.6 63.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 110.027 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -50.16 73.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.139 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.88 -35.24 77.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.754 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.63 137.0 10.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 109.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 -179.725 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 110.514 -0.61 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.6 p -57.18 -35.31 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.362 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 26.1 tp -57.07 -41.44 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 62' ' ' ILE . 58.4 t -61.46 -45.37 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.469 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 29' ' ' ILE . 88.5 mt -66.64 -38.17 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.19 -43.97 96.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 110.465 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.13 -43.2 99.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.354 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.96 95.7 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.9 -45.59 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.267 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.15 -41.05 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.732 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.41 97.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.238 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 p -59.42 -48.01 83.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.191 -0.943 . . . . 0.0 110.686 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.47 -33.1 59.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 tp -107.54 108.51 19.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.603 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -147.05 38.45 0.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.731 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.05 -145.25 11.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 92.4 m-85 -135.96 145.42 46.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.362 -1.081 . . . . 0.0 110.524 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 30.7 tp -176.62 144.71 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 109.979 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -106.69 161.94 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.32 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -60.13 138.69 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.19 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.74 -134.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.25 -33.02 73.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.284 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.87 140.5 16.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.9 52.46 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.879 1.463 . . . . 0.0 110.107 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.77 63.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -49.26 62.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.56 75.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.328 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 mm -65.25 -43.69 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.893 . . . . 0.0 110.269 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.49 -46.06 76.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.471 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.15 -44.02 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.15 -49.86 57.89 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.7 tt -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -1.214 . . . . 0.0 110.427 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 m -64.2 -50.11 69.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -67.4 -42.27 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.912 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.6 -48.54 80.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.976 -1.077 . . . . 0.0 109.823 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.91 85.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.988 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 ' CG1' ' A' ' 28' ' ' VAL . 78.9 mt -63.65 -45.24 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.85 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.96 -39.46 89.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.211 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -65.96 -51.25 60.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 110.075 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -57.98 -49.41 76.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.043 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 39.7 ttm180 -57.93 -39.95 79.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 76.6 mt-30 -155.55 150.01 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.356 -0.84 . . . . 0.0 109.85 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 110.405 -179.825 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -22.25 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.955 1.503 . . . . 0.0 110.503 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.63 -34.63 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.345 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -36.79 75.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 110.273 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.78 -42.72 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.447 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.3 -37.65 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.345 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 79.1 mt -61.82 -43.53 98.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 0.0 110.426 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.1 -42.96 99.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.46 95.68 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.6 t -58.38 -45.29 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -1.108 . . . . 0.0 110.34 -179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.09 -40.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.55 -40.58 96.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -59.72 -38.54 81.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.238 . . . . 0.0 110.521 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 t -58.13 -47.93 81.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.9 61.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 110.314 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -108.13 106.71 17.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.602 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 t -142.46 37.37 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.16 143.77 15.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.61 173.92 3.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -1.154 . . . . 0.0 110.469 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -174.98 129.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.87 . . . . 0.0 109.97 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.08 -178.21 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.929 . . . . 0.0 110.314 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.52 127.09 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.12 -145.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -57.95 -38.0 75.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.892 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 120.56 3.36 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.22 65.02 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.869 1.457 . . . . 0.0 110.137 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.06 -32.3 67.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 28.8 tp -67.2 -49.38 64.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.0 77.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.305 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.41 -44.07 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 110.348 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.61 -45.47 73.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.485 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.82 -43.74 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 110.425 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.85 -50.52 57.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.05 -37.66 88.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 177.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.4 m -64.87 -49.83 68.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.48 -42.79 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.869 . . . . 0.0 110.969 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -60.1 -49.1 78.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.91 -1.119 . . . . 0.0 109.856 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.24 93.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 111.019 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.5 mt -63.99 -45.31 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.881 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.78 -51.68 57.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.074 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -57.17 -47.99 79.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 110.122 178.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -56.1 -39.79 72.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 109.812 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.37 145.81 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.03 33.3 5.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 110.463 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t0 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.181 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.41 -21.45 35.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.432 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.408 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.8 p -64.87 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 110.399 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.408 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 27.0 tp -58.79 -37.04 75.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.86 -43.22 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.474 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.9 mt -65.97 -38.27 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.345 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 3.1 mm? -63.39 -43.77 96.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 110.478 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tt -63.4 -43.29 97.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.05 -38.96 96.02 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.41 -45.72 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -1.06 . . . . 0.0 110.327 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.54 -40.94 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 110.658 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.26 97.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.0 tp -60.04 -38.55 83.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -1.223 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -58.34 -47.92 82.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.168 -0.957 . . . . 0.0 110.736 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.19 64.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.103 -0.998 . . . . 0.0 110.355 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.74 107.56 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.7 p -147.94 38.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.674 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 -147.69 18.31 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -132.69 140.93 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -1.099 . . . . 0.0 110.487 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.3 tt -163.61 133.96 4.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.017 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -78.05 -167.27 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.579 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.8 p90 -85.02 124.31 31.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.134 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.407 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 4.2 m -103.87 -147.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.407 ' N ' ' CG2' ' A' ' 46' ' ' VAL . 28.6 tp -54.11 -39.97 66.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -161.04 137.08 6.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.675 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -72.92 67.43 3.99 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.912 1.48 . . . . 0.0 110.159 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -38.49 65.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.128 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -49.9 61.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.274 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.87 -44.25 77.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.2 -44.35 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -54.17 -44.86 71.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 110.452 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.26 -44.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.166 -0.959 . . . . 0.0 110.406 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -54.16 -50.49 55.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.79 -36.68 83.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 110.453 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.9 m -64.77 -49.83 69.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.403 HD12 HG22 ' A' ' 59' ' ' ILE . 91.3 mt -66.05 -42.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 111.008 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 6.5 m-85 -59.73 -49.56 77.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 0.0 109.859 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.931 178.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 80.9 mt -63.33 -46.09 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 110.854 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.66 -39.74 89.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.65 -51.42 56.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 24.1 mttp -57.48 -49.48 76.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.104 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.43 -38.98 78.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.96 149.76 23.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.41 173.51 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.474 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.192 -0.942 . . . . 0.0 110.15 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.68 -49.32 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 110.432 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.79 -33.12 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.29 -38.22 73.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.53 -44.03 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.422 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 ' CD1' ' CZ ' ' A' ' 66' ' ' ARG . 94.7 mt -66.28 -37.97 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.364 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.6 tt -63.21 -43.4 98.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.467 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.6 tt -62.87 -43.56 98.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -38.3 95.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.5 t -58.19 -45.81 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -1.067 . . . . 0.0 110.297 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.6 t -59.77 -40.44 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -0.808 . . . . 0.0 110.705 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.02 98.21 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.58 -38.98 82.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.093 -1.239 . . . . 0.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.4 t -59.07 -48.85 80.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.773 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.78 64.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.405 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -107.84 102.43 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.0 p -137.73 36.47 2.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.643 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.78 148.09 19.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.43 170.27 3.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.1 tp -174.73 129.96 0.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.973 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.96 -178.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 19.6 p90 -100.99 127.2 47.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.504 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 1.1 p -91.98 -157.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.504 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 80.2 mt -61.36 -44.61 96.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.349 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -128.06 110.79 20.01 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.668 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -70.4 65.27 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.924 1.486 . . . . 0.0 110.117 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.86 71.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.216 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.14 -50.02 65.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.62 80.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 0.0 110.327 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.2 -44.07 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -54.81 -46.09 74.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -63.55 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.359 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.95 -50.71 57.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.84 -38.0 89.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.411 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.1 m -64.97 -50.02 68.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 110.521 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.6 mm -66.63 -42.71 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.975 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 66.3 t80 -59.18 -48.55 81.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.908 -1.12 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.82 -39.72 78.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.337 -0.852 . . . . 0.0 110.983 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.859 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -58.38 -39.57 79.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 110.334 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.439 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 77.8 mtp180 -66.44 -49.19 67.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -56.88 -51.06 70.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.079 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' CZ ' ' CD1' ' A' ' 29' ' ' ILE . 86.3 mtt180 -55.79 -35.28 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -172.73 138.28 0.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.827 . . . . 0.0 109.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.71 131.08 37.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 110.553 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.867 . . . . 0.0 110.13 179.836 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.49 ' O ' HG21 ' A' ' 28' ' ' VAL . 40.0 Cg_endo -69.66 -26.97 27.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.951 1.501 . . . . 0.0 110.507 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.55 -30.04 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.92 -35.85 67.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.193 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 25' ' ' PRO . 3.4 m -58.92 -35.37 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.438 -0.788 . . . . 0.0 110.489 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.44 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 89.6 mt -65.28 -37.71 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.352 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.82 -43.71 98.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.06 -43.23 96.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.42 96.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.5 t -58.4 -45.43 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -1.111 . . . . 0.0 110.33 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.53 -40.83 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.8 . . . . 0.0 110.698 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.0 97.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.15 -37.7 80.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.276 . . . . 0.0 110.536 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 t -57.93 -47.5 82.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.727 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.56 61.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.9 tt -107.47 110.95 23.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.565 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -148.86 38.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.705 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.74 -148.42 20.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.97 142.71 47.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.9 tt -162.0 132.57 4.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.001 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -80.55 -164.26 0.68 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 110.331 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 14.3 p90 -91.96 122.96 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 m -102.69 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -54.73 -39.07 67.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 110.318 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.76 136.36 7.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.655 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -73.06 63.61 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.962 1.506 . . . . 0.0 110.127 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.51 66.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -49.71 62.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.86 77.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -65.05 -43.97 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -54.54 -44.76 73.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.5 mm -64.28 -43.76 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.452 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' TYR . . . -54.55 -50.23 57.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.94 -38.36 90.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.255 . . . . 0.0 110.416 177.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -64.63 -50.1 68.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.7 mt -67.5 -43.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.849 . . . . 0.0 110.958 178.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 5.6 m-85 -60.2 -49.22 78.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.848 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.34 88.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.877 . . . . 0.0 111.039 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.05 -45.19 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.849 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -61.29 -39.19 89.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.037 -1.039 . . . . 0.0 110.289 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.6 mtp-105 -66.2 -51.33 58.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.059 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -57.35 -48.64 78.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.132 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.27 -40.35 74.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 109.815 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -157.65 151.0 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.858 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -175.88 150.34 1.0 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.149 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.36 84.98 1.47 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 0.0 110.517 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.404 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.1 p -60.09 -34.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -58.05 -37.83 75.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.23 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -60.9 -43.83 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 110.566 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.44 HG23 HD11 ' A' ' 29' ' ' ILE . 90.5 mt -65.64 -38.37 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.323 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.41 -43.63 98.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 110.435 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tt -63.32 -43.65 97.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.84 96.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 58.8 t -58.02 -45.41 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 110.346 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.32 -40.76 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.852 . . . . 0.0 110.678 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.23 -41.22 98.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.9 -38.86 83.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.125 -1.221 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.2 m -58.78 -48.08 82.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.741 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -34.08 63.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.085 -1.01 . . . . 0.0 110.381 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.47 103.65 13.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 p -139.73 36.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.182 -0.949 . . . . 0.0 110.644 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.25 145.81 17.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.96 170.27 3.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -1.138 . . . . 0.0 110.483 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.8 tp -173.45 127.65 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 109.996 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -68.87 -178.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 21.3 p90 -104.21 129.42 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.8 m -98.14 -146.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.0 -35.0 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 110.324 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -145.88 119.13 5.24 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.648 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -70.42 64.64 2.19 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.022 1.538 . . . . 0.0 110.153 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.08 -31.9 53.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.191 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 52' ' ' ALA . 2.3 pp -69.37 -46.24 67.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.561 ' H ' ' HG ' ' A' ' 51' ' ' LEU . . . -55.78 -45.09 78.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.368 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.16 -43.84 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.865 . . . . 0.0 110.344 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.27 -47.03 76.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.459 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.4 -44.42 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.361 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.21 -51.32 54.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.3 tt -62.17 -38.09 87.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.241 . . . . 0.0 110.452 177.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.7 m -65.05 -50.14 67.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.476 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.29 -43.07 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.955 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.443 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.3 t80 -59.64 -49.13 78.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.122 . . . . 0.0 109.811 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.77 80.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.991 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG2' ' NE ' ' A' ' 66' ' ' ARG . 78.9 mt -63.24 -44.81 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.25 -40.58 86.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.443 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.3 mtm180 -66.56 -49.57 65.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -51.93 67.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 110.057 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' CG2' ' A' ' 62' ' ' ILE . 96.7 mtt180 -55.81 -40.21 72.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.792 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -162.15 165.66 26.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.89 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . 61.58 55.17 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.8 t0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.832 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.421 ' O ' HG21 ' A' ' 24' ' ' THR . 4.9 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.39 -12.91 32.51 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.996 1.524 . . . . 0.0 110.521 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.7 -36.24 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 tt -58.83 -37.23 75.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -43.29 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 110.479 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.6 mt -65.53 -38.35 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tt -62.89 -43.73 98.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.476 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.63 -43.29 97.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.397 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -39.19 95.94 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.8 t -58.55 -46.03 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.394 -1.062 . . . . 0.0 110.365 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.79 -41.06 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.384 -0.822 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.51 97.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.24 -38.55 83.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.239 . . . . 0.0 110.527 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 t -58.61 -47.89 82.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.768 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.25 -33.76 63.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.393 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.9 tp -106.43 109.98 22.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 39.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 110.716 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.0 -150.28 24.0 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.32 143.97 48.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -1.106 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.8 tp -167.14 137.47 3.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 109.953 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.23 -165.78 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.237 -0.915 . . . . 0.0 110.24 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 15.4 p90 -88.75 123.39 33.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.153 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -102.31 -146.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.176 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.8 tp -55.71 -38.7 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 10.4 tp -154.97 136.27 9.16 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.634 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -72.59 63.73 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.893 1.47 . . . . 0.0 110.168 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.77 68.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.0 -50.17 63.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.75 76.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.1 mp -65.12 -44.33 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.38 -44.77 72.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.495 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.49 -43.92 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.42 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.94 -50.24 55.58 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.49 -37.07 85.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -1.207 . . . . 0.0 110.421 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -64.99 -49.85 68.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.09 -43.28 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.955 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 5.7 m-85 -59.96 -49.23 78.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.963 -1.085 . . . . 0.0 109.837 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.91 88.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.062 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mm -62.83 -46.12 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.857 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.47 -39.8 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.075 -1.015 . . . . 0.0 110.221 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -66.7 -51.35 57.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.065 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -57.27 -49.89 74.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -57.63 -38.7 75.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.739 178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -160.59 141.76 12.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.74 -69.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.497 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.131 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.466 ' CG2' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HD2' ' CG2' ' A' ' 24' ' ' THR . 57.5 Cg_endo -79.4 109.24 2.46 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 0.0 110.438 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.86 -40.19 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -56.3 -44.32 79.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.159 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.82 -46.49 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 86.6 mt -66.79 -38.94 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.355 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.28 -43.7 93.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.487 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.5 tt -63.71 -44.4 93.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.16 96.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.0 t -58.54 -46.83 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.364 -1.08 . . . . 0.0 110.316 -179.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.12 -41.56 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.815 . . . . 0.0 110.729 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.04 99.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.5 tp -60.2 -41.19 92.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -1.233 . . . . 0.0 110.499 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 p -59.47 -48.84 80.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.816 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.86 65.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.099 -1.0 . . . . 0.0 110.347 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -107.19 105.71 15.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 110.601 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.09 37.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 110.725 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.4 145.14 16.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.22 173.03 5.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -1.116 . . . . 0.0 110.491 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.7 tp -175.54 128.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.937 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.86 -175.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 25.3 p90 -109.16 130.6 55.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.212 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.5 m -95.91 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.269 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.78 112.21 8.26 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 110.661 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.14 62.82 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.972 1.512 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -30.79 70.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.4 mt -67.1 -49.32 65.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.98 79.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 mm -65.76 -44.19 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.255 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -54.45 -45.27 73.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.468 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.9 mm -63.88 -43.96 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 0.0 110.385 178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.37 -51.01 57.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 57' ' ' LEU . 4.5 mm? -63.24 -38.58 91.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -1.197 . . . . 0.0 110.37 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.1 m -64.95 -49.81 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 89.0 mt -67.3 -43.7 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.859 . . . . 0.0 111.013 178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -60.41 -48.97 79.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.812 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.7 87.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 5.4 mm -64.22 -45.29 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.863 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -62.42 -42.07 99.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.088 -1.007 . . . . 0.0 110.275 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -66.46 -51.22 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.075 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -58.36 -49.99 75.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 110.077 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -57.59 -39.84 77.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.938 . . . . 0.0 109.782 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.65 157.04 31.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 132.33 53.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 110.48 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 110.092 179.813 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.36 -33.9 8.38 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.956 1.503 . . . . 0.0 110.436 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.27 -34.34 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.359 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.8 tt -58.33 -37.65 75.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.872 . . . . 0.0 110.176 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.26 -43.64 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 110.402 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 89.9 mt -65.35 -38.12 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.356 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.4 tt -60.69 -43.35 97.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.453 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.425 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.24 95.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.1 t -57.55 -45.13 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -1.112 . . . . 0.0 110.315 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.81 -39.47 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.437 -0.79 . . . . 0.0 110.788 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.85 -41.04 95.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 39' ' ' LEU . 26.7 tp -57.01 -37.17 71.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -1.214 . . . . 0.0 110.471 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 t -58.64 -49.6 76.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.22 64.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.093 -1.004 . . . . 0.0 110.367 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 39' ' ' LEU . 1.3 pp -107.6 103.07 12.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.564 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m -140.22 37.56 1.91 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.715 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.43 147.5 19.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 63.3 t80 -63.71 169.01 4.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.479 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 28.8 tp -174.26 128.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.959 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.29 179.95 0.89 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.552 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.3 p90 -99.23 127.15 45.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 110.199 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 1.4 p -93.15 -155.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.499 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 4.4 mm? -61.72 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.298 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.05 111.09 20.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.588 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 65.47 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.886 1.466 . . . . 0.0 110.168 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.58 -32.02 71.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 8.8 tt -66.02 -50.18 65.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.8 80.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.294 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.65 -43.96 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -55.35 -46.56 76.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 110.485 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.0 mm -63.62 -44.7 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.955 . . . . 0.0 110.443 178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.23 -50.96 57.33 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.31 -38.69 92.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -1.21 . . . . 0.0 110.451 177.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.9 m -64.82 -50.11 68.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.547 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.4 mt -67.35 -43.62 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.369 -0.832 . . . . 0.0 110.959 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.442 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.4 t80 -59.39 -48.88 79.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.934 -1.104 . . . . 0.0 109.871 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 111.088 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 3.3 mm -62.45 -45.36 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -59.35 -40.65 87.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 110.235 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.442 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.4 mtm180 -67.42 -49.93 61.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -51.37 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -58.69 -35.48 72.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -162.63 138.98 7.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.65 141.14 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.141 -0.974 . . . . 0.0 110.547 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.643 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -78.25 63.62 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.94 1.495 . . . . 0.0 110.47 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.4 m -69.81 -33.73 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.328 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.81 -34.88 75.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.205 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.12 -40.78 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 110.507 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.7 mt -65.27 -38.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.255 -0.903 . . . . 0.0 110.297 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.78 -43.47 98.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.397 -0.814 . . . . 0.0 110.443 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.45 -42.46 98.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.89 96.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.59 -44.91 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.086 . . . . 0.0 110.324 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.01 -40.89 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.467 -0.771 . . . . 0.0 110.777 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.54 -40.0 95.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.9 mt -60.49 -38.18 83.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.08 -1.247 . . . . 0.0 110.54 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 p -58.07 -47.21 83.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.17 60.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.411 178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.412 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.4 mm? -107.65 108.55 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 110.557 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.2 p -147.04 38.35 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.933 . . . . 0.0 110.696 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.97 -146.38 13.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.56 138.71 48.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -1.141 . . . . 0.0 110.521 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 tp -176.14 142.88 0.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -105.17 164.64 11.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.323 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -57.84 140.55 51.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.196 -179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 21.3 m -105.17 -135.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.8 tp -60.08 -34.13 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.937 . . . . 0.0 110.263 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 13.1 tp -144.45 133.49 11.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.685 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -76.77 55.01 4.71 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.863 1.454 . . . . 0.0 110.171 -179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.67 -42.9 65.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.1 tt -67.49 -49.13 64.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.41 -44.3 76.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.9 mm -65.17 -43.55 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -55.62 -46.1 77.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.3 mm -64.09 -44.12 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.38 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 -50.19 57.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.4 tt -64.02 -38.79 92.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.119 -1.224 . . . . 0.0 110.468 177.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -64.85 -50.25 67.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.93 -43.41 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.94 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.99 -48.43 81.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.842 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.97 89.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.016 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.41 -45.57 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.852 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -62.66 -39.85 95.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -65.41 -51.9 57.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 110.076 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -57.77 -48.02 80.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 20.5 mtp180 -59.81 -38.97 83.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.798 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 67.2 mt-30 -155.26 148.89 25.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -0.786 . . . . 0.0 109.842 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.83 -164.62 0.23 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 110.514 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.1 t0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.2 -25.47 37.0 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.973 1.512 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.403 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.0 p -61.85 -34.28 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.862 . . . . 0.0 110.299 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -58.49 -36.8 74.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.2 t -61.07 -43.63 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.507 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 91.5 mt -65.72 -38.11 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.337 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.3 tt -63.33 -43.56 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.436 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 9.4 tt -62.81 -43.31 99.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 60.1 t -57.5 -44.81 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.381 -1.07 . . . . 0.0 110.289 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.72 -40.18 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.734 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.66 97.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 -38.73 82.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.24 . . . . 0.0 110.528 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.4 t -59.05 -48.46 81.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.765 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.13 64.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.995 . . . . 0.0 110.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.2 mt -107.25 100.23 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.535 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.3 p -133.38 35.66 3.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 110.708 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.85 146.51 17.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.93 174.71 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -175.89 131.15 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.968 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.06 136.66 33.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -62.07 139.15 58.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.0 m -100.49 -138.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.0 tp -65.27 -35.33 80.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.315 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.58 107.73 6.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.624 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.16 61.62 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.0 1.526 . . . . 0.0 110.12 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.03 70.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.191 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -66.3 -50.43 63.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -0.832 . . . . 0.0 110.242 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.08 76.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.18 -44.53 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.272 -0.892 . . . . 0.0 110.315 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -54.29 -44.43 71.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.514 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.67 -44.34 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.436 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.77 57.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.73 -38.01 89.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -1.192 . . . . 0.0 110.419 177.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.7 m -64.03 -50.29 69.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.57 -42.87 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.828 . . . . 0.0 110.959 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -59.28 -49.02 79.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 109.845 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.45 92.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.3 mt -64.45 -45.96 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.823 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.09 -40.18 96.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.035 -1.041 . . . . 0.0 110.282 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.15 -51.9 53.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.091 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -57.37 -47.89 80.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.7 mtp180 -57.84 -41.03 81.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.77 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -158.67 157.85 32.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 109.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.34 -158.83 0.36 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 110.47 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.77 -37.47 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.008 1.53 . . . . 0.0 110.518 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.3 -34.6 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 110.315 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.81 -37.63 74.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.236 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.35 -43.79 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.477 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 33' ' ' VAL . 94.1 mt -65.67 -38.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.306 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.58 ' O ' HG21 ' A' ' 33' ' ' VAL . 26.0 tp -60.68 -42.25 96.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 110.408 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 tp -69.47 -45.76 68.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.75 -47.84 82.64 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 30' ' ' LEU . 34.2 m -59.42 -42.68 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -1.102 . . . . 0.0 110.346 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.423 ' N ' ' CG2' ' A' ' 33' ' ' VAL . 55.1 t -61.76 -40.06 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 0.0 110.742 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.06 94.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.13 -38.63 80.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.163 -1.198 . . . . 0.0 110.587 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.1 p -57.85 -47.91 81.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.77 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.55 -34.75 64.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.6 mt -107.58 104.19 13.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -140.91 37.6 1.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.678 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.54 146.07 17.22 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -65.55 172.06 3.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.528 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -173.81 127.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.28 -176.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.118 -0.989 . . . . 0.0 110.296 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 24.7 p90 -109.11 131.22 55.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.07 -145.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.213 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 26.2 tp -57.89 -36.63 72.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 110.247 -179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.05 118.53 4.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.637 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.19 64.64 2.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.199 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.36 69.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.146 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 3.2 mm? -67.2 -49.34 64.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.74 80.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 53' ' ' ILE . 30.6 mm -66.1 -43.83 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.285 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.84 -45.57 74.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.6 mm -63.71 -44.29 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.224 -0.923 . . . . 0.0 110.385 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.9 -50.7 57.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.31 -37.85 88.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -1.22 . . . . 0.0 110.36 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.3 m -64.61 -50.14 68.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.74 -42.76 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 0.0 110.941 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.78 -48.77 80.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.92 -1.113 . . . . 0.0 109.869 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.75 90.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.034 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.86 -45.39 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.03 -40.12 94.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.235 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -65.18 -51.6 60.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 110.112 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -57.59 -48.49 79.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -60.7 -36.29 78.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -157.44 141.8 16.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.56 138.99 39.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.198 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.81 -24.05 47.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.482 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -65.69 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.357 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.14 -37.38 77.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 110.247 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 94.5 t -59.96 -43.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.8 mm -65.85 -38.15 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.316 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.57 -43.32 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.37 -42.18 98.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.4 -38.79 96.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.07 -44.73 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 110.379 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.8 -40.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.375 -0.828 . . . . 0.0 110.74 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.59 -40.22 96.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.03 -37.97 81.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -1.201 . . . . 0.0 110.53 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -57.6 -47.53 81.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 110.761 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.54 60.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 110.364 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.5 mt -108.12 107.08 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 t -143.74 37.68 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.05 146.32 17.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.54 169.17 5.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.137 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -175.41 130.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -68.66 -175.98 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.327 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -104.07 128.41 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.158 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.49 ' CG1' ' N ' ' A' ' 47' ' ' LEU . 1.4 p -92.36 -155.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.176 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' N ' ' CG1' ' A' ' 46' ' ' VAL . 27.4 tp -61.29 -44.0 97.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.306 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 tp -129.89 110.33 17.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.672 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.18 65.26 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.936 1.493 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.92 -31.93 73.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.298 -0.877 . . . . 0.0 110.148 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.11 -50.28 64.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.87 84.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.34 -44.79 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.288 -0.883 . . . . 0.0 110.303 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.88 -45.27 74.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.503 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.7 -44.85 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.168 -0.958 . . . . 0.0 110.375 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.41 -50.59 59.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.65 -38.06 89.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.081 -1.246 . . . . 0.0 110.451 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -64.74 -50.05 68.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.505 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 86.8 mt -67.01 -43.45 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.961 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.87 -48.86 79.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.823 -1.173 . . . . 0.0 109.84 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.54 92.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 111.046 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 71.2 mt -63.5 -45.58 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.871 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -63.15 -42.34 99.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 110.25 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -65.98 -51.55 57.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.054 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -57.87 -48.92 78.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 61.2 ttp180 -56.06 -40.51 73.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -158.39 152.3 23.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.21 148.46 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.448 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 110.109 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.432 ' O ' HG21 ' A' ' 28' ' ' VAL . 57.2 Cg_endo -77.13 51.41 3.45 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.966 1.508 . . . . 0.0 110.533 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.62 -31.46 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.386 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -34.04 69.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -178.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 25' ' ' PRO . 3.0 m -58.24 -33.82 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.399 -0.813 . . . . 0.0 110.525 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.418 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 40.7 mm -64.39 -38.24 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.7 tp -61.86 -43.18 99.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.471 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.24 -43.11 98.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.336 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.71 -38.37 95.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.7 t -57.49 -44.99 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.1 . . . . 0.0 110.276 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.73 -40.43 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.696 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.82 98.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.67 -38.68 82.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.199 -1.177 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 17.4 t -58.3 -48.08 81.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.763 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.42 64.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.112 -0.993 . . . . 0.0 110.387 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -106.77 100.43 9.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.551 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.0 p -132.52 35.2 3.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.665 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.1 144.06 15.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -62.8 173.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -1.131 . . . . 0.0 110.472 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.2 tp -173.69 130.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 109.952 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -72.58 -177.63 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.357 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.52 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -102.2 129.54 48.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.205 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.35 -143.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 9.1 tt -57.9 -35.9 71.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.269 -179.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 121.67 3.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.601 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -71.64 65.69 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.893 1.47 . . . . 0.0 110.084 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.39 66.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.188 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 27.5 tp -67.65 -49.55 62.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.321 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.1 77.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.1 mm -65.62 -44.52 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -54.44 -45.4 73.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.443 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.44 -44.2 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.447 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.26 -49.96 57.9 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.25 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.333 177.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.3 m -64.71 -50.24 67.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.462 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.84 -43.85 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 0.0 110.875 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.48 -49.48 77.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.868 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.92 87.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 111.047 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.1 mp -64.46 -45.63 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.87 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -62.12 -40.48 96.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 0.0 110.294 179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -66.05 -51.61 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -56.59 -47.94 78.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -62.19 -35.77 79.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 109.754 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -160.43 134.59 7.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.837 . . . . 0.0 109.815 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.19 134.7 2.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.516 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.874 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -84.89 63.03 6.28 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.008 1.531 . . . . 0.0 110.409 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 6.4 p -67.97 -33.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 28.0 tp -60.29 -34.67 74.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 78.0 t -59.84 -40.99 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 110.496 -178.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 96.0 mt -64.59 -37.07 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.374 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 110.412 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.26 -43.47 97.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.41 -38.67 96.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.7 -45.42 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -1.138 . . . . 0.0 110.317 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.98 -41.48 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 0.0 110.68 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.86 -40.66 98.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.6 mp -60.29 -41.52 93.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.102 -1.234 . . . . 0.0 110.572 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 t -59.12 -48.72 80.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.13 62.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.352 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.22 101.7 10.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 35.8 p -135.57 36.08 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.671 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.26 147.73 19.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.85 174.89 3.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.123 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 tp -175.33 129.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.57 131.89 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -60.98 141.41 57.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -0.969 . . . . 0.0 110.133 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.404 ' CG2' ' N ' ' A' ' 47' ' ' LEU . 19.1 m -103.45 -136.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.24 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.404 ' N ' ' CG2' ' A' ' 46' ' ' VAL . 9.3 tt -62.67 -35.18 78.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 4.5 tp -130.98 108.28 15.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.685 179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.85 62.16 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.962 1.506 . . . . 0.0 110.126 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.25 -50.66 64.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.294 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.73 78.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 110.332 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.57 -44.56 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.311 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -54.98 -45.44 75.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.487 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.7 -44.93 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.07 -50.5 58.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.6 tt -63.56 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -1.201 . . . . 0.0 110.454 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.1 m -64.8 -50.13 67.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.51 -43.46 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 111.036 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.417 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 25.8 t80 -59.23 -48.56 81.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.969 -1.082 . . . . 0.0 109.806 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.4 -39.8 84.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 111.077 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.94 -45.15 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.23 -40.93 95.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.02 -1.05 . . . . 0.0 110.241 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.417 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 55.8 mtp180 -66.34 -50.6 63.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 110.027 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -50.16 73.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.139 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -61.88 -35.24 77.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.754 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.63 137.0 10.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 109.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.49 137.38 35.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.948 . . . . 0.0 110.147 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.23 66.49 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 0.0 110.514 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.418 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 9.6 p -57.18 -35.31 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.362 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 26.1 tp -57.07 -41.44 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' CG1' HG12 ' A' ' 62' ' ' ILE . 58.4 t -61.46 -45.37 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.469 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.484 HG22 HD11 ' A' ' 29' ' ' ILE . 88.5 mt -66.64 -38.17 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.19 -43.97 96.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 110.465 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.13 -43.2 99.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.354 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.96 95.7 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.9 -45.59 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.267 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.15 -41.05 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.732 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.41 97.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.238 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 p -59.42 -48.01 83.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.191 -0.943 . . . . 0.0 110.686 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.47 -33.1 59.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 tp -107.54 108.51 19.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.603 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.9 t -147.05 38.45 0.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.731 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.05 -145.25 11.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 92.4 m-85 -135.96 145.42 46.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.362 -1.081 . . . . 0.0 110.524 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 42' ' ' TYR . 30.7 tp -176.62 144.71 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 109.979 -179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -106.69 161.94 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.32 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -60.13 138.69 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.19 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.74 -134.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.25 -33.02 73.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.284 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.87 140.5 16.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.9 52.46 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.879 1.463 . . . . 0.0 110.107 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.77 63.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -49.26 62.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.29 -44.56 75.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.328 179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 mm -65.25 -43.69 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.893 . . . . 0.0 110.269 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.49 -46.06 76.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.471 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.15 -44.02 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.15 -49.86 57.89 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.7 tt -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -1.214 . . . . 0.0 110.427 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 m -64.2 -50.11 69.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 88.4 mt -67.4 -42.27 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.912 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.6 -48.54 80.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.976 -1.077 . . . . 0.0 109.823 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.91 85.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.988 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG12 ' CG1' ' A' ' 28' ' ' VAL . 78.9 mt -63.65 -45.24 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.85 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.96 -39.46 89.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.211 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -65.96 -51.25 60.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 110.075 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -57.98 -49.41 76.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.043 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 39.7 ttm180 -57.93 -39.95 79.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 76.6 mt-30 -155.55 150.01 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.356 -0.84 . . . . 0.0 109.85 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.44 148.67 44.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 110.405 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.759 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.503 -0.614 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.63 -34.63 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.345 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.81 -36.79 75.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 110.273 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.559 HG12 HG23 ' A' ' 62' ' ' ILE . 70.7 t -59.78 -42.72 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.447 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 ' CD ' ' A' ' 66' ' ' ARG . 97.1 mt -65.3 -37.65 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.345 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 HD22 ' A' ' 27' ' ' LEU . 79.1 mt -61.82 -43.53 98.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 0.0 110.426 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.1 -42.96 99.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.46 95.68 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.6 t -58.38 -45.29 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -1.108 . . . . 0.0 110.34 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.09 -40.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.55 -40.58 96.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -59.72 -38.54 81.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.238 . . . . 0.0 110.521 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 t -58.13 -47.93 81.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.9 61.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 110.314 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 51' ' ' LEU . 25.0 tp -108.13 106.71 17.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 t -142.46 37.37 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.16 143.77 15.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.61 173.92 3.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -1.154 . . . . 0.0 110.469 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -174.98 129.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.87 . . . . 0.0 109.97 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.08 -178.21 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.929 . . . . 0.0 110.314 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.52 127.09 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.12 -145.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -57.95 -38.0 75.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.892 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 120.56 3.36 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.22 65.02 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.869 1.457 . . . . 0.0 110.137 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.06 -32.3 67.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 39' ' ' LEU . 28.8 tp -67.2 -49.38 64.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.0 77.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.305 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.41 -44.07 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 110.348 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.61 -45.47 73.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.485 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.82 -43.74 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 110.425 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.85 -50.52 57.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -63.05 -37.66 88.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.4 m -64.87 -49.83 68.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.48 -42.79 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.869 . . . . 0.0 110.969 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -60.1 -49.1 78.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.91 -1.119 . . . . 0.0 109.856 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.24 93.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 111.019 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 28' ' ' VAL . 79.5 mt -63.99 -45.31 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.881 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.78 -51.68 57.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.074 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 28' ' ' VAL . 27.7 mmtp -57.17 -47.99 79.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.867 ' CD ' HD11 ' A' ' 29' ' ' ILE . 16.9 ttp180 -56.1 -39.79 72.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 109.812 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.37 145.81 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 110.463 -179.583 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.484 0.968 0 N-CA-C 110.432 -0.642 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.8 p -64.87 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 110.399 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 26' ' ' VAL . 27.0 tp -58.79 -37.04 75.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.86 -43.22 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.474 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.9 mt -65.97 -38.27 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 3.1 mm? -63.39 -43.77 96.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 110.478 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -63.4 -43.29 97.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.05 -38.96 96.02 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.41 -45.72 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -1.06 . . . . 0.0 110.327 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.54 -40.94 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 110.658 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.26 97.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.0 tp -60.04 -38.55 83.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -1.223 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -58.34 -47.92 82.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.168 -0.957 . . . . 0.0 110.736 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.19 64.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.103 -0.998 . . . . 0.0 110.355 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.74 107.56 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.7 p -147.94 38.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.674 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 -147.69 18.31 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -132.69 140.93 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -1.099 . . . . 0.0 110.487 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.3 tt -163.61 133.96 4.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.017 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.638 ' O ' HD23 ' A' ' 43' ' ' LEU . 87.6 m-20 -78.05 -167.27 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.579 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.8 p90 -85.02 124.31 31.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.134 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.2 m -103.87 -147.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 46' ' ' VAL . 28.6 tp -54.11 -39.97 66.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -161.04 137.08 6.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.675 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.741 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.3 Cg_endo -72.92 67.43 3.99 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.912 1.48 . . . . 0.0 110.159 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -38.49 65.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.128 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -49.9 61.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.274 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.87 -44.25 77.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.2 -44.35 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -54.17 -44.86 71.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 110.452 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.26 -44.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.166 -0.959 . . . . 0.0 110.406 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -54.16 -50.49 55.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.517 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.2 tt -62.79 -36.68 83.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 110.453 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.9 m -64.77 -49.83 69.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -66.05 -42.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 111.008 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 6.5 m-85 -59.73 -49.56 77.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 0.0 109.859 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB1' ' NZ ' ' A' ' 65' ' ' LYS . . . -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.931 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 29' ' ' ILE . 80.9 mt -63.33 -46.09 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.66 -39.74 89.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.65 -51.42 56.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' NZ ' ' HB1' ' A' ' 61' ' ' ALA . 24.1 mttp -57.48 -49.48 76.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.104 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.43 -38.98 78.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.96 149.76 23.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.474 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.483 0.878 0 N-CA-C 110.432 -0.641 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.79 -33.12 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.598 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -57.29 -38.22 73.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 62' ' ' ILE . 74.4 t -61.53 -44.03 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.422 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.793 ' O ' HG23 ' A' ' 33' ' ' VAL . 94.7 mt -66.28 -37.97 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.364 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.6 tt -63.21 -43.4 98.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.467 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.6 tt -62.87 -43.56 98.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -38.3 95.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.5 t -58.19 -45.81 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -1.067 . . . . 0.0 110.297 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.6 t -59.77 -40.44 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -0.808 . . . . 0.0 110.705 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.02 98.21 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.58 -38.98 82.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.093 -1.239 . . . . 0.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.4 t -59.07 -48.85 80.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.773 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.78 64.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.405 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -107.84 102.43 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.0 p -137.73 36.47 2.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.643 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.78 148.09 19.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.43 170.27 3.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.1 tp -174.73 129.96 0.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.973 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.96 -178.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 19.6 p90 -100.99 127.2 47.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.764 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.1 p -91.98 -157.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.764 ' N ' HG13 ' A' ' 46' ' ' VAL . 80.2 mt -61.36 -44.61 96.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.349 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -128.06 110.79 20.01 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.668 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 48' ' ' LEU . 45.8 Cg_endo -70.4 65.27 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.924 1.486 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.86 71.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.216 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.14 -50.02 65.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.62 80.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 0.0 110.327 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.2 -44.07 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -54.81 -46.09 74.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -63.55 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.359 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.95 -50.71 57.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.84 -38.0 89.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.411 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.1 m -64.97 -50.02 68.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 110.521 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' HD12 ' A' ' 62' ' ' ILE . 39.6 mm -66.63 -42.71 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.975 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 66.3 t80 -59.18 -48.55 81.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.908 -1.12 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.82 -39.72 78.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.337 -0.852 . . . . 0.0 110.983 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 HG12 ' A' ' 28' ' ' VAL . 76.8 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -58.38 -39.57 79.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 110.334 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 77.8 mtp180 -66.44 -49.19 67.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -56.88 -51.06 70.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.079 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.494 HH21 HG21 ' A' ' 62' ' ' ILE . 86.3 mtt180 -55.79 -35.28 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -172.73 138.28 0.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.827 . . . . 0.0 109.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 110.553 -179.782 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.787 ' O ' HG22 ' A' ' 28' ' ' VAL . 40.0 Cg_endo . . . . . 0 N--CA 1.483 0.909 0 N-CA-C 110.507 -0.613 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.55 -30.04 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.92 -35.85 67.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.193 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.4 m -58.92 -35.37 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.438 -0.788 . . . . 0.0 110.489 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.6 mt -65.28 -37.71 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.352 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.82 -43.71 98.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.06 -43.23 96.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.42 96.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.5 t -58.4 -45.43 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -1.111 . . . . 0.0 110.33 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.53 -40.83 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.8 . . . . 0.0 110.698 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.0 97.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.15 -37.7 80.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.276 . . . . 0.0 110.536 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 t -57.93 -47.5 82.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.727 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.56 61.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.515 ' C ' HD23 ' A' ' 39' ' ' LEU . 8.9 tt -107.47 110.95 23.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.565 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -148.86 38.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.705 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.74 -148.42 20.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.97 142.71 47.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.9 tt -162.0 132.57 4.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.001 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.772 ' O ' HD23 ' A' ' 43' ' ' LEU . 6.2 t0 -80.55 -164.26 0.68 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 110.331 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 14.3 p90 -91.96 122.96 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.8 m -102.69 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.3 tp -54.73 -39.07 67.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 110.318 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -157.76 136.36 7.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.655 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.7 Cg_endo -73.06 63.61 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.962 1.506 . . . . 0.0 110.127 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.51 66.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -49.71 62.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.82 -43.86 77.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -65.05 -43.97 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -54.54 -44.76 73.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' CD1' ' A' ' 59' ' ' ILE . 37.5 mm -64.28 -43.76 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.452 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' TYR . . . -54.55 -50.23 57.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.504 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.3 tt -63.94 -38.36 90.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.255 . . . . 0.0 110.416 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -64.63 -50.1 68.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 55' ' ' ILE . 86.7 mt -67.5 -43.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.849 . . . . 0.0 110.958 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 5.6 m-85 -60.2 -49.22 78.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.848 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.34 88.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.877 . . . . 0.0 111.039 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.05 -45.19 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.849 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -61.29 -39.19 89.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.037 -1.039 . . . . 0.0 110.289 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.6 mtp-105 -66.2 -51.33 58.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.059 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -57.35 -48.64 78.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.132 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.27 -40.35 74.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 109.815 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 pt20 -157.65 151.0 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.858 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 110.517 -0.609 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.1 p -60.09 -34.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.05 -37.83 75.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.23 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -60.9 -43.83 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 110.566 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 33' ' ' VAL . 90.5 mt -65.64 -38.37 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.323 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.41 -43.63 98.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 110.435 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.2 tt -63.32 -43.65 97.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.84 96.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' ILE . 58.8 t -58.02 -45.41 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 110.346 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.32 -40.76 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.852 . . . . 0.0 110.678 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.23 -41.22 98.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.9 -38.86 83.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.125 -1.221 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.2 m -58.78 -48.08 82.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.741 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -34.08 63.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.085 -1.01 . . . . 0.0 110.381 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.47 103.65 13.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 p -139.73 36.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.182 -0.949 . . . . 0.0 110.644 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.25 145.81 17.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.96 170.27 3.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -1.138 . . . . 0.0 110.483 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 51' ' ' LEU . 26.8 tp -173.45 127.65 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 109.996 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -68.87 -178.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 21.3 p90 -104.21 129.42 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.609 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.8 m -98.14 -146.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.598 ' N ' HG23 ' A' ' 46' ' ' VAL . 74.9 mt -58.0 -35.0 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 110.324 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.609 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -145.88 119.13 5.24 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.648 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 48.1 Cg_endo -70.42 64.64 2.19 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.022 1.538 . . . . 0.0 110.153 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.08 -31.9 53.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.191 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 52' ' ' ALA . 2.3 pp -69.37 -46.24 67.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 51' ' ' LEU . . . -55.78 -45.09 78.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.368 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.16 -43.84 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.865 . . . . 0.0 110.344 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.27 -47.03 76.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.459 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.4 -44.42 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.361 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.21 -51.32 54.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.3 tt -62.17 -38.09 87.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.241 . . . . 0.0 110.452 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.7 m -65.05 -50.14 67.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.476 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.29 -43.07 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.955 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.3 t80 -59.64 -49.13 78.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.122 . . . . 0.0 109.811 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.77 80.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.991 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG2' ' NE ' ' A' ' 66' ' ' ARG . 78.9 mt -63.24 -44.81 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.25 -40.58 86.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.427 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.3 mtm180 -66.56 -49.57 65.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -51.93 67.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 110.057 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' CG2' ' A' ' 62' ' ' ILE . 96.7 mtt180 -55.81 -40.21 72.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.792 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 63.2 tt0 -162.15 165.66 26.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.89 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.521 -0.607 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.7 -36.24 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.3 tt -58.83 -37.23 75.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 62' ' ' ILE . 54.0 t -60.53 -43.29 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.6 mt -65.53 -38.35 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.4 tt -62.89 -43.73 98.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.476 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.63 -43.29 97.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.397 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -39.19 95.94 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 29' ' ' ILE . 56.8 t -58.55 -46.03 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.394 -1.062 . . . . 0.0 110.365 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.79 -41.06 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.384 -0.822 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.51 97.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.24 -38.55 83.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.239 . . . . 0.0 110.527 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 t -58.61 -47.89 82.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.768 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.25 -33.76 63.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.393 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.9 tp -106.43 109.98 22.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 39.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 110.716 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.0 -150.28 24.0 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.32 143.97 48.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -1.106 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.8 tp -167.14 137.47 3.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 109.953 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.23 -165.78 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.237 -0.915 . . . . 0.0 110.24 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 15.4 p90 -88.75 123.39 33.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.153 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.5 m -102.31 -146.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.176 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.8 tp -55.71 -38.7 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' H ' HG23 ' A' ' 46' ' ' VAL . 10.4 tp -154.97 136.27 9.16 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.634 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.842 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 54.6 Cg_endo -72.59 63.73 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.893 1.47 . . . . 0.0 110.168 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.77 68.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.0 -50.17 63.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.61 -43.75 76.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.1 mp -65.12 -44.33 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.38 -44.77 72.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.495 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.49 -43.92 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.42 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.94 -50.24 55.58 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.49 -37.07 85.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -1.207 . . . . 0.0 110.421 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -64.99 -49.85 68.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.09 -43.28 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.955 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 5.7 m-85 -59.96 -49.23 78.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.963 -1.085 . . . . 0.0 109.837 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.91 88.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.062 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.579 HD11 HG12 ' A' ' 28' ' ' VAL . 1.9 mm -62.83 -46.12 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.857 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.47 -39.8 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.075 -1.015 . . . . 0.0 110.221 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -66.7 -51.35 57.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.065 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -57.27 -49.89 74.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HD2' HD11 ' A' ' 29' ' ' ILE . 82.6 mtp180 -57.63 -38.7 75.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.739 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -160.59 141.76 12.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.497 -179.726 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' CD ' ' HA ' ' A' ' 66' ' ' ARG . 57.5 Cg_endo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 110.438 -0.639 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.86 -40.19 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -56.3 -44.32 79.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.159 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.82 -46.49 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 33' ' ' VAL . 86.6 mt -66.79 -38.94 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.355 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.28 -43.7 93.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.487 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.5 tt -63.71 -44.4 93.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.16 96.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.54 -46.83 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.364 -1.08 . . . . 0.0 110.316 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.12 -41.56 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.815 . . . . 0.0 110.729 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.04 99.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.5 tp -60.2 -41.19 92.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -1.233 . . . . 0.0 110.499 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 p -59.47 -48.84 80.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.816 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.86 65.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.099 -1.0 . . . . 0.0 110.347 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -107.19 105.71 15.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 110.601 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.09 37.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 110.725 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.4 145.14 16.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.22 173.03 5.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -1.116 . . . . 0.0 110.491 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 51' ' ' LEU . 25.7 tp -175.54 128.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.937 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.86 -175.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 25.3 p90 -109.16 130.6 55.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.212 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.5 m -95.91 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.269 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.597 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.626 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -138.78 112.21 8.26 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 110.661 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.14 62.82 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.972 1.512 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -30.79 70.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 43' ' ' LEU . 63.4 mt -67.1 -49.32 65.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.98 79.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 mm -65.76 -44.19 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.255 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -54.45 -45.27 73.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.468 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' A' ' 59' ' ' ILE . 39.9 mm -63.88 -43.96 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 0.0 110.385 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.37 -51.01 57.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 57' ' ' LEU . 4.5 mm? -63.24 -38.58 91.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -1.197 . . . . 0.0 110.37 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.1 m -64.95 -49.81 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.503 ' CD1' HG22 ' A' ' 55' ' ' ILE . 89.0 mt -67.3 -43.7 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.859 . . . . 0.0 111.013 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -60.41 -48.97 79.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.812 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.7 87.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.572 HG22 ' NE ' ' A' ' 66' ' ' ARG . 5.4 mm -64.22 -45.29 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -62.42 -42.07 99.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.088 -1.007 . . . . 0.0 110.275 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -66.46 -51.22 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.075 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -58.36 -49.99 75.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 110.077 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.572 ' NE ' HG22 ' A' ' 62' ' ' ILE . 63.1 mtm180 -57.59 -39.84 77.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.938 . . . . 0.0 109.782 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.65 157.04 31.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 110.48 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.484 0.951 0 N-CA-C 110.436 -0.64 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.27 -34.34 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.359 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.486 HD23 ' C ' ' A' ' 27' ' ' LEU . 9.8 tt -58.33 -37.65 75.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.872 . . . . 0.0 110.176 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.925 HG12 HD13 ' A' ' 62' ' ' ILE . 97.2 t -60.26 -43.64 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 110.402 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.9 mt -65.35 -38.12 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.356 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.532 HD23 ' C ' ' A' ' 30' ' ' LEU . 9.4 tt -60.69 -43.35 97.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.453 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.2 tt -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.425 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.24 95.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 29' ' ' ILE . 66.1 t -57.55 -45.13 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -1.112 . . . . 0.0 110.315 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.81 -39.47 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.437 -0.79 . . . . 0.0 110.788 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' HD23 ' A' ' 39' ' ' LEU . . . -58.85 -41.04 95.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 39' ' ' LEU . 26.7 tp -57.01 -37.17 71.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -1.214 . . . . 0.0 110.471 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 t -58.64 -49.6 76.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.22 64.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.093 -1.004 . . . . 0.0 110.367 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 36' ' ' LEU . 1.3 pp -107.6 103.07 12.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.564 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m -140.22 37.56 1.91 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.715 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.43 147.5 19.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 63.3 t80 -63.71 169.01 4.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.479 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 28.8 tp -174.26 128.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.959 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.29 179.95 0.89 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 16.3 p90 -99.23 127.15 45.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 110.199 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -93.15 -155.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.76 ' N ' HG13 ' A' ' 46' ' ' VAL . 4.4 mm? -61.72 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.298 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.544 ' H ' HG13 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -128.05 111.09 20.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.588 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 65.47 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.886 1.466 . . . . 0.0 110.168 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.58 -32.02 71.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 51' ' ' LEU . 8.8 tt -66.02 -50.18 65.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.8 80.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.294 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.65 -43.96 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -55.35 -46.56 76.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 110.485 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.47 HG22 ' CD1' ' A' ' 59' ' ' ILE . 41.0 mm -63.62 -44.7 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.955 . . . . 0.0 110.443 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.23 -50.96 57.33 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.31 -38.69 92.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -1.21 . . . . 0.0 110.451 177.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.9 m -64.82 -50.11 68.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.547 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' HG22 ' A' ' 55' ' ' ILE . 91.4 mt -67.35 -43.62 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.369 -0.832 . . . . 0.0 110.959 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.4 t80 -59.39 -48.88 79.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.934 -1.104 . . . . 0.0 109.871 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 111.088 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.925 HD13 HG12 ' A' ' 28' ' ' VAL . 3.3 mm -62.45 -45.36 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.815 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -59.35 -40.65 87.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 110.235 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.4 mtm180 -67.42 -49.93 61.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -51.37 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.621 ' CD ' HD11 ' A' ' 29' ' ' ILE . 68.0 mtm180 -58.69 -35.48 72.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -162.63 138.98 7.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.141 -0.974 . . . . 0.0 110.547 -179.718 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 58.1 Cg_endo . . . . . 0 N--CA 1.484 0.931 0 N-CA-C 110.47 -0.627 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 27' ' ' LEU . 11.4 m -69.81 -33.73 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.328 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -60.81 -34.88 75.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.205 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.12 -40.78 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 110.507 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 33' ' ' VAL . 93.7 mt -65.27 -38.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.255 -0.903 . . . . 0.0 110.297 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.78 -43.47 98.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.397 -0.814 . . . . 0.0 110.443 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.45 -42.46 98.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.89 96.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.9 t -58.59 -44.91 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.086 . . . . 0.0 110.324 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.01 -40.89 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.467 -0.771 . . . . 0.0 110.777 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.54 -40.0 95.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 36' ' ' LEU . 75.9 mt -60.49 -38.18 83.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.08 -1.247 . . . . 0.0 110.54 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 p -58.07 -47.21 83.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' C ' HD22 ' A' ' 39' ' ' LEU . . . -54.76 -33.17 60.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.411 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 38' ' ' ALA . 3.4 mm? -107.65 108.55 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 110.557 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.2 p -147.04 38.35 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.933 . . . . 0.0 110.696 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.97 -146.38 13.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.56 138.71 48.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -1.141 . . . . 0.0 110.521 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 tp -176.14 142.88 0.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -105.17 164.64 11.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.323 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.643 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 76.4 m-85 -57.84 140.55 51.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.196 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 47' ' ' LEU . 21.3 m -105.17 -135.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.569 ' N ' HG23 ' A' ' 46' ' ' VAL . 26.8 tp -60.08 -34.13 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.937 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' H ' HG23 ' A' ' 46' ' ' VAL . 13.1 tp -144.45 133.49 11.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.685 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.763 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.2 Cg_endo -76.77 55.01 4.71 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.863 1.454 . . . . 0.0 110.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.67 -42.9 65.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 51' ' ' LEU . 9.1 tt -67.49 -49.13 64.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.41 -44.3 76.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 53' ' ' ILE . 41.9 mm -65.17 -43.55 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -55.62 -46.1 77.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.3 mm -64.09 -44.12 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.38 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 -50.19 57.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.525 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.4 tt -64.02 -38.79 92.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.119 -1.224 . . . . 0.0 110.468 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -64.85 -50.25 67.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.93 -43.41 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.94 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.99 -48.43 81.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.842 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.97 89.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.016 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.41 -45.57 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.852 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -62.66 -39.85 95.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -65.41 -51.9 57.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 110.076 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -57.77 -48.02 80.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 mtp180 -59.81 -38.97 83.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.798 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 67.2 mt-30 -155.26 148.89 25.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -0.786 . . . . 0.0 109.842 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 110.514 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.483 0.884 0 N-CA-C 110.489 -0.62 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.0 p -61.85 -34.28 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.862 . . . . 0.0 110.299 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.49 -36.8 74.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HG23 ' A' ' 62' ' ' ILE . 94.2 t -61.07 -43.63 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.507 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.5 mt -65.72 -38.11 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.337 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.3 tt -63.33 -43.56 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -62.81 -43.31 99.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.1 t -57.5 -44.81 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.381 -1.07 . . . . 0.0 110.289 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.72 -40.18 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.734 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.66 97.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 -38.73 82.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.24 . . . . 0.0 110.528 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 40' ' ' THR . 18.4 t -59.05 -48.46 81.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.765 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.13 64.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.995 . . . . 0.0 110.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.2 mt -107.25 100.23 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.535 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' SER . 41.3 p -133.38 35.66 3.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 110.708 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -140.85 146.51 17.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.93 174.71 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -175.89 131.15 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.968 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.06 136.66 33.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -62.07 139.15 58.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 47' ' ' LEU . 16.0 m -100.49 -138.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.0 tp -65.27 -35.33 80.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.315 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -140.58 107.73 6.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.624 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.16 61.62 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.0 1.526 . . . . 0.0 110.12 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.03 70.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.191 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -66.3 -50.43 63.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -0.832 . . . . 0.0 110.242 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.08 76.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.18 -44.53 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.272 -0.892 . . . . 0.0 110.315 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -54.29 -44.43 71.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.514 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.67 -44.34 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.436 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.77 57.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.73 -38.01 89.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -1.192 . . . . 0.0 110.419 177.348 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.7 m -64.03 -50.29 69.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.57 -42.87 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.828 . . . . 0.0 110.959 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -59.28 -49.02 79.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 109.845 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.45 92.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 28' ' ' VAL . 68.3 mt -64.45 -45.96 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.823 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.09 -40.18 96.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.035 -1.041 . . . . 0.0 110.282 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.15 -51.9 53.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.091 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -57.37 -47.89 80.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HE ' HD11 ' A' ' 29' ' ' ILE . 67.7 mtp180 -57.84 -41.03 81.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.77 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -158.67 157.85 32.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 109.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 110.47 -179.824 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.484 0.94 0 N-CA-C 110.518 -0.608 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.454 HG23 ' N ' ' A' ' 27' ' ' LEU . 19.7 m -61.3 -34.6 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 110.315 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -57.81 -37.63 74.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.236 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.35 -43.79 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.477 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.691 ' O ' HG13 ' A' ' 33' ' ' VAL . 94.1 mt -65.67 -38.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.306 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 34' ' ' VAL . 26.0 tp -60.68 -42.25 96.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 110.408 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 tp -69.47 -45.76 68.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.75 -47.84 82.64 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 29' ' ' ILE . 34.2 m -59.42 -42.68 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -1.102 . . . . 0.0 110.346 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.579 ' N ' HG23 ' A' ' 33' ' ' VAL . 55.1 t -61.76 -40.06 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 0.0 110.742 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.06 94.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.13 -38.63 80.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.163 -1.198 . . . . 0.0 110.587 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.1 p -57.85 -47.91 81.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.77 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.55 -34.75 64.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.6 mt -107.58 104.19 13.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -140.91 37.6 1.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.678 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.54 146.07 17.22 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -65.55 172.06 3.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.528 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -173.81 127.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.28 -176.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.118 -0.989 . . . . 0.0 110.296 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 24.7 p90 -109.11 131.22 55.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.07 -145.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.213 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 48' ' ' LEU . 26.2 tp -57.89 -36.63 72.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 110.247 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.902 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -147.05 118.53 4.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.637 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.902 ' HD2' HD13 ' A' ' 48' ' ' LEU . 50.5 Cg_endo -71.19 64.64 2.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.199 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.36 69.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.146 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 3.2 mm? -67.2 -49.34 64.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.74 80.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.1 -43.83 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.285 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.84 -45.57 74.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.6 mm -63.71 -44.29 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.224 -0.923 . . . . 0.0 110.385 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.9 -50.7 57.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.31 -37.85 88.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -1.22 . . . . 0.0 110.36 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.3 m -64.61 -50.14 68.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.74 -42.76 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 0.0 110.941 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.78 -48.77 80.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.92 -1.113 . . . . 0.0 109.869 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.75 90.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.034 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.86 -45.39 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.03 -40.12 94.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.235 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -65.18 -51.6 60.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 110.112 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -57.59 -48.49 79.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -60.7 -36.29 78.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -157.44 141.8 16.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.483 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 110.482 -0.622 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -65.69 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.357 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -59.14 -37.38 77.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 110.247 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.612 HG12 HG23 ' A' ' 62' ' ' ILE . 94.5 t -59.96 -43.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' A' ' 62' ' ' ILE . 20.8 mm -65.85 -38.15 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.316 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.57 -43.32 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.37 -42.18 98.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.4 -38.79 96.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 29' ' ' ILE . 63.3 t -58.07 -44.73 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 110.379 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.8 -40.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.375 -0.828 . . . . 0.0 110.74 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.59 -40.22 96.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.03 -37.97 81.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -1.201 . . . . 0.0 110.53 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -57.6 -47.53 81.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 110.761 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.54 60.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 110.364 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.704 HD13 HD11 ' A' ' 51' ' ' LEU . 57.5 mt -108.12 107.08 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 t -143.74 37.68 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.05 146.32 17.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.54 169.17 5.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.137 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -175.41 130.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -68.66 -175.98 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.327 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -104.07 128.41 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.158 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.745 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -92.36 -155.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.176 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.745 ' N ' HG13 ' A' ' 46' ' ' VAL . 27.4 tp -61.29 -44.0 97.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.306 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.535 ' H ' HG13 ' A' ' 46' ' ' VAL . 7.1 tp -129.89 110.33 17.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.672 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.18 65.26 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.936 1.493 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.92 -31.93 73.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.298 -0.877 . . . . 0.0 110.148 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.704 HD11 HD13 ' A' ' 39' ' ' LEU . 31.9 tp -66.11 -50.28 64.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.87 84.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.34 -44.79 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.288 -0.883 . . . . 0.0 110.303 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.88 -45.27 74.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.503 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.7 -44.85 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.168 -0.958 . . . . 0.0 110.375 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.41 -50.59 59.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.65 -38.06 89.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.081 -1.246 . . . . 0.0 110.451 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -64.74 -50.05 68.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.505 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.457 HG22 ' OE1' ' A' ' 63' ' ' GLN . 86.8 mt -67.01 -43.45 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.961 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.87 -48.86 79.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.823 -1.173 . . . . 0.0 109.84 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.54 92.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 111.046 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.683 ' CG2' HD13 ' A' ' 29' ' ' ILE . 71.2 mt -63.5 -45.58 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.871 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.457 ' OE1' HG22 ' A' ' 59' ' ' ILE . 44.4 mt-30 -63.15 -42.34 99.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 110.25 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -65.98 -51.55 57.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.054 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -57.87 -48.92 78.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' A' ' 29' ' ' ILE . 61.2 ttp180 -56.06 -40.51 73.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -158.39 152.3 23.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.448 -179.856 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.764 ' O ' HG22 ' A' ' 28' ' ' VAL . 57.2 Cg_endo . . . . . 0 N--CA 1.483 0.894 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.62 -31.46 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.386 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.2 -34.04 69.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.0 m -58.24 -33.82 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.399 -0.813 . . . . 0.0 110.525 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 33' ' ' VAL . 40.7 mm -64.39 -38.24 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.7 tp -61.86 -43.18 99.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.471 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.24 -43.11 98.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.336 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.71 -38.37 95.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 29' ' ' ILE . 65.7 t -57.49 -44.99 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.1 . . . . 0.0 110.276 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.73 -40.43 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.696 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.82 98.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.67 -38.68 82.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.199 -1.177 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 40' ' ' THR . 17.4 t -58.3 -48.08 81.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.763 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.42 64.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.112 -0.993 . . . . 0.0 110.387 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 51' ' ' LEU . 23.3 tp -106.77 100.43 9.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' SER . 41.0 p -132.52 35.2 3.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.665 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.1 144.06 15.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -62.8 173.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -1.131 . . . . 0.0 110.472 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.2 tp -173.69 130.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 109.952 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -72.58 -177.63 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.357 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 20.8 p90 -102.2 129.54 48.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.205 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.35 -143.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.1 tt -57.9 -35.9 71.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.269 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 121.67 3.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.601 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 50.8 Cg_endo -71.64 65.69 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.893 1.47 . . . . 0.0 110.084 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.39 66.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.188 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 39' ' ' LEU . 27.5 tp -67.65 -49.55 62.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.321 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.73 -44.1 77.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.1 mm -65.62 -44.52 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -54.44 -45.4 73.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.443 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.44 -44.2 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.447 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.26 -49.96 57.9 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.25 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.333 177.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' HD13 ' A' ' 62' ' ' ILE . 87.3 m -64.71 -50.24 67.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.462 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.84 -43.85 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 0.0 110.875 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.48 -49.48 77.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.868 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.92 87.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 111.047 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 58' ' ' THR . 1.1 mp -64.46 -45.63 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.87 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.472 ' N ' HG22 ' A' ' 62' ' ' ILE . 49.3 tt0 -62.12 -40.48 96.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 0.0 110.294 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -66.05 -51.61 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -56.59 -47.94 78.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HD3' HD11 ' A' ' 29' ' ' ILE . 65.2 mtm180 -62.19 -35.77 79.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 109.754 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -160.43 134.59 7.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.837 . . . . 0.0 109.815 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.516 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.484 0.917 0 N-CA-C 110.409 -0.65 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 6.4 p -67.97 -33.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 28.0 tp -60.29 -34.67 74.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 65' ' ' LYS . 78.0 t -59.84 -40.99 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 110.496 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.0 mt -64.59 -37.07 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.374 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 110.412 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.26 -43.47 97.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -64.41 -38.67 96.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 29' ' ' ILE . 59.6 t -57.7 -45.42 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -1.138 . . . . 0.0 110.317 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.98 -41.48 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 0.0 110.68 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.86 -40.66 98.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.6 mp -60.29 -41.52 93.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.102 -1.234 . . . . 0.0 110.572 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 40' ' ' THR . 19.8 t -59.12 -48.72 80.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.13 62.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.352 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.22 101.7 10.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 37' ' ' SER . 35.8 p -135.57 36.08 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.671 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.26 147.73 19.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.85 174.89 3.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.123 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 tp -175.33 129.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.57 131.89 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -60.98 141.41 57.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -0.969 . . . . 0.0 110.133 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 47' ' ' LEU . 19.1 m -103.45 -136.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.24 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.585 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.3 tt -62.67 -35.18 78.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 46' ' ' VAL . 4.5 tp -130.98 108.28 15.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.685 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 48' ' ' LEU . 49.6 Cg_endo -70.85 62.16 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.962 1.506 . . . . 0.0 110.126 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.25 -50.66 64.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.294 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.73 78.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 110.332 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.57 -44.56 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.311 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -54.98 -45.44 75.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.487 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.7 -44.93 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.07 -50.5 58.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.6 tt -63.56 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -1.201 . . . . 0.0 110.454 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.1 m -64.8 -50.13 67.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.51 -43.46 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 111.036 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 25.8 t80 -59.23 -48.56 81.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.969 -1.082 . . . . 0.0 109.806 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.4 -39.8 84.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 111.077 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.94 -45.15 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.23 -40.93 95.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.02 -1.05 . . . . 0.0 110.241 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 55.8 mtp180 -66.34 -50.6 63.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 110.027 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.45 -50.16 73.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.139 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 98.9 mtt180 -61.88 -35.24 77.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.754 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.63 137.0 10.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 109.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 -179.725 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 110.514 -0.61 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.6 p -57.18 -35.31 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.362 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 26' ' ' VAL . 26.1 tp -57.07 -41.44 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' CG1' HG12 ' A' ' 62' ' ' ILE . 58.4 t -61.46 -45.37 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.469 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.762 ' O ' HG23 ' A' ' 33' ' ' VAL . 88.5 mt -66.64 -38.17 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.19 -43.97 96.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 110.465 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.13 -43.2 99.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.354 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.96 95.7 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.4 t -58.9 -45.59 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.267 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.15 -41.05 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.732 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.41 97.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.238 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 p -59.42 -48.01 83.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.191 -0.943 . . . . 0.0 110.686 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.47 -33.1 59.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 tp -107.54 108.51 19.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.603 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 40' ' ' THR . 9.9 t -147.05 38.45 0.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.731 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.05 -145.25 11.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -135.96 145.42 46.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.362 -1.081 . . . . 0.0 110.524 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 tp -176.62 144.71 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 109.979 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -106.69 161.94 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.32 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -60.13 138.69 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.19 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.74 -134.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.25 -33.02 73.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.284 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.87 140.5 16.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.681 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.8 Cg_endo -77.9 52.46 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.879 1.463 . . . . 0.0 110.107 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.77 63.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -49.26 62.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.29 -44.56 75.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.328 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 mm -65.25 -43.69 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.893 . . . . 0.0 110.269 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.49 -46.06 76.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.471 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.15 -44.02 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.15 -49.86 57.89 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.7 tt -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -1.214 . . . . 0.0 110.427 177.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 m -64.2 -50.11 69.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 62' ' ' ILE . 88.4 mt -67.4 -42.27 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.6 -48.54 80.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.976 -1.077 . . . . 0.0 109.823 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.91 85.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.988 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 59' ' ' ILE . 78.9 mt -63.65 -45.24 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.85 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.96 -39.46 89.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.211 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -65.96 -51.25 60.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 110.075 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -57.98 -49.41 76.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.043 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 39.7 ttm180 -57.93 -39.95 79.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 76.6 mt-30 -155.55 150.01 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.356 -0.84 . . . . 0.0 109.85 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 110.405 -179.825 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -22.25 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.955 1.503 . . . . 0.0 110.503 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.63 -34.63 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.345 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.81 -36.79 75.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 110.273 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.559 HG12 HG23 ' A' ' 62' ' ' ILE . 70.7 t -59.78 -42.72 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.447 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 ' CD ' ' A' ' 66' ' ' ARG . 97.1 mt -65.3 -37.65 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.345 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 HD22 ' A' ' 27' ' ' LEU . 79.1 mt -61.82 -43.53 98.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 0.0 110.426 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.1 -42.96 99.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.46 95.68 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.6 t -58.38 -45.29 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -1.108 . . . . 0.0 110.34 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.09 -40.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.55 -40.58 96.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -59.72 -38.54 81.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.238 . . . . 0.0 110.521 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 t -58.13 -47.93 81.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.9 61.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 110.314 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 51' ' ' LEU . 25.0 tp -108.13 106.71 17.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 t -142.46 37.37 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.16 143.77 15.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.61 173.92 3.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -1.154 . . . . 0.0 110.469 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -174.98 129.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.87 . . . . 0.0 109.97 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.08 -178.21 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.929 . . . . 0.0 110.314 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.52 127.09 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.12 -145.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 4.5 mm? -57.95 -38.0 75.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.892 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 120.56 3.36 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.22 65.02 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.869 1.457 . . . . 0.0 110.137 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.06 -32.3 67.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 39' ' ' LEU . 28.8 tp -67.2 -49.38 64.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.0 77.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.305 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.41 -44.07 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 110.348 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.61 -45.47 73.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.485 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.82 -43.74 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 110.425 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.85 -50.52 57.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.553 ' O ' HD13 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -63.05 -37.66 88.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.4 m -64.87 -49.83 68.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.48 -42.79 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.869 . . . . 0.0 110.969 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -60.1 -49.1 78.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.91 -1.119 . . . . 0.0 109.856 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.24 93.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 111.019 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 28' ' ' VAL . 79.5 mt -63.99 -45.31 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.881 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.78 -51.68 57.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.074 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 28' ' ' VAL . 27.7 mmtp -57.17 -47.99 79.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.867 ' CD ' HD11 ' A' ' 29' ' ' ILE . 16.9 ttp180 -56.1 -39.79 72.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 109.812 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.37 145.81 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.03 33.3 5.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 110.463 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t0 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.181 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.41 -21.45 35.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.432 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.8 p -64.87 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 110.399 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 26' ' ' VAL . 27.0 tp -58.79 -37.04 75.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.86 -43.22 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.474 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.9 mt -65.97 -38.27 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 3.1 mm? -63.39 -43.77 96.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 110.478 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -63.4 -43.29 97.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.05 -38.96 96.02 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.41 -45.72 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -1.06 . . . . 0.0 110.327 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.54 -40.94 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 110.658 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.26 97.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.0 tp -60.04 -38.55 83.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -1.223 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -58.34 -47.92 82.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.168 -0.957 . . . . 0.0 110.736 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.19 64.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.103 -0.998 . . . . 0.0 110.355 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.74 107.56 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.7 p -147.94 38.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.674 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 -147.69 18.31 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -132.69 140.93 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -1.099 . . . . 0.0 110.487 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.3 tt -163.61 133.96 4.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.017 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.638 ' O ' HD23 ' A' ' 43' ' ' LEU . 87.6 m-20 -78.05 -167.27 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.579 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.8 p90 -85.02 124.31 31.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.134 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.2 m -103.87 -147.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 46' ' ' VAL . 28.6 tp -54.11 -39.97 66.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -161.04 137.08 6.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.675 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.741 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.3 Cg_endo -72.92 67.43 3.99 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.912 1.48 . . . . 0.0 110.159 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -38.49 65.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.128 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -49.9 61.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.274 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.87 -44.25 77.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.2 -44.35 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -54.17 -44.86 71.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 110.452 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.26 -44.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.166 -0.959 . . . . 0.0 110.406 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -54.16 -50.49 55.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.517 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.2 tt -62.79 -36.68 83.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 110.453 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.9 m -64.77 -49.83 69.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -66.05 -42.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 111.008 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 6.5 m-85 -59.73 -49.56 77.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 0.0 109.859 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB1' ' NZ ' ' A' ' 65' ' ' LYS . . . -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.931 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 29' ' ' ILE . 80.9 mt -63.33 -46.09 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.66 -39.74 89.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.65 -51.42 56.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' NZ ' ' HB1' ' A' ' 61' ' ' ALA . 24.1 mttp -57.48 -49.48 76.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.104 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.43 -38.98 78.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.96 149.76 23.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.41 173.51 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.474 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.192 -0.942 . . . . 0.0 110.15 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.606 HG22 ' HB2' ' A' ' 27' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.68 -49.32 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 110.432 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.79 -33.12 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -57.29 -38.22 73.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 62' ' ' ILE . 74.4 t -61.53 -44.03 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.422 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.793 ' O ' HG23 ' A' ' 33' ' ' VAL . 94.7 mt -66.28 -37.97 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.364 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.6 tt -63.21 -43.4 98.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.467 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.6 tt -62.87 -43.56 98.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -38.3 95.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.5 t -58.19 -45.81 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -1.067 . . . . 0.0 110.297 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.6 t -59.77 -40.44 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -0.808 . . . . 0.0 110.705 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.02 98.21 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.58 -38.98 82.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.093 -1.239 . . . . 0.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.4 t -59.07 -48.85 80.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.773 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.78 64.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.405 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -107.84 102.43 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.0 p -137.73 36.47 2.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.643 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.78 148.09 19.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.43 170.27 3.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.1 tp -174.73 129.96 0.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.973 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.96 -178.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 19.6 p90 -100.99 127.2 47.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.764 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.1 p -91.98 -157.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.764 ' N ' HG13 ' A' ' 46' ' ' VAL . 80.2 mt -61.36 -44.61 96.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.349 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -128.06 110.79 20.01 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.668 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 48' ' ' LEU . 45.8 Cg_endo -70.4 65.27 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.924 1.486 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.86 71.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.216 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.14 -50.02 65.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.62 80.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 0.0 110.327 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.2 -44.07 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -54.81 -46.09 74.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -63.55 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.359 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.95 -50.71 57.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.84 -38.0 89.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.411 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.1 m -64.97 -50.02 68.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 110.521 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' HD12 ' A' ' 62' ' ' ILE . 39.6 mm -66.63 -42.71 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.975 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 66.3 t80 -59.18 -48.55 81.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.908 -1.12 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.82 -39.72 78.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.337 -0.852 . . . . 0.0 110.983 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 HG12 ' A' ' 28' ' ' VAL . 76.8 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -58.38 -39.57 79.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 110.334 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 77.8 mtp180 -66.44 -49.19 67.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -56.88 -51.06 70.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.079 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.494 HH21 HG21 ' A' ' 62' ' ' ILE . 86.3 mtt180 -55.79 -35.28 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -172.73 138.28 0.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.827 . . . . 0.0 109.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.71 131.08 37.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 110.553 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.867 . . . . 0.0 110.13 179.836 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.787 ' O ' HG22 ' A' ' 28' ' ' VAL . 40.0 Cg_endo -69.66 -26.97 27.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.951 1.501 . . . . 0.0 110.507 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.55 -30.04 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.92 -35.85 67.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.193 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.4 m -58.92 -35.37 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.438 -0.788 . . . . 0.0 110.489 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.6 mt -65.28 -37.71 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.352 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.82 -43.71 98.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.06 -43.23 96.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.42 96.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.5 t -58.4 -45.43 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -1.111 . . . . 0.0 110.33 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.53 -40.83 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.8 . . . . 0.0 110.698 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.0 97.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.15 -37.7 80.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.276 . . . . 0.0 110.536 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 t -57.93 -47.5 82.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.727 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.56 61.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.515 ' C ' HD23 ' A' ' 39' ' ' LEU . 8.9 tt -107.47 110.95 23.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.565 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -148.86 38.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.705 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.74 -148.42 20.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.97 142.71 47.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.9 tt -162.0 132.57 4.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.001 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.772 ' O ' HD23 ' A' ' 43' ' ' LEU . 6.2 t0 -80.55 -164.26 0.68 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 110.331 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 14.3 p90 -91.96 122.96 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.8 m -102.69 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.3 tp -54.73 -39.07 67.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 110.318 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -157.76 136.36 7.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.655 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.7 Cg_endo -73.06 63.61 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.962 1.506 . . . . 0.0 110.127 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.51 66.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -49.71 62.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.82 -43.86 77.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -65.05 -43.97 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -54.54 -44.76 73.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' CD1' ' A' ' 59' ' ' ILE . 37.5 mm -64.28 -43.76 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.452 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' TYR . . . -54.55 -50.23 57.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.504 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.3 tt -63.94 -38.36 90.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.255 . . . . 0.0 110.416 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -64.63 -50.1 68.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 55' ' ' ILE . 86.7 mt -67.5 -43.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.849 . . . . 0.0 110.958 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 5.6 m-85 -60.2 -49.22 78.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.848 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.34 88.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.877 . . . . 0.0 111.039 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.05 -45.19 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.849 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -61.29 -39.19 89.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.037 -1.039 . . . . 0.0 110.289 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.6 mtp-105 -66.2 -51.33 58.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.059 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -57.35 -48.64 78.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.132 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.27 -40.35 74.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 109.815 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 pt20 -157.65 151.0 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.858 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' GLN . . . -175.88 150.34 1.0 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.503 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.149 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.36 84.98 1.47 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 0.0 110.517 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.1 p -60.09 -34.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.05 -37.83 75.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.23 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -60.9 -43.83 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 110.566 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 33' ' ' VAL . 90.5 mt -65.64 -38.37 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.323 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.41 -43.63 98.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 110.435 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.2 tt -63.32 -43.65 97.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.84 96.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' ILE . 58.8 t -58.02 -45.41 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 110.346 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.32 -40.76 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.852 . . . . 0.0 110.678 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.23 -41.22 98.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.9 -38.86 83.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.125 -1.221 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.2 m -58.78 -48.08 82.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.741 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -34.08 63.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.085 -1.01 . . . . 0.0 110.381 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.47 103.65 13.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 p -139.73 36.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.182 -0.949 . . . . 0.0 110.644 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.25 145.81 17.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.96 170.27 3.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -1.138 . . . . 0.0 110.483 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 51' ' ' LEU . 26.8 tp -173.45 127.65 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 109.996 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -68.87 -178.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 21.3 p90 -104.21 129.42 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.609 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.8 m -98.14 -146.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.598 ' N ' HG23 ' A' ' 46' ' ' VAL . 74.9 mt -58.0 -35.0 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 110.324 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.609 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -145.88 119.13 5.24 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.648 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 48.1 Cg_endo -70.42 64.64 2.19 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.022 1.538 . . . . 0.0 110.153 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.08 -31.9 53.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.191 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 52' ' ' ALA . 2.3 pp -69.37 -46.24 67.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 51' ' ' LEU . . . -55.78 -45.09 78.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.368 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.16 -43.84 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.865 . . . . 0.0 110.344 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.27 -47.03 76.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.459 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.4 -44.42 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.361 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.21 -51.32 54.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.5 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.3 tt -62.17 -38.09 87.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.241 . . . . 0.0 110.452 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.7 m -65.05 -50.14 67.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.476 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.29 -43.07 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.955 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.3 t80 -59.64 -49.13 78.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.122 . . . . 0.0 109.811 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.77 80.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.991 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG2' ' NE ' ' A' ' 66' ' ' ARG . 78.9 mt -63.24 -44.81 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.25 -40.58 86.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.427 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.3 mtm180 -66.56 -49.57 65.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -51.93 67.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 110.057 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' CG2' ' A' ' 62' ' ' ILE . 96.7 mtt180 -55.81 -40.21 72.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.792 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 63.2 tt0 -162.15 165.66 26.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.89 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . 61.58 55.17 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.8 t0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.832 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 24' ' ' THR . 4.9 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.39 -12.91 32.51 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.996 1.524 . . . . 0.0 110.521 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.7 -36.24 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.3 tt -58.83 -37.23 75.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 62' ' ' ILE . 54.0 t -60.53 -43.29 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.6 mt -65.53 -38.35 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.4 tt -62.89 -43.73 98.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.476 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.63 -43.29 97.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.397 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -39.19 95.94 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 29' ' ' ILE . 56.8 t -58.55 -46.03 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.394 -1.062 . . . . 0.0 110.365 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.79 -41.06 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.384 -0.822 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.51 97.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.24 -38.55 83.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.239 . . . . 0.0 110.527 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 t -58.61 -47.89 82.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.768 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.25 -33.76 63.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.393 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.9 tp -106.43 109.98 22.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 39.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 110.716 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.0 -150.28 24.0 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.32 143.97 48.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -1.106 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.8 tp -167.14 137.47 3.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 109.953 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.23 -165.78 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.237 -0.915 . . . . 0.0 110.24 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 15.4 p90 -88.75 123.39 33.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.153 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.5 m -102.31 -146.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.176 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.62 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.8 tp -55.71 -38.7 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' H ' HG23 ' A' ' 46' ' ' VAL . 10.4 tp -154.97 136.27 9.16 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.634 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.842 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 54.6 Cg_endo -72.59 63.73 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.893 1.47 . . . . 0.0 110.168 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.77 68.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.0 -50.17 63.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.61 -43.75 76.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.1 mp -65.12 -44.33 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.38 -44.77 72.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.495 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.49 -43.92 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.42 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.94 -50.24 55.58 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.49 -37.07 85.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -1.207 . . . . 0.0 110.421 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -64.99 -49.85 68.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.09 -43.28 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.955 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 5.7 m-85 -59.96 -49.23 78.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.963 -1.085 . . . . 0.0 109.837 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.91 88.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.062 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.579 HD11 HG12 ' A' ' 28' ' ' VAL . 1.9 mm -62.83 -46.12 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.857 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.47 -39.8 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.075 -1.015 . . . . 0.0 110.221 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -66.7 -51.35 57.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.065 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -57.27 -49.89 74.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HD2' HD11 ' A' ' 29' ' ' ILE . 82.6 mtp180 -57.63 -38.7 75.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.739 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -160.59 141.76 12.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.74 -69.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.497 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.131 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.595 ' HD2' HG22 ' A' ' 24' ' ' THR . 57.5 Cg_endo -79.4 109.24 2.46 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 0.0 110.438 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.86 -40.19 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -56.3 -44.32 79.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.159 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.82 -46.49 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 33' ' ' VAL . 86.6 mt -66.79 -38.94 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.355 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.28 -43.7 93.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.487 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.5 tt -63.71 -44.4 93.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.16 96.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.54 -46.83 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.364 -1.08 . . . . 0.0 110.316 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.12 -41.56 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.815 . . . . 0.0 110.729 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.04 99.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.5 tp -60.2 -41.19 92.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -1.233 . . . . 0.0 110.499 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 p -59.47 -48.84 80.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.816 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.86 65.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.099 -1.0 . . . . 0.0 110.347 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -107.19 105.71 15.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 110.601 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.09 37.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 110.725 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.4 145.14 16.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.22 173.03 5.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -1.116 . . . . 0.0 110.491 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 51' ' ' LEU . 25.7 tp -175.54 128.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.937 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.86 -175.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 25.3 p90 -109.16 130.6 55.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.212 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.5 m -95.91 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.269 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.597 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.626 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -138.78 112.21 8.26 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 110.661 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.14 62.82 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.972 1.512 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -30.79 70.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 43' ' ' LEU . 63.4 mt -67.1 -49.32 65.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.98 79.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 mm -65.76 -44.19 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.255 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -54.45 -45.27 73.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.468 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' A' ' 59' ' ' ILE . 39.9 mm -63.88 -43.96 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 0.0 110.385 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.37 -51.01 57.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 57' ' ' LEU . 4.5 mm? -63.24 -38.58 91.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -1.197 . . . . 0.0 110.37 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.1 m -64.95 -49.81 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' CD1' HG22 ' A' ' 55' ' ' ILE . 89.0 mt -67.3 -43.7 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.859 . . . . 0.0 111.013 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -60.41 -48.97 79.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.812 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.7 87.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.572 HG22 ' NE ' ' A' ' 66' ' ' ARG . 5.4 mm -64.22 -45.29 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -62.42 -42.07 99.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.088 -1.007 . . . . 0.0 110.275 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -66.46 -51.22 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.075 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -58.36 -49.99 75.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 110.077 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.572 ' NE ' HG22 ' A' ' 62' ' ' ILE . 63.1 mtm180 -57.59 -39.84 77.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.938 . . . . 0.0 109.782 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.65 157.04 31.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 132.33 53.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 110.48 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 110.092 179.813 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.685 HG22 ' HB2' ' A' ' 27' ' ' LEU . 1.7 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.36 -33.9 8.38 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.956 1.503 . . . . 0.0 110.436 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.27 -34.34 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.359 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.685 ' HB2' HG22 ' A' ' 24' ' ' THR . 9.8 tt -58.33 -37.65 75.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.872 . . . . 0.0 110.176 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.925 HG12 HD13 ' A' ' 62' ' ' ILE . 97.2 t -60.26 -43.64 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 110.402 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.9 mt -65.35 -38.12 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.356 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.532 HD23 ' C ' ' A' ' 30' ' ' LEU . 9.4 tt -60.69 -43.35 97.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.453 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.2 tt -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.425 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.24 95.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 29' ' ' ILE . 66.1 t -57.55 -45.13 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -1.112 . . . . 0.0 110.315 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.81 -39.47 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.437 -0.79 . . . . 0.0 110.788 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' HD23 ' A' ' 39' ' ' LEU . . . -58.85 -41.04 95.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 39' ' ' LEU . 26.7 tp -57.01 -37.17 71.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -1.214 . . . . 0.0 110.471 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 t -58.64 -49.6 76.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.22 64.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.093 -1.004 . . . . 0.0 110.367 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 36' ' ' LEU . 1.3 pp -107.6 103.07 12.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.564 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m -140.22 37.56 1.91 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.715 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.43 147.5 19.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 63.3 t80 -63.71 169.01 4.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.479 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 28.8 tp -174.26 128.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.959 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.29 179.95 0.89 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 16.3 p90 -99.23 127.15 45.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 110.199 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -93.15 -155.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.76 ' N ' HG13 ' A' ' 46' ' ' VAL . 4.4 mm? -61.72 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.298 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.544 ' H ' HG13 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -128.05 111.09 20.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.588 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 65.47 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.886 1.466 . . . . 0.0 110.168 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.58 -32.02 71.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 51' ' ' LEU . 8.8 tt -66.02 -50.18 65.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.8 80.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.294 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.65 -43.96 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -55.35 -46.56 76.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 110.485 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.47 HG22 ' CD1' ' A' ' 59' ' ' ILE . 41.0 mm -63.62 -44.7 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.955 . . . . 0.0 110.443 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.23 -50.96 57.33 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.31 -38.69 92.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -1.21 . . . . 0.0 110.451 177.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.9 m -64.82 -50.11 68.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.547 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' HG22 ' A' ' 55' ' ' ILE . 91.4 mt -67.35 -43.62 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.369 -0.832 . . . . 0.0 110.959 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.4 t80 -59.39 -48.88 79.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.934 -1.104 . . . . 0.0 109.871 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 111.088 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.925 HD13 HG12 ' A' ' 28' ' ' VAL . 3.3 mm -62.45 -45.36 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.815 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -59.35 -40.65 87.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 110.235 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.4 mtm180 -67.42 -49.93 61.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -51.37 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.621 ' CD ' HD11 ' A' ' 29' ' ' ILE . 68.0 mtm180 -58.69 -35.48 72.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -162.63 138.98 7.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.65 141.14 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.141 -0.974 . . . . 0.0 110.547 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.643 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 58.1 Cg_endo -78.25 63.62 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.94 1.495 . . . . 0.0 110.47 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 27' ' ' LEU . 11.4 m -69.81 -33.73 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.328 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.1 OUTLIER -60.81 -34.88 75.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.205 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.12 -40.78 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 110.507 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 33' ' ' VAL . 93.7 mt -65.27 -38.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.255 -0.903 . . . . 0.0 110.297 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.78 -43.47 98.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.397 -0.814 . . . . 0.0 110.443 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.45 -42.46 98.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.89 96.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.9 t -58.59 -44.91 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.086 . . . . 0.0 110.324 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.01 -40.89 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.467 -0.771 . . . . 0.0 110.777 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.54 -40.0 95.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 36' ' ' LEU . 75.9 mt -60.49 -38.18 83.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.08 -1.247 . . . . 0.0 110.54 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 p -58.07 -47.21 83.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' C ' HD22 ' A' ' 39' ' ' LEU . . . -54.76 -33.17 60.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.411 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 38' ' ' ALA . 3.4 mm? -107.65 108.55 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 110.557 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.2 p -147.04 38.35 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.933 . . . . 0.0 110.696 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.97 -146.38 13.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.56 138.71 48.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -1.141 . . . . 0.0 110.521 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 tp -176.14 142.88 0.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -105.17 164.64 11.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.323 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.643 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 76.4 m-85 -57.84 140.55 51.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.196 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 47' ' ' LEU . 21.3 m -105.17 -135.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.569 ' N ' HG23 ' A' ' 46' ' ' VAL . 26.8 tp -60.08 -34.13 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.937 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' H ' HG23 ' A' ' 46' ' ' VAL . 13.1 tp -144.45 133.49 11.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.685 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.763 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.2 Cg_endo -76.77 55.01 4.71 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.863 1.454 . . . . 0.0 110.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.67 -42.9 65.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.483 ' C ' HD23 ' A' ' 51' ' ' LEU . 9.1 tt -67.49 -49.13 64.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.41 -44.3 76.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 53' ' ' ILE . 41.9 mm -65.17 -43.55 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -55.62 -46.1 77.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.3 mm -64.09 -44.12 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.38 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 -50.19 57.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.525 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.4 tt -64.02 -38.79 92.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.119 -1.224 . . . . 0.0 110.468 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -64.85 -50.25 67.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.93 -43.41 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.94 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.99 -48.43 81.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.842 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.97 89.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.016 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.41 -45.57 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.852 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -62.66 -39.85 95.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -65.41 -51.9 57.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 110.076 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -57.77 -48.02 80.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 mtp180 -59.81 -38.97 83.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.798 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 67.2 mt-30 -155.26 148.89 25.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -0.786 . . . . 0.0 109.842 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.83 -164.62 0.23 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 110.514 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.1 t0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.2 -25.47 37.0 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.973 1.512 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.0 p -61.85 -34.28 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.862 . . . . 0.0 110.299 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.543 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.49 -36.8 74.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HG23 ' A' ' 62' ' ' ILE . 94.2 t -61.07 -43.63 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.507 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.5 mt -65.72 -38.11 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.337 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.3 tt -63.33 -43.56 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -62.81 -43.31 99.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.1 t -57.5 -44.81 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.381 -1.07 . . . . 0.0 110.289 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.72 -40.18 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.734 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.66 97.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 -38.73 82.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.24 . . . . 0.0 110.528 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 40' ' ' THR . 18.4 t -59.05 -48.46 81.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.765 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.13 64.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.995 . . . . 0.0 110.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.2 mt -107.25 100.23 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.535 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' SER . 41.3 p -133.38 35.66 3.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 110.708 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -140.85 146.51 17.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.93 174.71 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -175.89 131.15 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.968 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.06 136.66 33.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -62.07 139.15 58.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 47' ' ' LEU . 16.0 m -100.49 -138.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.0 tp -65.27 -35.33 80.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.315 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -140.58 107.73 6.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.624 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.16 61.62 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.0 1.526 . . . . 0.0 110.12 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.03 70.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.191 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -66.3 -50.43 63.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -0.832 . . . . 0.0 110.242 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.08 76.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.18 -44.53 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.272 -0.892 . . . . 0.0 110.315 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -54.29 -44.43 71.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.514 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.67 -44.34 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.436 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.77 57.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.427 ' O ' HD13 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.73 -38.01 89.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -1.192 . . . . 0.0 110.419 177.348 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.7 m -64.03 -50.29 69.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.57 -42.87 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.828 . . . . 0.0 110.959 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -59.28 -49.02 79.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 109.845 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.45 92.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 28' ' ' VAL . 68.3 mt -64.45 -45.96 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.823 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.09 -40.18 96.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.035 -1.041 . . . . 0.0 110.282 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.15 -51.9 53.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.091 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -57.37 -47.89 80.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HE ' HD11 ' A' ' 29' ' ' ILE . 67.7 mtp180 -57.84 -41.03 81.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.77 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -158.67 157.85 32.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 109.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.34 -158.83 0.36 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 110.47 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.77 -37.47 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.008 1.53 . . . . 0.0 110.518 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.454 HG23 ' N ' ' A' ' 27' ' ' LEU . 19.7 m -61.3 -34.6 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 110.315 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.706 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -57.81 -37.63 74.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.236 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.35 -43.79 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.477 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.691 ' O ' HG13 ' A' ' 33' ' ' VAL . 94.1 mt -65.67 -38.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.306 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 34' ' ' VAL . 26.0 tp -60.68 -42.25 96.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 110.408 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 tp -69.47 -45.76 68.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.75 -47.84 82.64 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 29' ' ' ILE . 34.2 m -59.42 -42.68 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -1.102 . . . . 0.0 110.346 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.579 ' N ' HG23 ' A' ' 33' ' ' VAL . 55.1 t -61.76 -40.06 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 0.0 110.742 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.06 94.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.13 -38.63 80.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.163 -1.198 . . . . 0.0 110.587 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.1 p -57.85 -47.91 81.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.77 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.55 -34.75 64.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.6 mt -107.58 104.19 13.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -140.91 37.6 1.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.678 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.54 146.07 17.22 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -65.55 172.06 3.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.528 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -173.81 127.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.28 -176.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.118 -0.989 . . . . 0.0 110.296 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 24.7 p90 -109.11 131.22 55.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.07 -145.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.213 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 48' ' ' LEU . 26.2 tp -57.89 -36.63 72.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 110.247 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.902 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -147.05 118.53 4.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.637 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.902 ' HD2' HD13 ' A' ' 48' ' ' LEU . 50.5 Cg_endo -71.19 64.64 2.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.199 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.36 69.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.146 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 3.2 mm? -67.2 -49.34 64.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.74 80.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.1 -43.83 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.285 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.84 -45.57 74.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.6 mm -63.71 -44.29 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.224 -0.923 . . . . 0.0 110.385 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.9 -50.7 57.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.31 -37.85 88.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -1.22 . . . . 0.0 110.36 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.3 m -64.61 -50.14 68.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.74 -42.76 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 0.0 110.941 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.78 -48.77 80.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.92 -1.113 . . . . 0.0 109.869 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.75 90.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.034 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.86 -45.39 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.03 -40.12 94.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.235 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -65.18 -51.6 60.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 110.112 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -57.59 -48.49 79.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -60.7 -36.29 78.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -157.44 141.8 16.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.56 138.99 39.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.198 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -66.81 -24.05 47.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.482 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -65.69 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.357 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.563 HD13 ' O ' ' A' ' 27' ' ' LEU . 0.2 OUTLIER -59.14 -37.38 77.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 110.247 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.612 HG12 HG23 ' A' ' 62' ' ' ILE . 94.5 t -59.96 -43.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' A' ' 62' ' ' ILE . 20.8 mm -65.85 -38.15 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.316 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.57 -43.32 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.37 -42.18 98.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.4 -38.79 96.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 29' ' ' ILE . 63.3 t -58.07 -44.73 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 110.379 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.8 -40.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.375 -0.828 . . . . 0.0 110.74 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.59 -40.22 96.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.03 -37.97 81.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -1.201 . . . . 0.0 110.53 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -57.6 -47.53 81.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 110.761 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.54 60.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 110.364 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.704 HD13 HD11 ' A' ' 51' ' ' LEU . 57.5 mt -108.12 107.08 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 t -143.74 37.68 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.05 146.32 17.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.54 169.17 5.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.137 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -175.41 130.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -68.66 -175.98 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.327 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -104.07 128.41 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.158 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.745 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -92.36 -155.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.176 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.745 ' N ' HG13 ' A' ' 46' ' ' VAL . 27.4 tp -61.29 -44.0 97.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.306 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.535 ' H ' HG13 ' A' ' 46' ' ' VAL . 7.1 tp -129.89 110.33 17.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.672 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.18 65.26 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.936 1.493 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.92 -31.93 73.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.298 -0.877 . . . . 0.0 110.148 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.704 HD11 HD13 ' A' ' 39' ' ' LEU . 31.9 tp -66.11 -50.28 64.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.87 84.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.34 -44.79 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.288 -0.883 . . . . 0.0 110.303 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.88 -45.27 74.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.503 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.7 -44.85 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.168 -0.958 . . . . 0.0 110.375 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.41 -50.59 59.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.65 -38.06 89.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.081 -1.246 . . . . 0.0 110.451 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -64.74 -50.05 68.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.505 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.457 HG22 ' OE1' ' A' ' 63' ' ' GLN . 86.8 mt -67.01 -43.45 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.961 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.87 -48.86 79.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.823 -1.173 . . . . 0.0 109.84 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.54 92.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 111.046 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.683 ' CG2' HD13 ' A' ' 29' ' ' ILE . 71.2 mt -63.5 -45.58 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.871 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.457 ' OE1' HG22 ' A' ' 59' ' ' ILE . 44.4 mt-30 -63.15 -42.34 99.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 110.25 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -65.98 -51.55 57.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.054 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -57.87 -48.92 78.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' A' ' 29' ' ' ILE . 61.2 ttp180 -56.06 -40.51 73.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -158.39 152.3 23.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.21 148.46 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.448 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 110.109 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.764 ' O ' HG22 ' A' ' 28' ' ' VAL . 57.2 Cg_endo -77.13 51.41 3.45 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.966 1.508 . . . . 0.0 110.533 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.62 -31.46 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.386 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.2 -34.04 69.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.0 m -58.24 -33.82 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.399 -0.813 . . . . 0.0 110.525 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 33' ' ' VAL . 40.7 mm -64.39 -38.24 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.7 tp -61.86 -43.18 99.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.471 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.457 HD13 ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.24 -43.11 98.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.336 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.71 -38.37 95.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 29' ' ' ILE . 65.7 t -57.49 -44.99 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.1 . . . . 0.0 110.276 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.73 -40.43 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.696 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.82 98.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.67 -38.68 82.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.199 -1.177 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 40' ' ' THR . 17.4 t -58.3 -48.08 81.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.763 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.42 64.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.112 -0.993 . . . . 0.0 110.387 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 51' ' ' LEU . 23.3 tp -106.77 100.43 9.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' SER . 41.0 p -132.52 35.2 3.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.665 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.1 144.06 15.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -62.8 173.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -1.131 . . . . 0.0 110.472 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.2 tp -173.69 130.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 109.952 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -72.58 -177.63 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.357 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 20.8 p90 -102.2 129.54 48.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.205 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.35 -143.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.1 tt -57.9 -35.9 71.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.269 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 121.67 3.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.601 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 50.8 Cg_endo -71.64 65.69 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.893 1.47 . . . . 0.0 110.084 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.39 66.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.188 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 39' ' ' LEU . 27.5 tp -67.65 -49.55 62.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.321 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.73 -44.1 77.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.1 mm -65.62 -44.52 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -54.44 -45.4 73.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.443 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.44 -44.2 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.447 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.26 -49.96 57.9 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.25 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.333 177.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' HD13 ' A' ' 62' ' ' ILE . 87.3 m -64.71 -50.24 67.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.462 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.84 -43.85 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 0.0 110.875 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.48 -49.48 77.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.868 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.92 87.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 111.047 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 58' ' ' THR . 1.1 mp -64.46 -45.63 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.87 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.472 ' N ' HG22 ' A' ' 62' ' ' ILE . 49.3 tt0 -62.12 -40.48 96.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 0.0 110.294 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -66.05 -51.61 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -56.59 -47.94 78.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HD3' HD11 ' A' ' 29' ' ' ILE . 65.2 mtm180 -62.19 -35.77 79.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 109.754 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -160.43 134.59 7.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.837 . . . . 0.0 109.815 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.19 134.7 2.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.516 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.874 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 24' ' ' THR . 1.5 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -84.89 63.03 6.28 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.008 1.531 . . . . 0.0 110.409 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 6.4 p -67.97 -33.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 28.0 tp -60.29 -34.67 74.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 65' ' ' LYS . 78.0 t -59.84 -40.99 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 110.496 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.0 mt -64.59 -37.07 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.374 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 110.412 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.26 -43.47 97.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -64.41 -38.67 96.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 29' ' ' ILE . 59.6 t -57.7 -45.42 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -1.138 . . . . 0.0 110.317 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.98 -41.48 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 0.0 110.68 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.86 -40.66 98.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.6 mp -60.29 -41.52 93.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.102 -1.234 . . . . 0.0 110.572 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 40' ' ' THR . 19.8 t -59.12 -48.72 80.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.13 62.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.352 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.22 101.7 10.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 37' ' ' SER . 35.8 p -135.57 36.08 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.671 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.26 147.73 19.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.85 174.89 3.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.123 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 tp -175.33 129.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.57 131.89 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -60.98 141.41 57.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -0.969 . . . . 0.0 110.133 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 47' ' ' LEU . 19.1 m -103.45 -136.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.24 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.585 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.3 tt -62.67 -35.18 78.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 46' ' ' VAL . 4.5 tp -130.98 108.28 15.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.685 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 48' ' ' LEU . 49.6 Cg_endo -70.85 62.16 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.962 1.506 . . . . 0.0 110.126 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.25 -50.66 64.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.294 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.73 78.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 110.332 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.57 -44.56 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.311 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -54.98 -45.44 75.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.487 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.7 -44.93 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.07 -50.5 58.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.6 tt -63.56 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -1.201 . . . . 0.0 110.454 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.1 m -64.8 -50.13 67.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.51 -43.46 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 111.036 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 25.8 t80 -59.23 -48.56 81.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.969 -1.082 . . . . 0.0 109.806 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.4 -39.8 84.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 111.077 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.94 -45.15 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.23 -40.93 95.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.02 -1.05 . . . . 0.0 110.241 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 55.8 mtp180 -66.34 -50.6 63.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 110.027 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.45 -50.16 73.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.139 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 98.9 mtt180 -61.88 -35.24 77.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.754 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.63 137.0 10.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 109.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.49 137.38 35.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.948 . . . . 0.0 110.147 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.23 66.49 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 0.0 110.514 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.6 p -57.18 -35.31 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.362 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 26' ' ' VAL . 26.1 tp -57.07 -41.44 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' CG1' HG12 ' A' ' 62' ' ' ILE . 58.4 t -61.46 -45.37 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.469 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.762 ' O ' HG23 ' A' ' 33' ' ' VAL . 88.5 mt -66.64 -38.17 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.19 -43.97 96.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 110.465 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.13 -43.2 99.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.354 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.96 95.7 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.4 t -58.9 -45.59 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.267 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.15 -41.05 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.732 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.41 97.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.238 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 p -59.42 -48.01 83.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.191 -0.943 . . . . 0.0 110.686 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.47 -33.1 59.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 tp -107.54 108.51 19.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.603 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 40' ' ' THR . 9.9 t -147.05 38.45 0.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.731 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.05 -145.25 11.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -135.96 145.42 46.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.362 -1.081 . . . . 0.0 110.524 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 tp -176.62 144.71 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 109.979 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -106.69 161.94 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.32 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -60.13 138.69 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.19 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.74 -134.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.25 -33.02 73.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.284 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.87 140.5 16.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.681 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.8 Cg_endo -77.9 52.46 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.879 1.463 . . . . 0.0 110.107 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.77 63.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -49.26 62.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.29 -44.56 75.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.328 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 mm -65.25 -43.69 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.893 . . . . 0.0 110.269 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.49 -46.06 76.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.471 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.15 -44.02 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.15 -49.86 57.89 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.499 ' C ' HD23 ' A' ' 57' ' ' LEU . 9.7 tt -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -1.214 . . . . 0.0 110.427 177.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 m -64.2 -50.11 69.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 62' ' ' ILE . 88.4 mt -67.4 -42.27 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.6 -48.54 80.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.976 -1.077 . . . . 0.0 109.823 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.91 85.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.988 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 59' ' ' ILE . 78.9 mt -63.65 -45.24 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.85 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.96 -39.46 89.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.211 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -65.96 -51.25 60.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 110.075 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -57.98 -49.41 76.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.043 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 39.7 ttm180 -57.93 -39.95 79.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 76.6 mt-30 -155.55 150.01 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.356 -0.84 . . . . 0.0 109.85 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.44 148.67 44.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 110.405 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.759 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.503 -0.614 . . . . 0.0 110.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.63 -34.63 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.345 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.81 -36.79 75.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 110.273 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.559 HG12 HG23 ' A' ' 62' ' ' ILE . 70.7 t -59.78 -42.72 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.447 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 ' CD ' ' A' ' 66' ' ' ARG . 97.1 mt -65.3 -37.65 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.345 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 HD22 ' A' ' 27' ' ' LEU . 79.1 mt -61.82 -43.53 98.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 0.0 110.426 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.1 -42.96 99.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.46 95.68 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.6 t -58.38 -45.29 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -1.108 . . . . 0.0 110.34 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.09 -40.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.55 -40.58 96.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -59.72 -38.54 81.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.238 . . . . 0.0 110.521 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 t -58.13 -47.93 81.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.9 61.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 110.314 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 51' ' ' LEU . 25.0 tp -108.13 106.71 17.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 t -142.46 37.37 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.16 143.77 15.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.61 173.92 3.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -1.154 . . . . 0.0 110.469 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -174.98 129.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.87 . . . . 0.0 109.97 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.08 -178.21 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.929 . . . . 0.0 110.314 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.52 127.09 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.12 -145.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 4.5 mm? -57.95 -38.0 75.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.892 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 120.56 3.36 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.22 65.02 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.869 1.457 . . . . 0.0 110.137 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.06 -32.3 67.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 39' ' ' LEU . 28.8 tp -67.2 -49.38 64.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.0 77.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.305 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.41 -44.07 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 110.348 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.61 -45.47 73.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.485 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.82 -43.74 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 110.425 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.85 -50.52 57.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -63.05 -37.66 88.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.4 m -64.87 -49.83 68.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.48 -42.79 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.869 . . . . 0.0 110.969 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -60.1 -49.1 78.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.91 -1.119 . . . . 0.0 109.856 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.24 93.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 111.019 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 28' ' ' VAL . 79.5 mt -63.99 -45.31 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.881 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.78 -51.68 57.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.074 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 28' ' ' VAL . 27.7 mmtp -57.17 -47.99 79.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.867 ' CD ' HD11 ' A' ' 29' ' ' ILE . 16.9 ttp180 -56.1 -39.79 72.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 109.812 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.37 145.81 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 110.463 -179.583 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo . . . . . 0 N--CA 1.484 0.968 0 N-CA-C 110.432 -0.642 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.8 p -64.87 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 110.399 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 26' ' ' VAL . 27.0 tp -58.79 -37.04 75.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.86 -43.22 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.474 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.9 mt -65.97 -38.27 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 3.1 mm? -63.39 -43.77 96.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 110.478 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -63.4 -43.29 97.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.05 -38.96 96.02 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.41 -45.72 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -1.06 . . . . 0.0 110.327 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.54 -40.94 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 110.658 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.26 97.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.0 tp -60.04 -38.55 83.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -1.223 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -58.34 -47.92 82.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.168 -0.957 . . . . 0.0 110.736 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.19 64.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.103 -0.998 . . . . 0.0 110.355 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.74 107.56 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.7 p -147.94 38.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.674 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 -147.69 18.31 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -132.69 140.93 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -1.099 . . . . 0.0 110.487 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.3 tt -163.61 133.96 4.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.017 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.638 ' O ' HD23 ' A' ' 43' ' ' LEU . 87.6 m-20 -78.05 -167.27 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.579 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.8 p90 -85.02 124.31 31.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.134 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.2 m -103.87 -147.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 46' ' ' VAL . 28.6 tp -54.11 -39.97 66.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.495 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -161.04 137.08 6.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.675 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.741 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.3 Cg_endo -72.92 67.43 3.99 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.912 1.48 . . . . 0.0 110.159 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -38.49 65.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.128 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -49.9 61.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.274 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.87 -44.25 77.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.2 -44.35 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -54.17 -44.86 71.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 110.452 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.26 -44.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.166 -0.959 . . . . 0.0 110.406 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -54.16 -50.49 55.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.2 tt -62.79 -36.68 83.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 110.453 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.9 m -64.77 -49.83 69.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -66.05 -42.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 111.008 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 6.5 m-85 -59.73 -49.56 77.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 0.0 109.859 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB1' ' NZ ' ' A' ' 65' ' ' LYS . . . -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.931 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 29' ' ' ILE . 80.9 mt -63.33 -46.09 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.66 -39.74 89.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.65 -51.42 56.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.556 ' NZ ' ' HB1' ' A' ' 61' ' ' ALA . 24.1 mttp -57.48 -49.48 76.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.104 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.43 -38.98 78.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.96 149.76 23.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.474 -179.83 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.483 0.878 0 N-CA-C 110.432 -0.641 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.79 -33.12 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -57.29 -38.22 73.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 62' ' ' ILE . 74.4 t -61.53 -44.03 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.422 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.793 ' O ' HG23 ' A' ' 33' ' ' VAL . 94.7 mt -66.28 -37.97 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.364 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.6 tt -63.21 -43.4 98.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.467 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.6 tt -62.87 -43.56 98.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -38.3 95.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.5 t -58.19 -45.81 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -1.067 . . . . 0.0 110.297 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.6 t -59.77 -40.44 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -0.808 . . . . 0.0 110.705 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.02 98.21 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.58 -38.98 82.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.093 -1.239 . . . . 0.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.4 t -59.07 -48.85 80.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.773 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.78 64.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.405 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -107.84 102.43 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.0 p -137.73 36.47 2.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.643 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.78 148.09 19.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.43 170.27 3.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.1 tp -174.73 129.96 0.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.973 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.96 -178.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 19.6 p90 -100.99 127.2 47.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.764 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.1 p -91.98 -157.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.764 ' N ' HG13 ' A' ' 46' ' ' VAL . 80.2 mt -61.36 -44.61 96.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.349 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -128.06 110.79 20.01 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.668 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 48' ' ' LEU . 45.8 Cg_endo -70.4 65.27 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.924 1.486 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.86 71.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.216 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.14 -50.02 65.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.62 80.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 0.0 110.327 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.2 -44.07 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -54.81 -46.09 74.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -63.55 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.359 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.95 -50.71 57.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.84 -38.0 89.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.411 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.1 m -64.97 -50.02 68.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 110.521 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' HD12 ' A' ' 62' ' ' ILE . 39.6 mm -66.63 -42.71 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.975 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 66.3 t80 -59.18 -48.55 81.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.908 -1.12 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.82 -39.72 78.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.337 -0.852 . . . . 0.0 110.983 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 HG12 ' A' ' 28' ' ' VAL . 76.8 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -58.38 -39.57 79.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 110.334 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 77.8 mtp180 -66.44 -49.19 67.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -56.88 -51.06 70.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.079 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.494 HH21 HG21 ' A' ' 62' ' ' ILE . 86.3 mtt180 -55.79 -35.28 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -172.73 138.28 0.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.827 . . . . 0.0 109.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 110.553 -179.782 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.787 ' O ' HG22 ' A' ' 28' ' ' VAL . 40.0 Cg_endo . . . . . 0 N--CA 1.483 0.909 0 N-CA-C 110.507 -0.613 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.55 -30.04 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.92 -35.85 67.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.193 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.4 m -58.92 -35.37 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.438 -0.788 . . . . 0.0 110.489 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.6 mt -65.28 -37.71 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.352 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.82 -43.71 98.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.06 -43.23 96.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.42 96.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.5 t -58.4 -45.43 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -1.111 . . . . 0.0 110.33 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.53 -40.83 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.8 . . . . 0.0 110.698 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.0 97.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.15 -37.7 80.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.276 . . . . 0.0 110.536 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 t -57.93 -47.5 82.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.727 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.56 61.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.515 HD23 ' C ' ' A' ' 39' ' ' LEU . 8.9 tt -107.47 110.95 23.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.565 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -148.86 38.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.705 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.74 -148.42 20.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.97 142.71 47.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.9 tt -162.0 132.57 4.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.001 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.772 ' O ' HD23 ' A' ' 43' ' ' LEU . 6.2 t0 -80.55 -164.26 0.68 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 110.331 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 14.3 p90 -91.96 122.96 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.8 m -102.69 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.3 tp -54.73 -39.07 67.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 110.318 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.489 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -157.76 136.36 7.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.655 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.7 Cg_endo -73.06 63.61 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.962 1.506 . . . . 0.0 110.127 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.51 66.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -49.71 62.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.82 -43.86 77.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -65.05 -43.97 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -54.54 -44.76 73.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' CD1' ' A' ' 59' ' ' ILE . 37.5 mm -64.28 -43.76 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.452 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' TYR . . . -54.55 -50.23 57.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.3 tt -63.94 -38.36 90.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.255 . . . . 0.0 110.416 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -64.63 -50.1 68.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 55' ' ' ILE . 86.7 mt -67.5 -43.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.849 . . . . 0.0 110.958 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 5.6 m-85 -60.2 -49.22 78.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.848 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.34 88.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.877 . . . . 0.0 111.039 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.05 -45.19 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.849 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -61.29 -39.19 89.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.037 -1.039 . . . . 0.0 110.289 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.6 mtp-105 -66.2 -51.33 58.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.059 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -57.35 -48.64 78.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.132 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.27 -40.35 74.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 109.815 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 pt20 -157.65 151.0 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.858 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.503 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo . . . . . 0 N--CA 1.483 0.881 0 N-CA-C 110.517 -0.609 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.1 p -60.09 -34.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.607 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.05 -37.83 75.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.23 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -60.9 -43.83 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 110.566 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 33' ' ' VAL . 90.5 mt -65.64 -38.37 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.323 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.41 -43.63 98.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 110.435 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.2 tt -63.32 -43.65 97.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.84 96.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' ILE . 58.8 t -58.02 -45.41 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 110.346 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.32 -40.76 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.852 . . . . 0.0 110.678 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.23 -41.22 98.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.9 -38.86 83.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.125 -1.221 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.2 m -58.78 -48.08 82.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.741 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -34.08 63.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.085 -1.01 . . . . 0.0 110.381 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.47 103.65 13.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 p -139.73 36.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.182 -0.949 . . . . 0.0 110.644 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.25 145.81 17.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.96 170.27 3.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -1.138 . . . . 0.0 110.483 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 51' ' ' LEU . 26.8 tp -173.45 127.65 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 109.996 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -68.87 -178.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 21.3 p90 -104.21 129.42 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.609 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.8 m -98.14 -146.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.598 ' N ' HG23 ' A' ' 46' ' ' VAL . 74.9 mt -58.0 -35.0 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 110.324 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.609 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -145.88 119.13 5.24 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.648 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 48.1 Cg_endo -70.42 64.64 2.19 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.022 1.538 . . . . 0.0 110.153 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.08 -31.9 53.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.191 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 52' ' ' ALA . 2.3 pp -69.37 -46.24 67.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 51' ' ' LEU . . . -55.78 -45.09 78.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.368 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.16 -43.84 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.865 . . . . 0.0 110.344 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.27 -47.03 76.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.459 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.4 -44.42 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.361 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.21 -51.32 54.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.3 tt -62.17 -38.09 87.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.241 . . . . 0.0 110.452 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.7 m -65.05 -50.14 67.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.476 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.29 -43.07 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.955 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.3 t80 -59.64 -49.13 78.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.122 . . . . 0.0 109.811 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.77 80.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.991 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG2' ' NE ' ' A' ' 66' ' ' ARG . 78.9 mt -63.24 -44.81 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.25 -40.58 86.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.427 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.3 mtm180 -66.56 -49.57 65.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -51.93 67.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 110.057 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' CG2' ' A' ' 62' ' ' ILE . 96.7 mtt180 -55.81 -40.21 72.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.792 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 63.2 tt0 -162.15 165.66 26.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.89 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo . . . . . 0 N--CA 1.483 0.883 0 N-CA-C 110.521 -0.607 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.7 -36.24 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 27' ' ' LEU . 9.3 tt -58.83 -37.23 75.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 62' ' ' ILE . 54.0 t -60.53 -43.29 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.6 mt -65.53 -38.35 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.4 tt -62.89 -43.73 98.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.476 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.63 -43.29 97.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.397 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -39.19 95.94 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 29' ' ' ILE . 56.8 t -58.55 -46.03 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.394 -1.062 . . . . 0.0 110.365 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.79 -41.06 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.384 -0.822 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.51 97.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.24 -38.55 83.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.239 . . . . 0.0 110.527 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 t -58.61 -47.89 82.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.768 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.25 -33.76 63.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.393 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.9 tp -106.43 109.98 22.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 39.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 110.716 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.0 -150.28 24.0 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.32 143.97 48.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -1.106 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.8 tp -167.14 137.47 3.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 109.953 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.23 -165.78 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.237 -0.915 . . . . 0.0 110.24 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 15.4 p90 -88.75 123.39 33.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.153 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.5 m -102.31 -146.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.176 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.8 tp -55.71 -38.7 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.5 ' H ' HG23 ' A' ' 46' ' ' VAL . 10.4 tp -154.97 136.27 9.16 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.634 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.842 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 54.6 Cg_endo -72.59 63.73 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.893 1.47 . . . . 0.0 110.168 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.77 68.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.0 -50.17 63.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.61 -43.75 76.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.1 mp -65.12 -44.33 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.38 -44.77 72.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.495 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.49 -43.92 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.42 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.94 -50.24 55.58 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.49 -37.07 85.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -1.207 . . . . 0.0 110.421 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -64.99 -49.85 68.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.09 -43.28 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.955 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 5.7 m-85 -59.96 -49.23 78.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.963 -1.085 . . . . 0.0 109.837 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.91 88.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.062 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.579 HD11 HG12 ' A' ' 28' ' ' VAL . 1.9 mm -62.83 -46.12 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.857 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.47 -39.8 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.075 -1.015 . . . . 0.0 110.221 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -66.7 -51.35 57.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.065 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -57.27 -49.89 74.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HD2' HD11 ' A' ' 29' ' ' ILE . 82.6 mtp180 -57.63 -38.7 75.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.739 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -160.59 141.76 12.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.497 -179.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.42 ' CD ' ' HA ' ' A' ' 66' ' ' ARG . 57.5 Cg_endo . . . . . 0 N--CA 1.485 0.976 0 N-CA-C 110.438 -0.639 . . . . 0.0 110.438 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.86 -40.19 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -56.3 -44.32 79.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.159 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.82 -46.49 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 33' ' ' VAL . 86.6 mt -66.79 -38.94 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.355 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.28 -43.7 93.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.487 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.521 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.5 tt -63.71 -44.4 93.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.16 96.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.54 -46.83 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.364 -1.08 . . . . 0.0 110.316 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.12 -41.56 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.815 . . . . 0.0 110.729 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.04 99.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.5 tp -60.2 -41.19 92.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -1.233 . . . . 0.0 110.499 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 p -59.47 -48.84 80.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.816 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.86 65.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.099 -1.0 . . . . 0.0 110.347 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -107.19 105.71 15.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 110.601 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.09 37.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 110.725 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.4 145.14 16.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.22 173.03 5.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -1.116 . . . . 0.0 110.491 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 51' ' ' LEU . 25.7 tp -175.54 128.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.937 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.86 -175.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 25.3 p90 -109.16 130.6 55.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.212 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.5 m -95.91 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.269 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.597 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.626 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -138.78 112.21 8.26 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 110.661 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.14 62.82 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.972 1.512 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -30.79 70.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 43' ' ' LEU . 63.4 mt -67.1 -49.32 65.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.98 79.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 mm -65.76 -44.19 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.255 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -54.45 -45.27 73.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.468 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' A' ' 59' ' ' ILE . 39.9 mm -63.88 -43.96 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 0.0 110.385 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.37 -51.01 57.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HA ' HD13 ' A' ' 57' ' ' LEU . 4.5 mm? -63.24 -38.58 91.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -1.197 . . . . 0.0 110.37 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.1 m -64.95 -49.81 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.503 ' CD1' HG22 ' A' ' 55' ' ' ILE . 89.0 mt -67.3 -43.7 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.859 . . . . 0.0 111.013 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -60.41 -48.97 79.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.812 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.7 87.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.572 HG22 ' NE ' ' A' ' 66' ' ' ARG . 5.4 mm -64.22 -45.29 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -62.42 -42.07 99.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.088 -1.007 . . . . 0.0 110.275 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -66.46 -51.22 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.075 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -58.36 -49.99 75.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 110.077 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.572 ' NE ' HG22 ' A' ' 62' ' ' ILE . 63.1 mtm180 -57.59 -39.84 77.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.938 . . . . 0.0 109.782 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.65 157.04 31.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 110.48 -179.857 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 N--CA 1.484 0.951 0 N-CA-C 110.436 -0.64 . . . . 0.0 110.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.27 -34.34 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.359 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.486 ' C ' HD23 ' A' ' 27' ' ' LEU . 9.8 tt -58.33 -37.65 75.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.872 . . . . 0.0 110.176 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.925 HG12 HD13 ' A' ' 62' ' ' ILE . 97.2 t -60.26 -43.64 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 110.402 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.9 mt -65.35 -38.12 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.356 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.4 tt -60.69 -43.35 97.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.453 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 31' ' ' LEU . 9.2 tt -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.425 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.24 95.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 29' ' ' ILE . 66.1 t -57.55 -45.13 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -1.112 . . . . 0.0 110.315 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.81 -39.47 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.437 -0.79 . . . . 0.0 110.788 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' HD23 ' A' ' 39' ' ' LEU . . . -58.85 -41.04 95.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 39' ' ' LEU . 26.7 tp -57.01 -37.17 71.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -1.214 . . . . 0.0 110.471 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 t -58.64 -49.6 76.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.22 64.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.093 -1.004 . . . . 0.0 110.367 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 36' ' ' LEU . 1.3 pp -107.6 103.07 12.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.564 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m -140.22 37.56 1.91 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.715 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.43 147.5 19.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 63.3 t80 -63.71 169.01 4.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.479 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 28.8 tp -174.26 128.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.959 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.29 179.95 0.89 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 16.3 p90 -99.23 127.15 45.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 110.199 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -93.15 -155.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.76 ' N ' HG13 ' A' ' 46' ' ' VAL . 4.4 mm? -61.72 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.298 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.544 ' H ' HG13 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -128.05 111.09 20.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.588 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 65.47 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.886 1.466 . . . . 0.0 110.168 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.58 -32.02 71.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.434 ' C ' HD23 ' A' ' 51' ' ' LEU . 8.8 tt -66.02 -50.18 65.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.8 80.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.294 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.65 -43.96 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -55.35 -46.56 76.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 110.485 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.47 HG22 ' CD1' ' A' ' 59' ' ' ILE . 41.0 mm -63.62 -44.7 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.955 . . . . 0.0 110.443 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.23 -50.96 57.33 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.31 -38.69 92.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -1.21 . . . . 0.0 110.451 177.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.9 m -64.82 -50.11 68.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.547 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' HG22 ' A' ' 55' ' ' ILE . 91.4 mt -67.35 -43.62 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.369 -0.832 . . . . 0.0 110.959 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.4 t80 -59.39 -48.88 79.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.934 -1.104 . . . . 0.0 109.871 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 111.088 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.925 HD13 HG12 ' A' ' 28' ' ' VAL . 3.3 mm -62.45 -45.36 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.815 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -59.35 -40.65 87.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 110.235 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.4 mtm180 -67.42 -49.93 61.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -51.37 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.621 ' CD ' HD11 ' A' ' 29' ' ' ILE . 68.0 mtm180 -58.69 -35.48 72.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -162.63 138.98 7.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.141 -0.974 . . . . 0.0 110.547 -179.718 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 58.1 Cg_endo . . . . . 0 N--CA 1.484 0.931 0 N-CA-C 110.47 -0.627 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 27' ' ' LEU . 11.4 m -69.81 -33.73 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.328 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -60.81 -34.88 75.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.205 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.12 -40.78 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 110.507 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 33' ' ' VAL . 93.7 mt -65.27 -38.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.255 -0.903 . . . . 0.0 110.297 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.78 -43.47 98.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.397 -0.814 . . . . 0.0 110.443 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.45 -42.46 98.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.89 96.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.9 t -58.59 -44.91 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.086 . . . . 0.0 110.324 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.01 -40.89 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.467 -0.771 . . . . 0.0 110.777 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.54 -40.0 95.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 36' ' ' LEU . 75.9 mt -60.49 -38.18 83.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.08 -1.247 . . . . 0.0 110.54 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 p -58.07 -47.21 83.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.416 ' C ' HD22 ' A' ' 39' ' ' LEU . . . -54.76 -33.17 60.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.411 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 38' ' ' ALA . 3.4 mm? -107.65 108.55 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 110.557 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.2 p -147.04 38.35 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.933 . . . . 0.0 110.696 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.97 -146.38 13.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.56 138.71 48.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -1.141 . . . . 0.0 110.521 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 tp -176.14 142.88 0.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -105.17 164.64 11.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.323 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.643 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 76.4 m-85 -57.84 140.55 51.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.196 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 47' ' ' LEU . 21.3 m -105.17 -135.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.569 ' N ' HG23 ' A' ' 46' ' ' VAL . 26.8 tp -60.08 -34.13 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.937 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.446 ' H ' HG23 ' A' ' 46' ' ' VAL . 13.1 tp -144.45 133.49 11.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.685 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.763 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.2 Cg_endo -76.77 55.01 4.71 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.863 1.454 . . . . 0.0 110.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.67 -42.9 65.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 51' ' ' LEU . 9.1 tt -67.49 -49.13 64.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.41 -44.3 76.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 53' ' ' ILE . 41.9 mm -65.17 -43.55 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -55.62 -46.1 77.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.3 mm -64.09 -44.12 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.38 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 -50.19 57.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.4 tt -64.02 -38.79 92.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.119 -1.224 . . . . 0.0 110.468 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -64.85 -50.25 67.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.93 -43.41 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.94 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.99 -48.43 81.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.842 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.97 89.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.016 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.41 -45.57 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.852 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -62.66 -39.85 95.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -65.41 -51.9 57.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 110.076 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -57.77 -48.02 80.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 mtp180 -59.81 -38.97 83.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.798 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 67.2 mt-30 -155.26 148.89 25.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -0.786 . . . . 0.0 109.842 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 110.514 -179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo . . . . . 0 N--CA 1.483 0.884 0 N-CA-C 110.489 -0.62 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.0 p -61.85 -34.28 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.862 . . . . 0.0 110.299 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.49 -36.8 74.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HG23 ' A' ' 62' ' ' ILE . 94.2 t -61.07 -43.63 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.507 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.5 mt -65.72 -38.11 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.337 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.3 tt -63.33 -43.56 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -62.81 -43.31 99.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.1 t -57.5 -44.81 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.381 -1.07 . . . . 0.0 110.289 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.72 -40.18 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.734 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.66 97.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 -38.73 82.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.24 . . . . 0.0 110.528 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 40' ' ' THR . 18.4 t -59.05 -48.46 81.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.765 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.13 64.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.995 . . . . 0.0 110.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.2 mt -107.25 100.23 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.535 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' SER . 41.3 p -133.38 35.66 3.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 110.708 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -140.85 146.51 17.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.93 174.71 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -175.89 131.15 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.968 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.06 136.66 33.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -62.07 139.15 58.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 47' ' ' LEU . 16.0 m -100.49 -138.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.0 tp -65.27 -35.33 80.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.315 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.565 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -140.58 107.73 6.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.624 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.16 61.62 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.0 1.526 . . . . 0.0 110.12 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.03 70.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.191 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -66.3 -50.43 63.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -0.832 . . . . 0.0 110.242 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.08 76.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.18 -44.53 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.272 -0.892 . . . . 0.0 110.315 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -54.29 -44.43 71.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.514 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.67 -44.34 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.436 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.77 57.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.73 -38.01 89.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -1.192 . . . . 0.0 110.419 177.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.7 m -64.03 -50.29 69.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.57 -42.87 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.828 . . . . 0.0 110.959 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -59.28 -49.02 79.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 109.845 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.45 92.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 28' ' ' VAL . 68.3 mt -64.45 -45.96 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.823 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.09 -40.18 96.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.035 -1.041 . . . . 0.0 110.282 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.15 -51.9 53.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.091 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -57.37 -47.89 80.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HE ' HD11 ' A' ' 29' ' ' ILE . 67.7 mtp180 -57.84 -41.03 81.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.77 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -158.67 157.85 32.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 109.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 110.47 -179.824 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.484 0.94 0 N-CA-C 110.518 -0.608 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.454 HG23 ' N ' ' A' ' 27' ' ' LEU . 19.7 m -61.3 -34.6 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 110.315 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -57.81 -37.63 74.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.236 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.35 -43.79 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.477 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.691 ' O ' HG13 ' A' ' 33' ' ' VAL . 94.1 mt -65.67 -38.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.306 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 34' ' ' VAL . 26.0 tp -60.68 -42.25 96.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 110.408 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 tp -69.47 -45.76 68.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.75 -47.84 82.64 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 29' ' ' ILE . 34.2 m -59.42 -42.68 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -1.102 . . . . 0.0 110.346 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.579 ' N ' HG23 ' A' ' 33' ' ' VAL . 55.1 t -61.76 -40.06 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 0.0 110.742 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.06 94.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.13 -38.63 80.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.163 -1.198 . . . . 0.0 110.587 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.1 p -57.85 -47.91 81.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.77 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.55 -34.75 64.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.6 mt -107.58 104.19 13.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -140.91 37.6 1.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.678 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.54 146.07 17.22 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -65.55 172.06 3.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.528 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -173.81 127.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.28 -176.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.118 -0.989 . . . . 0.0 110.296 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.491 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 24.7 p90 -109.11 131.22 55.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.07 -145.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.213 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 48' ' ' LEU . 26.2 tp -57.89 -36.63 72.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 110.247 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.902 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -147.05 118.53 4.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.637 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.902 ' HD2' HD13 ' A' ' 48' ' ' LEU . 50.5 Cg_endo -71.19 64.64 2.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.199 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.36 69.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.146 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 3.2 mm? -67.2 -49.34 64.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.74 80.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.1 -43.83 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.285 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.84 -45.57 74.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.6 mm -63.71 -44.29 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.224 -0.923 . . . . 0.0 110.385 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.9 -50.7 57.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.31 -37.85 88.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -1.22 . . . . 0.0 110.36 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.3 m -64.61 -50.14 68.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.74 -42.76 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 0.0 110.941 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.78 -48.77 80.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.92 -1.113 . . . . 0.0 109.869 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.75 90.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.034 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.86 -45.39 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.03 -40.12 94.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.235 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -65.18 -51.6 60.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 110.112 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -57.59 -48.49 79.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -60.7 -36.29 78.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -157.44 141.8 16.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.483 -179.958 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo . . . . . 0 N--CA 1.483 0.87 0 N-CA-C 110.482 -0.622 . . . . 0.0 110.482 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -65.69 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.357 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.563 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -59.14 -37.38 77.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 110.247 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.612 HG12 HG23 ' A' ' 62' ' ' ILE . 94.5 t -59.96 -43.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' A' ' 62' ' ' ILE . 20.8 mm -65.85 -38.15 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.316 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.57 -43.32 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.37 -42.18 98.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.4 -38.79 96.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 29' ' ' ILE . 63.3 t -58.07 -44.73 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 110.379 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.8 -40.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.375 -0.828 . . . . 0.0 110.74 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.59 -40.22 96.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.03 -37.97 81.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -1.201 . . . . 0.0 110.53 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -57.6 -47.53 81.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 110.761 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.54 60.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 110.364 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.704 HD13 HD11 ' A' ' 51' ' ' LEU . 57.5 mt -108.12 107.08 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 t -143.74 37.68 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.05 146.32 17.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.54 169.17 5.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.137 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -175.41 130.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -68.66 -175.98 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.327 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -104.07 128.41 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.158 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.745 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -92.36 -155.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.176 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.745 ' N ' HG13 ' A' ' 46' ' ' VAL . 27.4 tp -61.29 -44.0 97.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.306 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.535 ' H ' HG13 ' A' ' 46' ' ' VAL . 7.1 tp -129.89 110.33 17.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.672 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.18 65.26 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.936 1.493 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.92 -31.93 73.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.298 -0.877 . . . . 0.0 110.148 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.704 HD11 HD13 ' A' ' 39' ' ' LEU . 31.9 tp -66.11 -50.28 64.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.87 84.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.34 -44.79 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.288 -0.883 . . . . 0.0 110.303 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.88 -45.27 74.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.503 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.7 -44.85 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.168 -0.958 . . . . 0.0 110.375 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.41 -50.59 59.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.65 -38.06 89.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.081 -1.246 . . . . 0.0 110.451 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -64.74 -50.05 68.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.505 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 HE21 ' A' ' 63' ' ' GLN . 86.8 mt -67.01 -43.45 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.961 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.87 -48.86 79.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.823 -1.173 . . . . 0.0 109.84 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.54 92.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 111.046 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.683 ' CG2' HD13 ' A' ' 29' ' ' ILE . 71.2 mt -63.5 -45.58 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.871 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.725 HE21 HG22 ' A' ' 59' ' ' ILE . 57.3 mt-30 -63.15 -42.34 99.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 110.25 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -65.98 -51.55 57.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.054 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -57.87 -48.92 78.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' A' ' 29' ' ' ILE . 61.2 ttp180 -56.06 -40.51 73.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -158.39 152.3 23.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.448 -179.856 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.764 ' O ' HG22 ' A' ' 28' ' ' VAL . 57.2 Cg_endo . . . . . 0 N--CA 1.483 0.894 0 N-CA-C 110.533 -0.603 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.62 -31.46 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.386 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.2 -34.04 69.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.0 m -58.24 -33.82 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.399 -0.813 . . . . 0.0 110.525 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 33' ' ' VAL . 40.7 mm -64.39 -38.24 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.7 tp -61.86 -43.18 99.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.471 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.24 -43.11 98.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.336 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.71 -38.37 95.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 29' ' ' ILE . 65.7 t -57.49 -44.99 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.1 . . . . 0.0 110.276 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.73 -40.43 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.696 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.82 98.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.67 -38.68 82.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.199 -1.177 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 40' ' ' THR . 17.4 t -58.3 -48.08 81.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.763 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.42 64.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.112 -0.993 . . . . 0.0 110.387 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 51' ' ' LEU . 23.3 tp -106.77 100.43 9.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' SER . 41.0 p -132.52 35.2 3.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.665 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.1 144.06 15.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -62.8 173.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -1.131 . . . . 0.0 110.472 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.2 tp -173.69 130.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 109.952 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -72.58 -177.63 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.357 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 20.8 p90 -102.2 129.54 48.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.205 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.35 -143.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.1 tt -57.9 -35.9 71.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.269 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 121.67 3.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.601 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 50.8 Cg_endo -71.64 65.69 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.893 1.47 . . . . 0.0 110.084 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.39 66.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.188 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 39' ' ' LEU . 27.5 tp -67.65 -49.55 62.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.321 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.73 -44.1 77.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.1 mm -65.62 -44.52 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -54.44 -45.4 73.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.443 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.44 -44.2 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.447 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.26 -49.96 57.9 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.25 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.333 177.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' HD13 ' A' ' 62' ' ' ILE . 87.3 m -64.71 -50.24 67.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.462 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.84 -43.85 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 0.0 110.875 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.48 -49.48 77.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.868 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.92 87.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 111.047 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 58' ' ' THR . 1.1 mp -64.46 -45.63 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.87 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.472 ' N ' HG22 ' A' ' 62' ' ' ILE . 49.3 tt0 -62.12 -40.48 96.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 0.0 110.294 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -66.05 -51.61 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -56.59 -47.94 78.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HD3' HD11 ' A' ' 29' ' ' ILE . 65.2 mtm180 -62.19 -35.77 79.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 109.754 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -160.43 134.59 7.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.837 . . . . 0.0 109.815 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.516 -179.766 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 N--CA 1.484 0.917 0 N-CA-C 110.409 -0.65 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 6.4 p -67.97 -33.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 28.0 tp -60.29 -34.67 74.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 65' ' ' LYS . 78.0 t -59.84 -40.99 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 110.496 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.0 mt -64.59 -37.07 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.374 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 110.412 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.26 -43.47 97.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -64.41 -38.67 96.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 29' ' ' ILE . 59.6 t -57.7 -45.42 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -1.138 . . . . 0.0 110.317 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.98 -41.48 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 0.0 110.68 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.86 -40.66 98.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.6 mp -60.29 -41.52 93.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.102 -1.234 . . . . 0.0 110.572 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 40' ' ' THR . 19.8 t -59.12 -48.72 80.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.13 62.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.352 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.22 101.7 10.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 37' ' ' SER . 35.8 p -135.57 36.08 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.671 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.26 147.73 19.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.85 174.89 3.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.123 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 tp -175.33 129.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.57 131.89 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -60.98 141.41 57.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -0.969 . . . . 0.0 110.133 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 47' ' ' LEU . 19.1 m -103.45 -136.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.24 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.585 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.3 tt -62.67 -35.18 78.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 46' ' ' VAL . 4.5 tp -130.98 108.28 15.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.685 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 48' ' ' LEU . 49.6 Cg_endo -70.85 62.16 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.962 1.506 . . . . 0.0 110.126 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.25 -50.66 64.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.294 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.73 78.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 110.332 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.57 -44.56 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.311 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -54.98 -45.44 75.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.487 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.7 -44.93 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.07 -50.5 58.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.6 tt -63.56 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -1.201 . . . . 0.0 110.454 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.1 m -64.8 -50.13 67.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.51 -43.46 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 111.036 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 25.8 t80 -59.23 -48.56 81.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.969 -1.082 . . . . 0.0 109.806 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.4 -39.8 84.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 111.077 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.94 -45.15 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.23 -40.93 95.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.02 -1.05 . . . . 0.0 110.241 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 55.8 mtp180 -66.34 -50.6 63.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 110.027 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.45 -50.16 73.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.139 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 98.9 mtt180 -61.88 -35.24 77.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.754 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.63 137.0 10.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 109.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 -179.725 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.484 0.927 0 N-CA-C 110.514 -0.61 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.6 p -57.18 -35.31 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.362 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 26' ' ' VAL . 26.1 tp -57.07 -41.44 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.408 ' CG1' HG12 ' A' ' 62' ' ' ILE . 58.4 t -61.46 -45.37 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.469 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.762 ' O ' HG23 ' A' ' 33' ' ' VAL . 88.5 mt -66.64 -38.17 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.19 -43.97 96.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 110.465 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.13 -43.2 99.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.354 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.96 95.7 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.4 t -58.9 -45.59 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.267 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.15 -41.05 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.732 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.41 97.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.238 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 p -59.42 -48.01 83.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.191 -0.943 . . . . 0.0 110.686 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.47 -33.1 59.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 tp -107.54 108.51 19.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.603 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 40' ' ' THR . 9.9 t -147.05 38.45 0.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.731 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.05 -145.25 11.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -135.96 145.42 46.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.362 -1.081 . . . . 0.0 110.524 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 tp -176.62 144.71 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 109.979 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -106.69 161.94 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.32 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -60.13 138.69 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.19 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.74 -134.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.25 -33.02 73.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.284 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.87 140.5 16.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.681 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.8 Cg_endo -77.9 52.46 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.879 1.463 . . . . 0.0 110.107 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.77 63.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -49.26 62.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.29 -44.56 75.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.328 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 mm -65.25 -43.69 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.893 . . . . 0.0 110.269 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.49 -46.06 76.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.471 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.15 -44.02 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.15 -49.86 57.89 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.7 tt -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -1.214 . . . . 0.0 110.427 177.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 m -64.2 -50.11 69.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 62' ' ' ILE . 88.4 mt -67.4 -42.27 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.6 -48.54 80.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.976 -1.077 . . . . 0.0 109.823 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.91 85.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.988 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 59' ' ' ILE . 78.9 mt -63.65 -45.24 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.85 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.96 -39.46 89.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.211 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -65.96 -51.25 60.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 110.075 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -57.98 -49.41 76.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.043 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 39.7 ttm180 -57.93 -39.95 79.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 76.6 mt-30 -155.55 150.01 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.356 -0.84 . . . . 0.0 109.85 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 110.405 -179.825 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -66.72 -22.25 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.955 1.503 . . . . 0.0 110.503 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.8 t -65.63 -34.63 71.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.321 -0.862 . . . . 0.0 110.345 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.81 -36.79 75.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -0.895 . . . . 0.0 110.273 -179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.559 HG12 HG23 ' A' ' 62' ' ' ILE . 70.7 t -59.78 -42.72 89.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.365 -0.834 . . . . 0.0 110.447 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.867 HD11 ' CD ' ' A' ' 66' ' ' ARG . 97.1 mt -65.3 -37.65 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.232 -0.917 . . . . 0.0 110.345 179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.431 HD12 HD22 ' A' ' 27' ' ' LEU . 79.1 mt -61.82 -43.53 98.67 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.333 -0.854 . . . . 0.0 110.426 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.1 -42.96 99.7 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.375 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -38.46 95.68 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.6 t -58.38 -45.29 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.317 -1.108 . . . . 0.0 110.34 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.3 t -60.09 -40.97 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.429 -0.794 . . . . 0.0 110.733 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.55 -40.58 96.49 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.9 tp -59.72 -38.54 81.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.096 -1.238 . . . . 0.0 110.521 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.6 t -58.13 -47.93 81.81 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.207 -0.933 . . . . 0.0 110.75 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.9 61.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.124 -0.985 . . . . 0.0 110.314 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 51' ' ' LEU . 25.0 tp -108.13 106.71 17.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.281 -0.887 . . . . 0.0 110.602 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 11.9 t -142.46 37.37 1.51 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.201 -0.937 . . . . 0.0 110.694 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -137.16 143.77 15.11 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.61 173.92 3.86 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.238 -1.154 . . . . 0.0 110.469 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.2 tp -174.98 129.49 0.3 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.307 -0.87 . . . . 0.0 109.97 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -67.08 -178.21 0.75 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.213 -0.929 . . . . 0.0 110.314 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -103.52 127.09 50.99 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.263 -0.898 . . . . 0.0 110.168 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.12 -145.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.168 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.419 ' N ' ' CD2' ' A' ' 47' ' ' LEU . 4.5 mm? -57.95 -38.0 75.18 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.272 -0.892 . . . . 0.0 110.261 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -151.87 120.56 3.36 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.303 -0.873 . . . . 0.0 110.655 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -71.22 65.02 2.71 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.869 1.457 . . . . 0.0 110.137 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.06 -32.3 67.89 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.284 -0.885 . . . . 0.0 110.154 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD21 HD21 ' A' ' 39' ' ' LEU . 28.8 tp -67.2 -49.38 64.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.285 -0.884 . . . . 0.0 110.286 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.0 77.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.254 -0.904 . . . . 0.0 110.305 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -65.41 -44.07 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.3 -0.875 . . . . 0.0 110.348 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.61 -45.47 73.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 110.485 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 37.9 mm -63.82 -43.74 97.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.14 -0.975 . . . . 0.0 110.425 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.85 -50.52 57.97 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.553 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.2 OUTLIER -63.05 -37.66 88.07 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.111 -1.229 . . . . 0.0 110.383 177.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.4 m -64.87 -49.83 68.97 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.197 -0.94 . . . . 0.0 110.528 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 98.7 mt -66.48 -42.79 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.869 . . . . 0.0 110.969 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -60.1 -49.1 78.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.91 -1.119 . . . . 0.0 109.856 179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.86 -42.24 93.25 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.281 -0.887 . . . . 0.0 111.019 178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.559 HG23 HG12 ' A' ' 28' ' ' VAL . 79.5 mt -63.99 -45.31 97.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -0.946 . . . . 0.0 110.881 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.057 -1.027 . . . . 0.0 110.307 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 57.1 ttp180 -65.78 -51.68 57.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.209 -0.932 . . . . 0.0 110.074 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.475 ' HB2' HG11 ' A' ' 28' ' ' VAL . 27.7 mmtp -57.17 -47.99 79.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 110.122 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.867 ' CD ' HD11 ' A' ' 29' ' ' ILE . 16.9 ttp180 -56.1 -39.79 72.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.192 -0.942 . . . . 0.0 109.812 178.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -159.37 145.81 16.53 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.0 109.853 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.03 33.3 5.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.135 -0.978 . . . . 0.0 110.463 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 28.7 t0 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.271 -0.893 . . . . 0.0 110.181 179.927 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.41 -21.45 35.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.984 1.518 . . . . 0.0 110.432 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.8 p -64.87 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 110.399 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' N ' HG13 ' A' ' 26' ' ' VAL . 27.0 tp -58.79 -37.04 75.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.0 110.243 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.0 t -60.86 -43.22 95.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.436 -0.79 . . . . 0.0 110.474 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.776 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.9 mt -65.97 -38.27 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.345 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 30' ' ' LEU . 3.1 mm? -63.39 -43.77 96.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.203 -0.936 . . . . 0.0 110.478 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -63.4 -43.29 97.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.124 -0.985 . . . . 0.0 110.284 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.05 -38.96 96.02 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.41 -45.72 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.398 -1.06 . . . . 0.0 110.327 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.1 t -60.54 -40.94 86.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.339 -0.851 . . . . 0.0 110.658 179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.91 -41.26 97.71 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.0 tp -60.04 -38.55 83.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.12 -1.223 . . . . 0.0 110.531 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.3 m -58.34 -47.92 82.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.168 -0.957 . . . . 0.0 110.736 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.75 -34.19 64.97 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.103 -0.998 . . . . 0.0 110.355 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.6 mt -105.74 107.56 18.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 16.7 p -147.94 38.4 0.9 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.11 -0.994 . . . . 0.0 110.674 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -103.66 -147.69 18.31 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -132.69 140.93 48.35 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.332 -1.099 . . . . 0.0 110.487 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.3 tt -163.61 133.96 4.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.017 -179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.638 ' O ' HD23 ' A' ' 43' ' ' LEU . 87.6 m-20 -78.05 -167.27 0.97 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.194 -0.941 . . . . 0.0 110.319 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.579 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 16.8 p90 -85.02 124.31 31.56 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.247 -0.908 . . . . 0.0 110.134 -179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.617 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.2 m -103.87 -147.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.223 -0.923 . . . . 0.0 110.239 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' N ' HG23 ' A' ' 46' ' ' VAL . 28.6 tp -54.11 -39.97 66.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.329 -0.857 . . . . 0.0 110.259 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.495 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -161.04 137.08 6.08 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.267 -0.896 . . . . 0.0 110.675 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.741 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.3 Cg_endo -72.92 67.43 3.99 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.912 1.48 . . . . 0.0 110.159 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.24 -38.49 65.82 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.341 -0.849 . . . . 0.0 110.128 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.56 -49.9 61.01 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 0.0 110.274 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.741 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.87 -44.25 77.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 110.317 179.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 90.1 mt -65.2 -44.35 95.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.217 -0.927 . . . . 0.0 110.327 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -54.17 -44.86 71.86 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.295 -0.878 . . . . 0.0 110.452 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.8 mt -64.26 -44.06 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.166 -0.959 . . . . 0.0 110.406 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.413 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -54.16 -50.49 55.43 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.2 tt -62.79 -36.68 83.91 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -1.202 . . . . 0.0 110.453 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 72.9 m -64.77 -49.83 69.19 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 91.3 mt -66.05 -42.55 91.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.356 -0.84 . . . . 0.0 111.008 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.413 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 6.5 m-85 -59.73 -49.56 77.26 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.945 -1.097 . . . . 0.0 109.859 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.556 ' HB1' ' NZ ' ' A' ' 65' ' ' LYS . . . -59.33 -42.28 91.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.26 -0.9 . . . . 0.0 110.931 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 29' ' ' ILE . 80.9 mt -63.33 -46.09 96.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 110.854 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.66 -39.74 89.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.145 -0.972 . . . . 0.0 110.256 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -66.65 -51.42 56.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 110.038 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' NZ ' ' HB1' ' A' ' 61' ' ' ALA . 24.1 mttp -57.48 -49.48 76.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -0.89 . . . . 0.0 110.104 178.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.43 -38.98 78.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.185 -0.947 . . . . 0.0 109.796 178.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -156.96 149.76 23.6 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.258 -0.901 . . . . 0.0 109.903 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -159.41 173.51 16.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 110.474 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.192 -0.942 . . . . 0.0 110.15 179.962 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.606 HG22 ' HB2' ' A' ' 27' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -76.68 -49.32 0.11 Allowed 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.944 1.497 . . . . 0.0 110.432 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 8.4 p -56.79 -33.12 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.606 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -57.29 -38.22 73.62 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 110.246 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.636 HG12 HG12 ' A' ' 62' ' ' ILE . 74.4 t -61.53 -44.03 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.449 -0.782 . . . . 0.0 110.422 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.793 ' O ' HG23 ' A' ' 33' ' ' VAL . 94.7 mt -66.28 -37.97 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.298 -0.876 . . . . 0.0 110.364 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.6 tt -63.21 -43.4 98.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.226 -0.921 . . . . 0.0 110.467 -179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.6 tt -62.87 -43.56 98.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.19 -0.944 . . . . 0.0 110.405 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.36 -38.3 95.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.793 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.5 t -58.19 -45.81 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.386 -1.067 . . . . 0.0 110.297 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 70.6 t -59.77 -40.44 82.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.407 -0.808 . . . . 0.0 110.705 179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.02 98.21 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.6 mt -59.58 -38.98 82.64 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.093 -1.239 . . . . 0.0 110.579 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.4 t -59.07 -48.85 80.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.258 -0.901 . . . . 0.0 110.773 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.32 -34.78 64.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.086 -1.009 . . . . 0.0 110.405 178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.9 mt -107.84 102.43 11.64 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.612 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 40.0 p -137.73 36.47 2.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.202 -0.936 . . . . 0.0 110.643 -179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.78 148.09 19.72 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -63.43 170.27 3.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.318 -1.107 . . . . 0.0 110.478 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 25.1 tp -174.73 129.96 0.33 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.332 -0.855 . . . . 0.0 109.973 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -66.96 -178.0 0.7 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.256 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.541 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 19.6 p90 -100.99 127.2 47.59 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.18 -0.95 . . . . 0.0 110.193 -179.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.764 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.1 p -91.98 -157.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.228 -0.92 . . . . 0.0 110.191 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.764 ' N ' HG13 ' A' ' 46' ' ' VAL . 80.2 mt -61.36 -44.61 96.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.272 -0.893 . . . . 0.0 110.349 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -128.06 110.79 20.01 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 110.668 179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.625 ' HD2' HD13 ' A' ' 48' ' ' LEU . 45.8 Cg_endo -70.4 65.27 2.18 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.924 1.486 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.24 -31.86 71.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.0 110.216 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 64.3 mt -66.14 -50.02 65.44 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.268 -0.895 . . . . 0.0 110.289 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.37 -44.62 80.32 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.28 -0.888 . . . . 0.0 110.327 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.9 mt -66.2 -44.07 91.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 110.375 178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -54.81 -46.09 74.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.257 -0.902 . . . . 0.0 110.464 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 40.1 mm -63.55 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.914 . . . . 0.0 110.359 179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.95 -50.71 57.69 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.8 tp -62.84 -38.0 89.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -1.208 . . . . 0.0 110.411 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 85.1 m -64.97 -50.02 68.01 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.152 -0.967 . . . . 0.0 110.521 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HA ' HD12 ' A' ' 62' ' ' ILE . 39.6 mm -66.63 -42.71 90.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.297 -0.877 . . . . 0.0 110.975 178.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.455 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 66.3 t80 -59.18 -48.55 81.18 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.908 -1.12 . . . . 0.0 109.822 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.82 -39.72 78.32 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.337 -0.852 . . . . 0.0 110.983 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 HG12 ' A' ' 28' ' ' VAL . 76.8 mt -62.74 -44.54 99.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.173 -0.955 . . . . 0.0 110.859 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -58.38 -39.57 79.98 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.113 -0.992 . . . . 0.0 110.334 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.455 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 77.8 mtp180 -66.44 -49.19 67.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 110.026 179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -56.88 -51.06 70.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 110.079 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.494 HH21 HG21 ' A' ' 62' ' ' ILE . 86.3 mtt180 -55.79 -35.28 66.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.214 -0.929 . . . . 0.0 109.769 177.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -172.73 138.28 0.83 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.376 -0.827 . . . . 0.0 109.878 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.71 131.08 37.52 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.198 -0.939 . . . . 0.0 110.553 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 54.5 p-10 . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.867 . . . . 0.0 110.13 179.836 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.787 ' O ' HG22 ' A' ' 28' ' ' VAL . 40.0 Cg_endo -69.66 -26.97 27.51 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.951 1.501 . . . . 0.0 110.507 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.5 t -65.55 -30.04 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.282 -0.886 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -55.92 -35.85 67.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.345 -0.847 . . . . 0.0 110.193 -178.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.787 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.4 m -58.92 -35.37 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.438 -0.788 . . . . 0.0 110.489 -178.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.766 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.6 mt -65.28 -37.71 80.8 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.241 -0.912 . . . . 0.0 110.352 -179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 78.5 mt -62.82 -43.71 98.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.225 -0.922 . . . . 0.0 110.357 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 79.4 mt -64.06 -43.23 96.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.217 -0.927 . . . . 0.0 110.356 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.66 -39.42 96.71 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.5 t -58.4 -45.43 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.311 -1.111 . . . . 0.0 110.33 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -60.53 -40.83 85.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.8 . . . . 0.0 110.698 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.72 -41.0 97.3 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.9 mt -60.15 -37.7 80.9 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.031 -1.276 . . . . 0.0 110.536 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 t -57.93 -47.5 82.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.192 -0.942 . . . . 0.0 110.727 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.79 -33.56 61.57 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.135 -0.978 . . . . 0.0 110.405 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.515 HD23 ' C ' ' A' ' 39' ' ' LEU . 8.9 tt -107.47 110.95 23.02 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.257 -0.902 . . . . 0.0 110.565 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.6 p -148.86 38.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 110.705 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -102.74 -148.42 20.38 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.97 142.71 47.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.23 -1.159 . . . . 0.0 110.467 -179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.772 HD23 ' O ' ' A' ' 44' ' ' ASP . 4.9 tt -162.0 132.57 4.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.213 -0.93 . . . . 0.0 110.001 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.772 ' O ' HD23 ' A' ' 43' ' ' LEU . 6.2 t0 -80.55 -164.26 0.68 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.164 -0.96 . . . . 0.0 110.331 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.603 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 14.3 p90 -91.96 122.96 34.97 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.251 -0.905 . . . . 0.0 110.224 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.613 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.8 m -102.69 -145.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.212 -0.93 . . . . 0.0 110.236 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.613 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.3 tp -54.73 -39.07 67.88 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 110.318 -179.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.489 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.2 OUTLIER -157.76 136.36 7.79 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.315 -0.866 . . . . 0.0 110.655 179.869 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.789 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 55.7 Cg_endo -73.06 63.61 4.15 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 123.962 1.506 . . . . 0.0 110.127 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.98 -40.51 66.96 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 0.0 110.106 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -49.71 62.19 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.262 -0.899 . . . . 0.0 110.302 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.789 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.82 -43.86 77.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.223 -0.923 . . . . 0.0 110.333 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.2 mt -65.05 -43.97 95.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.172 -0.955 . . . . 0.0 110.315 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -54.54 -44.76 73.12 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.265 -0.897 . . . . 0.0 110.501 179.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.434 HG22 ' CD1' ' A' ' 59' ' ' ILE . 37.5 mm -64.28 -43.76 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.222 -0.924 . . . . 0.0 110.452 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' TYR . . . -54.55 -50.23 57.96 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.3 tt -63.94 -38.36 90.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.066 -1.255 . . . . 0.0 110.416 177.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.6 m -64.63 -50.1 68.46 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.233 -0.917 . . . . 0.0 110.522 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.434 ' CD1' HG22 ' A' ' 55' ' ' ILE . 86.7 mt -67.5 -43.24 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.342 -0.849 . . . . 0.0 110.958 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.402 ' CD1' ' O ' ' A' ' 56' ' ' GLY . 5.6 m-85 -60.2 -49.22 78.5 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.852 -1.155 . . . . 0.0 109.848 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.94 -40.34 88.6 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.296 -0.877 . . . . 0.0 111.039 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.5 mt -64.05 -45.19 97.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 110.849 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -61.29 -39.19 89.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.037 -1.039 . . . . 0.0 110.289 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 43.6 mtp-105 -66.2 -51.33 58.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.203 -0.935 . . . . 0.0 110.059 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -57.35 -48.64 78.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.309 -0.869 . . . . 0.0 110.132 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -56.27 -40.35 74.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.173 -0.955 . . . . 0.0 109.815 178.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 21.7 pt20 -157.65 151.0 23.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.217 -0.927 . . . . 0.0 109.858 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB2' ' O ' ' A' ' 67' ' ' GLN . . . -175.88 150.34 1.0 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.14 -0.975 . . . . 0.0 110.503 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.281 -0.887 . . . . 0.0 110.149 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 110.002 -0.369 . . . . 0.0 110.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -74.36 84.98 1.47 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 0.0 110.517 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.1 p -60.09 -34.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 110.348 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.607 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.05 -37.83 75.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -0.923 . . . . 0.0 110.23 -179.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 52.5 t -60.9 -43.83 96.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.0 110.566 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 33' ' ' VAL . 90.5 mt -65.64 -38.37 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.208 -0.932 . . . . 0.0 110.323 179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.2 tp -62.41 -43.63 98.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 0.0 110.435 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.52 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.2 tt -63.32 -43.65 97.2 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.226 -0.921 . . . . 0.0 110.389 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.6 -38.84 96.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 29' ' ' ILE . 58.8 t -58.02 -45.41 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.307 -1.114 . . . . 0.0 110.346 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.32 -40.76 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.338 -0.852 . . . . 0.0 110.678 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.23 -41.22 98.18 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.9 -38.86 83.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.125 -1.221 . . . . 0.0 110.503 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.2 m -58.78 -48.08 82.48 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.292 -0.88 . . . . 0.0 110.741 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.14 -34.08 63.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.085 -1.01 . . . . 0.0 110.381 178.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.0 tp -107.47 103.65 13.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.267 -0.895 . . . . 0.0 110.614 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 32.7 p -139.73 36.83 2.0 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.182 -0.949 . . . . 0.0 110.644 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -139.25 145.81 17.17 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -63.96 170.27 3.65 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.265 -1.138 . . . . 0.0 110.483 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.545 HD23 HD22 ' A' ' 51' ' ' LEU . 26.8 tp -173.45 127.65 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.329 -0.857 . . . . 0.0 109.996 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -68.87 -178.14 1.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.0 110.332 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 21.3 p90 -104.21 129.42 51.98 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 110.214 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.609 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.8 m -98.14 -146.9 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.236 -0.915 . . . . 0.0 110.163 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.598 ' N ' HG23 ' A' ' 46' ' ' VAL . 74.9 mt -58.0 -35.0 70.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.147 -0.97 . . . . 0.0 110.324 -179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.609 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -145.88 119.13 5.24 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.648 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.467 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 48.1 Cg_endo -70.42 64.64 2.19 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.022 1.538 . . . . 0.0 110.153 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -54.08 -31.9 53.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.31 -0.869 . . . . 0.0 110.191 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.678 HD12 ' N ' ' A' ' 52' ' ' ALA . 2.3 pp -69.37 -46.24 67.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.318 -0.864 . . . . 0.0 110.269 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 51' ' ' LEU . . . -55.78 -45.09 78.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.324 -0.86 . . . . 0.0 110.368 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -66.16 -43.84 91.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.317 -0.865 . . . . 0.0 110.344 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.27 -47.03 76.09 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 0.0 110.459 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.1 mm -63.4 -44.42 98.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.14 -0.975 . . . . 0.0 110.361 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.21 -51.32 54.95 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.5 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.3 tt -62.17 -38.09 87.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.09 -1.241 . . . . 0.0 110.452 177.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 90.7 m -65.05 -50.14 67.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.246 -0.909 . . . . 0.0 110.476 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 38.5 mm -66.29 -43.07 91.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.234 -0.916 . . . . 0.0 110.955 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.427 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.3 t80 -59.64 -49.13 78.94 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.904 -1.122 . . . . 0.0 109.811 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.8 -40.77 80.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.277 -0.889 . . . . 0.0 110.991 178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.42 ' CG2' ' NE ' ' A' ' 66' ' ' ARG . 78.9 mt -63.24 -44.81 99.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.175 -0.953 . . . . 0.0 110.807 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -59.25 -40.58 86.43 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.09 -1.006 . . . . 0.0 110.314 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.427 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 50.3 mtm180 -66.56 -49.57 65.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.93 . . . . 0.0 110.114 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.5 -51.93 67.78 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.253 -0.905 . . . . 0.0 110.057 178.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.42 ' NE ' ' CG2' ' A' ' 62' ' ' ILE . 96.7 mtt180 -55.81 -40.21 72.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.196 -0.94 . . . . 0.0 109.792 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 68' ' ' ALA . 63.2 tt0 -162.15 165.66 26.7 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.365 -0.834 . . . . 0.0 109.89 -179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 67' ' ' GLN . . . 61.58 55.17 2.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.111 -0.993 . . . . 0.0 110.473 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.8 t0 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.259 -0.901 . . . . 0.0 110.156 179.832 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.408 ' O ' HG23 ' A' ' 24' ' ' THR . 4.9 t . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -70.39 -12.91 32.51 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.996 1.524 . . . . 0.0 110.521 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 70.0 t -66.7 -36.24 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.384 -0.822 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.526 HD23 ' C ' ' A' ' 27' ' ' LEU . 9.3 tt -58.83 -37.23 75.97 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.234 -0.916 . . . . 0.0 110.211 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.579 HG12 HD11 ' A' ' 62' ' ' ILE . 54.0 t -60.53 -43.29 94.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.404 -0.81 . . . . 0.0 110.479 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.6 mt -65.53 -38.35 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.164 -0.96 . . . . 0.0 110.285 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.53 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.4 tt -62.89 -43.73 98.01 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.329 -0.857 . . . . 0.0 110.476 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.5 tp -63.63 -43.29 97.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.178 -0.951 . . . . 0.0 110.397 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.21 -39.19 95.94 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 29' ' ' ILE . 56.8 t -58.55 -46.03 90.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.394 -1.062 . . . . 0.0 110.365 -179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -60.79 -41.06 87.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.384 -0.822 . . . . 0.0 110.743 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.94 -41.51 97.86 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 26.7 tp -60.24 -38.55 83.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.094 -1.239 . . . . 0.0 110.527 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.2 t -58.61 -47.89 82.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.254 -0.904 . . . . 0.0 110.768 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.25 -33.76 63.44 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.114 -0.991 . . . . 0.0 110.393 178.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.9 tp -106.43 109.98 22.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.308 -0.87 . . . . 0.0 110.572 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.16 39.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.246 -0.909 . . . . 0.0 110.716 -179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.0 -150.28 24.0 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -134.32 143.97 48.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -1.106 . . . . 0.0 110.477 -179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 22.8 tp -167.14 137.47 3.0 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.833 . . . . 0.0 109.953 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -81.23 -165.78 1.01 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.237 -0.915 . . . . 0.0 110.24 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.594 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 15.4 p90 -88.75 123.39 33.13 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.24 -0.913 . . . . 0.0 110.153 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' N ' ' A' ' 47' ' ' LEU . 4.5 m -102.31 -146.05 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.324 -0.86 . . . . 0.0 110.176 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.62 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.8 tp -55.71 -38.7 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.198 -0.939 . . . . 0.0 110.215 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.5 ' H ' HG23 ' A' ' 46' ' ' VAL . 10.4 tp -154.97 136.27 9.16 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 110.634 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.842 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 54.6 Cg_endo -72.59 63.73 3.78 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.893 1.47 . . . . 0.0 110.168 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -53.71 -42.77 68.39 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 0.0 110.17 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.7 mt -67.0 -50.17 63.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.842 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.61 -43.75 76.39 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.272 -0.892 . . . . 0.0 110.286 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.404 ' N ' ' CD1' ' A' ' 53' ' ' ILE . 1.1 mp -65.12 -44.33 95.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.238 -0.914 . . . . 0.0 110.287 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -54.38 -44.77 72.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.288 -0.883 . . . . 0.0 110.495 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 36.0 mm -64.49 -43.92 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.173 -0.954 . . . . 0.0 110.42 178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.403 ' O ' ' CD2' ' A' ' 60' ' ' TYR . . . -53.94 -50.24 55.58 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 74.4 mt -63.49 -37.07 85.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.148 -1.207 . . . . 0.0 110.421 177.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 m -64.99 -49.85 68.65 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.199 -0.938 . . . . 0.0 110.524 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -67.09 -43.28 88.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.272 -0.892 . . . . 0.0 110.955 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CD2' ' O ' ' A' ' 56' ' ' GLY . 5.7 m-85 -59.96 -49.23 78.49 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.963 -1.085 . . . . 0.0 109.837 179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.45 -40.91 88.36 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.346 -0.846 . . . . 0.0 111.062 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.579 HD11 HG12 ' A' ' 28' ' ' VAL . 1.9 mm -62.83 -46.12 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.228 -0.92 . . . . 0.0 110.857 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -60.47 -39.8 88.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.075 -1.015 . . . . 0.0 110.221 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -66.7 -51.35 57.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.169 -0.957 . . . . 0.0 110.065 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -57.27 -49.89 74.63 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.285 -0.885 . . . . 0.0 110.109 178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.677 ' HD2' HD11 ' A' ' 29' ' ' ILE . 82.6 mtp180 -57.63 -38.7 75.44 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.135 -0.978 . . . . 0.0 109.739 178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -160.59 141.76 12.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.361 -0.837 . . . . 0.0 109.851 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.74 -69.88 0.62 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.181 -0.949 . . . . 0.0 110.497 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.2 p30 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.193 -0.942 . . . . 0.0 110.131 179.911 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.595 HG22 ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.595 ' HD2' HG22 ' A' ' 24' ' ' THR . 57.5 Cg_endo -79.4 109.24 2.46 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 0.0 110.438 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 77.5 t -61.86 -40.19 86.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.0 110.31 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -56.3 -44.32 79.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 0.0 110.159 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.4 t -62.82 -46.49 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 110.473 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.744 ' O ' HG23 ' A' ' 33' ' ' VAL . 86.6 mt -66.79 -38.94 82.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.237 -0.915 . . . . 0.0 110.355 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.5 tp -64.28 -43.7 93.98 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.316 -0.865 . . . . 0.0 110.487 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.521 ' C ' HD23 ' A' ' 31' ' ' LEU . 9.5 tt -63.71 -44.4 93.72 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.223 -0.923 . . . . 0.0 110.335 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.37 -39.16 96.72 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.0 t -58.54 -46.83 89.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.364 -1.08 . . . . 0.0 110.316 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.12 -41.56 86.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.397 -0.815 . . . . 0.0 110.729 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -61.03 -42.04 99.65 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 27.5 tp -60.2 -41.19 92.46 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.104 -1.233 . . . . 0.0 110.499 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.2 p -59.47 -48.84 80.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.816 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -34.86 65.61 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.099 -1.0 . . . . 0.0 110.347 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.3 tp -107.19 105.71 15.83 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.855 . . . . 0.0 110.601 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.09 37.75 1.28 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.181 -0.95 . . . . 0.0 110.725 -179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.4 145.14 16.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -68.22 173.03 5.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.302 -1.116 . . . . 0.0 110.491 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.588 HD23 HD12 ' A' ' 51' ' ' LEU . 25.7 tp -175.54 128.63 0.26 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.296 -0.878 . . . . 0.0 109.937 -179.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.86 -175.56 0.93 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.167 -0.958 . . . . 0.0 110.31 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.498 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 25.3 p90 -109.16 130.6 55.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.329 -0.857 . . . . 0.0 110.212 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.626 HG23 ' H ' ' A' ' 48' ' ' LEU . 4.5 m -95.91 -147.22 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -0.901 . . . . 0.0 110.269 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.597 ' N ' HG23 ' A' ' 46' ' ' VAL . 0.1 OUTLIER -61.26 -36.89 81.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.0 110.244 -179.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.626 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -138.78 112.21 8.26 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.254 -0.903 . . . . 0.0 110.661 179.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.14 62.82 2.6 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.972 1.512 . . . . 0.0 110.152 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.68 -30.79 70.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.274 -0.891 . . . . 0.0 110.173 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 43' ' ' LEU . 63.4 mt -67.1 -49.32 65.36 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.241 -0.912 . . . . 0.0 110.295 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.43 -43.98 79.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 0.0 110.269 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.4 mm -65.76 -44.19 93.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.202 -0.936 . . . . 0.0 110.255 178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -54.45 -45.27 73.06 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.245 -0.909 . . . . 0.0 110.468 179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.503 HG22 ' CD1' ' A' ' 59' ' ' ILE . 39.9 mm -63.88 -43.96 97.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.085 -1.009 . . . . 0.0 110.385 178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.37 -51.01 57.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.468 ' HA ' HD13 ' A' ' 57' ' ' LEU . 4.5 mm? -63.24 -38.58 91.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.165 -1.197 . . . . 0.0 110.37 177.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 92.1 m -64.95 -49.81 68.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.458 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.503 ' CD1' HG22 ' A' ' 55' ' ' ILE . 89.0 mt -67.3 -43.7 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.325 -0.859 . . . . 0.0 111.013 178.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -60.41 -48.97 79.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.008 -1.057 . . . . 0.0 109.812 179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -40.7 87.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.368 -0.832 . . . . 0.0 111.039 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.572 HG22 ' NE ' ' A' ' 66' ' ' ARG . 5.4 mm -64.22 -45.29 96.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.0 110.863 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -62.42 -42.07 99.17 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.088 -1.007 . . . . 0.0 110.275 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -66.46 -51.22 59.17 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.253 -0.904 . . . . 0.0 110.075 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.2 mmtt -58.36 -49.99 75.24 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 110.077 178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.572 ' NE ' HG22 ' A' ' 62' ' ' ILE . 63.1 mtm180 -57.59 -39.84 77.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.2 -0.938 . . . . 0.0 109.782 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -158.65 157.04 31.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.917 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.87 132.33 53.56 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 110.48 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.8 t0 . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 110.092 179.813 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.685 HG22 ' HB2' ' A' ' 27' ' ' LEU . 1.7 m . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 109.913 -0.402 . . . . 0.0 109.913 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.36 -33.9 8.38 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.956 1.503 . . . . 0.0 110.436 179.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 73.3 t -62.27 -34.34 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.33 -0.856 . . . . 0.0 110.359 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.685 ' HB2' HG22 ' A' ' 24' ' ' THR . 9.8 tt -58.33 -37.65 75.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.306 -0.872 . . . . 0.0 110.176 -179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.925 HG12 HD13 ' A' ' 62' ' ' ILE . 97.2 t -60.26 -43.64 93.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.372 -0.83 . . . . 0.0 110.402 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 33' ' ' VAL . 89.9 mt -65.35 -38.12 81.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.967 . . . . 0.0 110.356 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.532 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.4 tt -60.69 -43.35 97.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 110.453 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.526 ' C ' HD23 ' A' ' 31' ' ' LEU . 9.2 tt -62.7 -42.46 99.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.281 -0.887 . . . . 0.0 110.425 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.38 -38.24 95.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 29' ' ' ILE . 66.1 t -57.55 -45.13 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.309 -1.112 . . . . 0.0 110.315 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.9 t -59.81 -39.47 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.437 -0.79 . . . . 0.0 110.788 179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' O ' HD23 ' A' ' 39' ' ' LEU . . . -58.85 -41.04 95.91 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 39' ' ' LEU . 26.7 tp -57.01 -37.17 71.31 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.137 -1.214 . . . . 0.0 110.471 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 15.6 t -58.64 -49.6 76.91 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 110.754 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.11 -37.22 64.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.093 -1.004 . . . . 0.0 110.367 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 36' ' ' LEU . 1.3 pp -107.6 103.07 12.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.564 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m -140.22 37.56 1.91 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 0.0 110.715 -179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -141.43 147.5 19.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.411 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 63.3 t80 -63.71 169.01 4.33 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -1.133 . . . . 0.0 110.479 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.411 ' N ' ' CD2' ' A' ' 42' ' ' TYR . 28.8 tp -174.26 128.67 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.0 109.959 -179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -66.29 179.95 0.89 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.18 -0.95 . . . . 0.0 110.285 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.552 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 16.3 p90 -99.23 127.15 45.18 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.203 -0.935 . . . . 0.0 110.199 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.76 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -93.15 -155.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 110.205 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.76 ' N ' HG13 ' A' ' 46' ' ' VAL . 4.4 mm? -61.72 -43.6 98.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.311 -0.868 . . . . 0.0 110.298 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.544 ' H ' HG13 ' A' ' 46' ' ' VAL . 0.5 OUTLIER -128.05 111.09 20.04 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.328 -0.858 . . . . 0.0 110.588 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -70.36 65.47 2.15 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.886 1.466 . . . . 0.0 110.168 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.58 -32.02 71.13 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.284 -0.885 . . . . 0.0 110.139 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.434 ' C ' HD23 ' A' ' 51' ' ' LEU . 8.8 tt -66.02 -50.18 65.12 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.341 -0.849 . . . . 0.0 110.312 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.28 -44.8 80.14 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 110.294 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.1 mm -66.65 -43.96 90.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.371 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -55.35 -46.56 76.4 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.0 110.485 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.47 HG22 ' CD1' ' A' ' 59' ' ' ILE . 41.0 mm -63.62 -44.7 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.173 -0.955 . . . . 0.0 110.443 178.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.23 -50.96 57.33 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.447 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -63.31 -38.69 92.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.144 -1.21 . . . . 0.0 110.451 177.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.9 m -64.82 -50.11 68.0 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.201 -0.937 . . . . 0.0 110.547 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 ' CD1' HG22 ' A' ' 55' ' ' ILE . 91.4 mt -67.35 -43.62 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.369 -0.832 . . . . 0.0 110.959 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 64' ' ' ARG . 76.4 t80 -59.39 -48.88 79.95 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.934 -1.104 . . . . 0.0 109.871 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.38 -39.79 80.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.207 -0.933 . . . . 0.0 111.088 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.925 HD13 HG12 ' A' ' 28' ' ' VAL . 3.3 mm -62.45 -45.36 98.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.16 -0.962 . . . . 0.0 110.815 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -59.35 -40.65 87.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 0.0 110.235 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.425 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 48.4 mtm180 -67.42 -49.93 61.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.107 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -57.63 -51.37 69.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 110.149 178.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.621 ' CD ' HD11 ' A' ' 29' ' ' ILE . 68.0 mtm180 -58.69 -35.48 72.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.156 -0.965 . . . . 0.0 109.816 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -162.63 138.98 7.51 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.0 109.848 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -165.65 141.14 5.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.141 -0.974 . . . . 0.0 110.547 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 58.6 t0 . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.231 -0.918 . . . . 0.0 110.165 179.643 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.407 ' HG2' ' HG3' ' A' ' 66' ' ' ARG . 58.1 Cg_endo -78.25 63.62 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 O-C-N 123.94 1.495 . . . . 0.0 110.47 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 27' ' ' LEU . 11.4 m -69.81 -33.73 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 110.328 178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.508 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -60.81 -34.88 75.2 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 0.0 110.205 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.12 -40.78 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.377 -0.827 . . . . 0.0 110.507 -178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.711 ' O ' HG23 ' A' ' 33' ' ' VAL . 93.7 mt -65.27 -38.0 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.255 -0.903 . . . . 0.0 110.297 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.0 tp -60.78 -43.47 98.02 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.397 -0.814 . . . . 0.0 110.443 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.45 -42.46 98.64 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.248 -0.907 . . . . 0.0 110.421 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.96 -38.89 96.03 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 29' ' ' ILE . 72.9 t -58.59 -44.91 90.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.353 -1.086 . . . . 0.0 110.324 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -60.01 -40.89 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.467 -0.771 . . . . 0.0 110.777 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.54 -40.0 95.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 36' ' ' LEU . 75.9 mt -60.49 -38.18 83.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.08 -1.247 . . . . 0.0 110.54 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 p -58.07 -47.21 83.86 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.301 -0.874 . . . . 0.0 110.79 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.416 ' C ' HD22 ' A' ' 39' ' ' LEU . . . -54.76 -33.17 60.91 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.114 -0.991 . . . . 0.0 110.411 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.416 HD22 ' C ' ' A' ' 38' ' ' ALA . 3.4 mm? -107.65 108.55 19.85 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.324 -0.86 . . . . 0.0 110.557 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.2 p -147.04 38.35 0.98 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.206 -0.933 . . . . 0.0 110.696 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.97 -146.38 13.99 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -178.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.56 138.71 48.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.26 -1.141 . . . . 0.0 110.521 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.7 tp -176.14 142.88 0.51 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.341 -0.849 . . . . 0.0 109.978 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -105.17 164.64 11.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -0.962 . . . . 0.0 110.323 177.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.643 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 76.4 m-85 -57.84 140.55 51.56 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.257 -0.902 . . . . 0.0 110.196 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.569 HG23 ' N ' ' A' ' 47' ' ' LEU . 21.3 m -105.17 -135.41 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.569 ' N ' HG23 ' A' ' 46' ' ' VAL . 26.8 tp -60.08 -34.13 73.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.937 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.446 ' H ' HG23 ' A' ' 46' ' ' VAL . 13.1 tp -144.45 133.49 11.25 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.253 -0.904 . . . . 0.0 110.685 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.763 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.2 Cg_endo -76.77 55.01 4.71 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.863 1.454 . . . . 0.0 110.171 -179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.67 -42.9 65.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.336 -0.852 . . . . 0.0 110.167 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.483 HD23 ' C ' ' A' ' 51' ' ' LEU . 9.1 tt -67.49 -49.13 64.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.268 -0.895 . . . . 0.0 110.277 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.763 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.41 -44.3 76.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 ' HA ' ' A' ' 53' ' ' ILE . 41.9 mm -65.17 -43.55 95.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 0.0 110.259 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -55.62 -46.1 77.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 0.0 110.451 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.3 mm -64.09 -44.12 97.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.159 -0.963 . . . . 0.0 110.38 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.43 -50.19 57.64 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.525 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.4 tt -64.02 -38.79 92.37 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.119 -1.224 . . . . 0.0 110.468 177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -64.85 -50.25 67.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.198 -0.939 . . . . 0.0 110.472 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mm -67.93 -43.41 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.94 178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -58.99 -48.43 81.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.888 -1.133 . . . . 0.0 109.842 179.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.53 -39.97 89.8 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.283 -0.886 . . . . 0.0 111.016 178.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 65.8 mt -64.41 -45.57 95.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.219 -0.926 . . . . 0.0 110.852 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -62.66 -39.85 95.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.09 -1.006 . . . . 0.0 110.259 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -65.41 -51.9 57.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.192 -0.943 . . . . 0.0 110.076 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -57.77 -48.02 80.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.206 -0.934 . . . . 0.0 110.096 178.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 20.5 mtp180 -59.81 -38.97 83.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.219 -0.926 . . . . 0.0 109.798 178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 67.2 mt-30 -155.26 148.89 25.27 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.443 -0.786 . . . . 0.0 109.842 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -73.83 -164.62 0.23 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.183 -0.948 . . . . 0.0 110.514 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 60.1 t0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.29 -0.881 . . . . 0.0 110.129 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -68.2 -25.47 37.0 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.973 1.512 . . . . 0.0 110.489 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.416 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.0 p -61.85 -34.28 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.862 . . . . 0.0 110.299 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.543 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.49 -36.8 74.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 110.22 -179.826 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HG23 ' A' ' 62' ' ' ILE . 94.2 t -61.07 -43.63 96.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 110.507 -179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 33' ' ' VAL . 91.5 mt -65.72 -38.11 81.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.337 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.535 ' C ' HD23 ' A' ' 30' ' ' LEU . 9.3 tt -63.33 -43.56 97.42 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 0.0 110.436 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.53 HD23 ' C ' ' A' ' 31' ' ' LEU . 9.4 tt -62.81 -43.31 99.12 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.259 -0.901 . . . . 0.0 110.35 179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.86 -38.21 95.26 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 29' ' ' ILE . 60.1 t -57.5 -44.81 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.381 -1.07 . . . . 0.0 110.289 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.5 t -59.72 -40.18 81.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 110.734 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.33 -40.66 97.79 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.8 mp -59.74 -38.73 82.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.091 -1.24 . . . . 0.0 110.528 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 40' ' ' THR . 18.4 t -59.05 -48.46 81.5 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 0.0 110.765 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.45 -34.13 64.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -0.995 . . . . 0.0 110.406 177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 59.2 mt -107.25 100.23 9.71 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.34 -0.85 . . . . 0.0 110.535 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.504 HG23 ' O ' ' A' ' 37' ' ' SER . 41.3 p -133.38 35.66 3.43 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.986 . . . . 0.0 110.708 -179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 43' ' ' LEU . . . -140.85 146.51 17.84 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -64.93 174.71 1.78 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -1.101 . . . . 0.0 110.485 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.511 HD23 ' O ' ' A' ' 41' ' ' GLY . 0.7 OUTLIER -175.89 131.15 0.25 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.262 -0.899 . . . . 0.0 109.968 -179.08 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.06 136.66 33.47 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.227 -0.92 . . . . 0.0 110.237 179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -62.07 139.15 58.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.108 -0.995 . . . . 0.0 110.188 -179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG23 ' N ' ' A' ' 47' ' ' LEU . 16.0 m -100.49 -138.43 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.297 -0.877 . . . . 0.0 110.21 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.59 ' N ' HG23 ' A' ' 46' ' ' VAL . 27.0 tp -65.27 -35.33 80.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.205 -0.934 . . . . 0.0 110.315 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.565 ' H ' HG23 ' A' ' 46' ' ' VAL . 0.3 OUTLIER -140.58 107.73 6.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 110.624 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -71.16 61.62 2.54 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.0 1.526 . . . . 0.0 110.12 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.34 -30.03 70.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.347 -0.846 . . . . 0.0 110.191 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -66.3 -50.43 63.67 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.37 -0.832 . . . . 0.0 110.242 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.79 -43.08 76.48 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.325 -0.859 . . . . 0.0 110.313 178.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.3 mt -65.18 -44.53 95.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.272 -0.892 . . . . 0.0 110.315 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -54.29 -44.43 71.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.284 -0.885 . . . . 0.0 110.514 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 38.1 mm -64.67 -44.34 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.195 -0.941 . . . . 0.0 110.436 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.77 57.79 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.427 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.73 -38.01 89.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -1.192 . . . . 0.0 110.419 177.348 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.7 m -64.03 -50.29 69.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.224 -0.922 . . . . 0.0 110.488 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.1 mm -67.57 -42.87 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.374 -0.828 . . . . 0.0 110.959 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 71.6 t80 -59.28 -49.02 79.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.911 -1.118 . . . . 0.0 109.845 179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.45 92.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.239 -0.913 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.441 HG23 HG12 ' A' ' 28' ' ' VAL . 68.3 mt -64.45 -45.96 94.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 0.0 110.823 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.09 -40.18 96.9 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.035 -1.041 . . . . 0.0 110.282 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 45.1 ttp180 -66.15 -51.9 53.47 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.171 -0.956 . . . . 0.0 110.091 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.0 mtpt -57.37 -47.89 80.46 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 110.149 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.425 ' HE ' HD11 ' A' ' 29' ' ' ILE . 67.7 mtp180 -57.84 -41.03 81.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 0.0 109.77 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -158.67 157.85 32.62 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.358 -0.839 . . . . 0.0 109.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -84.34 -158.83 0.36 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 110.47 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.8 t70 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.217 -0.927 . . . . 0.0 110.086 179.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.706 HG22 ' HB2' ' A' ' 27' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -72.77 -37.47 3.81 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 124.008 1.53 . . . . 0.0 110.518 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.454 HG23 ' N ' ' A' ' 27' ' ' LEU . 19.7 m -61.3 -34.6 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 110.315 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.706 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -57.81 -37.63 74.11 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.236 -179.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -61.35 -43.79 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.394 -0.816 . . . . 0.0 110.477 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.691 ' O ' HG13 ' A' ' 33' ' ' VAL . 94.1 mt -65.67 -38.03 81.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.237 -0.914 . . . . 0.0 110.306 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 34' ' ' VAL . 26.0 tp -60.68 -42.25 96.75 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.41 -0.806 . . . . 0.0 110.408 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.8 tp -69.47 -45.76 68.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.0 110.326 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.75 -47.84 82.64 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -177.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 29' ' ' ILE . 34.2 m -59.42 -42.68 88.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.326 -1.102 . . . . 0.0 110.346 -177.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.579 ' N ' HG23 ' A' ' 33' ' ' VAL . 55.1 t -61.76 -40.06 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.409 -0.807 . . . . 0.0 110.742 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.23 -39.06 94.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.944 -1.263 . . . . 0.0 109.944 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.2 mt -59.13 -38.63 80.12 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.163 -1.198 . . . . 0.0 110.587 179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.1 p -57.85 -47.91 81.33 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.0 110.77 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.55 -34.75 64.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.092 -1.005 . . . . 0.0 110.318 178.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 54.6 mt -107.58 104.19 13.67 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 110.605 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 36.8 p -140.91 37.6 1.78 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.219 -0.926 . . . . 0.0 110.678 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.54 146.07 17.22 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -65.55 172.06 3.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.285 -1.127 . . . . 0.0 110.528 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 27.1 tp -173.81 127.66 0.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.989 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -68.28 -176.39 0.73 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.118 -0.989 . . . . 0.0 110.296 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.491 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 24.7 p90 -109.11 131.22 55.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 0.0 110.177 -179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -99.07 -145.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 0.0 110.213 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.511 ' O ' HD22 ' A' ' 48' ' ' LEU . 26.2 tp -57.89 -36.63 72.66 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -0.961 . . . . 0.0 110.247 -179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.902 HD13 ' HD2' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -147.05 118.53 4.67 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.334 -0.854 . . . . 0.0 110.637 179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.902 ' HD2' HD13 ' A' ' 48' ' ' LEU . 50.5 Cg_endo -71.19 64.64 2.69 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 123.922 1.485 . . . . 0.0 110.199 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.36 69.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.19 -0.944 . . . . 0.0 110.146 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.43 ' N ' ' CD2' ' A' ' 51' ' ' LEU . 3.2 mm? -67.2 -49.34 64.94 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.34 -0.85 . . . . 0.0 110.244 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.46 -44.74 80.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.0 110.245 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.6 mm -66.1 -43.83 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.272 -0.893 . . . . 0.0 110.285 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.84 -45.57 74.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.294 -0.879 . . . . 0.0 110.424 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.6 mm -63.71 -44.29 98.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.224 -0.923 . . . . 0.0 110.385 178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.9 -50.7 57.51 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 27.7 tp -63.31 -37.85 88.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.126 -1.22 . . . . 0.0 110.36 177.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 89.3 m -64.61 -50.14 68.33 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 110.488 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 41.8 mm -66.74 -42.76 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 0.0 110.941 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -59.78 -48.77 80.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.92 -1.113 . . . . 0.0 109.869 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.48 -41.75 90.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.357 -0.839 . . . . 0.0 111.034 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 78.6 mt -63.86 -45.39 97.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -62.03 -40.12 94.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.064 -1.022 . . . . 0.0 110.235 179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.4 ttt-85 -65.18 -51.6 60.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 110.112 179.557 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.7 mmtm -57.59 -48.49 79.25 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.269 -0.895 . . . . 0.0 110.028 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 80.6 mtp180 -60.7 -36.29 78.43 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.22 -0.925 . . . . 0.0 109.81 178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -157.44 141.8 16.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.239 -0.913 . . . . 0.0 109.836 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -103.56 138.99 39.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 110.483 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.328 -0.858 . . . . 0.0 110.198 179.962 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.401 ' CB ' ' HA ' ' A' ' 66' ' ' ARG . 36.5 Cg_endo -66.81 -24.05 47.31 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.891 1.469 . . . . 0.0 110.482 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 82.9 t -65.69 -34.97 73.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.403 -0.811 . . . . 0.0 110.357 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.563 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -59.14 -37.38 77.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.285 -0.885 . . . . 0.0 110.247 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.612 HG12 HG23 ' A' ' 62' ' ' ILE . 94.5 t -59.96 -43.31 92.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.362 -0.836 . . . . 0.0 110.53 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.683 HD13 ' CG2' ' A' ' 62' ' ' ILE . 20.8 mm -65.85 -38.15 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.204 -0.935 . . . . 0.0 110.316 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 28.7 tp -60.57 -43.32 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.286 -0.884 . . . . 0.0 110.48 -179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 24.8 tp -63.37 -42.18 98.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.242 -0.911 . . . . 0.0 110.362 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.4 -38.79 96.28 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 29' ' ' ILE . 63.3 t -58.07 -44.73 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.373 -1.075 . . . . 0.0 110.379 -179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 77.9 t -59.8 -40.8 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.375 -0.828 . . . . 0.0 110.74 179.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -59.59 -40.22 96.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.813 -1.315 . . . . 0.0 109.813 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 76.1 mt -60.03 -37.97 81.33 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.157 -1.201 . . . . 0.0 110.53 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.1 t -57.6 -47.53 81.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.29 -0.881 . . . . 0.0 110.761 -179.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.57 -33.54 60.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.141 -0.974 . . . . 0.0 110.364 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.704 HD13 HD11 ' A' ' 51' ' ' LEU . 57.5 mt -108.12 107.08 17.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 0.0 110.566 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.0 t -143.74 37.68 1.32 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.728 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.05 146.32 17.72 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -64.54 169.17 5.09 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.268 -1.137 . . . . 0.0 110.494 179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.5 tp -175.41 130.89 0.28 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 0.0 109.912 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 53.6 p30 -68.66 -175.98 0.75 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.178 -0.951 . . . . 0.0 110.327 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.528 ' O ' ' CG ' ' A' ' 45' ' ' TYR . 20.8 p90 -104.07 128.41 51.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 110.158 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.745 HG13 ' N ' ' A' ' 47' ' ' LEU . 1.4 p -92.36 -155.76 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.184 -0.948 . . . . 0.0 110.176 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.745 ' N ' HG13 ' A' ' 46' ' ' VAL . 27.4 tp -61.29 -44.0 97.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 110.306 -178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.535 ' H ' HG13 ' A' ' 46' ' ' VAL . 7.1 tp -129.89 110.33 17.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 110.672 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -70.18 65.26 2.05 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.936 1.493 . . . . 0.0 110.141 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.92 -31.93 73.11 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.298 -0.877 . . . . 0.0 110.148 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.704 HD11 HD13 ' A' ' 39' ' ' LEU . 31.9 tp -66.11 -50.28 64.58 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.265 -0.897 . . . . 0.0 110.219 -179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.37 -44.87 84.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 110.289 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 89.5 mt -66.34 -44.79 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.288 -0.883 . . . . 0.0 110.303 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -54.88 -45.27 74.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.306 -0.871 . . . . 0.0 110.503 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 95.0 mt -63.7 -44.85 98.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.168 -0.958 . . . . 0.0 110.375 179.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.41 -50.59 59.28 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 73.8 mt -63.65 -38.06 89.68 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.081 -1.246 . . . . 0.0 110.451 177.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.9 m -64.74 -50.05 68.42 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.505 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.725 HG22 HE21 ' A' ' 63' ' ' GLN . 86.8 mt -67.01 -43.45 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.269 -0.894 . . . . 0.0 110.961 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -59.87 -48.86 79.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.823 -1.173 . . . . 0.0 109.84 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.05 -41.54 92.53 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -0.866 . . . . 0.0 111.046 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.683 ' CG2' HD13 ' A' ' 29' ' ' ILE . 71.2 mt -63.5 -45.58 97.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.192 -0.942 . . . . 0.0 110.871 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.725 HE21 HG22 ' A' ' 59' ' ' ILE . 57.3 mt-30 -63.15 -42.34 99.43 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.071 -1.018 . . . . 0.0 110.25 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 50.6 ttm-85 -65.98 -51.55 57.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.284 -0.885 . . . . 0.0 110.054 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -57.87 -48.92 78.41 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.302 -0.874 . . . . 0.0 110.119 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.569 ' HD3' HD11 ' A' ' 29' ' ' ILE . 61.2 ttp180 -56.06 -40.51 73.64 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.17 -0.956 . . . . 0.0 109.74 178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -158.39 152.3 23.74 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.305 -0.872 . . . . 0.0 109.872 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.21 148.46 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.131 -0.981 . . . . 0.0 110.448 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.248 -0.908 . . . . 0.0 110.109 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.764 ' O ' HG22 ' A' ' 28' ' ' VAL . 57.2 Cg_endo -77.13 51.41 3.45 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.966 1.508 . . . . 0.0 110.533 -177.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 75.6 t -70.62 -31.46 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.346 -0.846 . . . . 0.0 110.386 178.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.622 ' O ' HD13 ' A' ' 27' ' ' LEU . 0.2 OUTLIER -58.2 -34.04 69.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 110.234 -178.85 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.764 HG22 ' O ' ' A' ' 25' ' ' PRO . 3.0 m -58.24 -33.82 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.399 -0.813 . . . . 0.0 110.525 -177.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.759 ' O ' HG23 ' A' ' 33' ' ' VAL . 40.7 mm -64.39 -38.24 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.199 -0.938 . . . . 0.0 110.332 -179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 27.7 tp -61.86 -43.18 99.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 0.0 110.471 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.457 ' O ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -63.24 -43.11 98.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.17 -0.956 . . . . 0.0 110.336 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.71 -38.37 95.54 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG23 ' O ' ' A' ' 29' ' ' ILE . 65.7 t -57.49 -44.99 85.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -1.1 . . . . 0.0 110.276 -179.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -59.73 -40.43 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.483 -0.76 . . . . 0.0 110.696 179.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.82 98.05 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 74.0 mt -59.67 -38.68 82.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.199 -1.177 . . . . 0.0 110.488 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 40' ' ' THR . 17.4 t -58.3 -48.08 81.61 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.24 -0.912 . . . . 0.0 110.763 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.5 -34.42 64.6 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.112 -0.993 . . . . 0.0 110.387 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 51' ' ' LEU . 23.3 tp -106.77 100.43 9.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 0.0 110.551 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 37' ' ' SER . 41.0 p -132.52 35.2 3.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.228 -0.92 . . . . 0.0 110.665 -179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.1 144.06 15.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -62.8 173.91 1.2 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.278 -1.131 . . . . 0.0 110.472 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 26.2 tp -173.69 130.85 0.43 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.273 -0.892 . . . . 0.0 109.952 -179.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -72.58 -177.63 2.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.202 -0.936 . . . . 0.0 110.357 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.52 ' CG ' ' O ' ' A' ' 45' ' ' TYR . 20.8 p90 -102.2 129.54 48.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 110.205 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.35 -143.07 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.904 . . . . 0.0 110.232 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 47' ' ' LEU . 9.1 tt -57.9 -35.9 71.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 110.269 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.89 121.67 3.5 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.233 -0.917 . . . . 0.0 110.601 -179.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 50.8 Cg_endo -71.64 65.69 3.04 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.893 1.47 . . . . 0.0 110.084 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -57.18 -32.39 66.39 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.282 -0.886 . . . . 0.0 110.188 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.929 HD21 HD21 ' A' ' 39' ' ' LEU . 27.5 tp -67.65 -49.55 62.32 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.313 -0.867 . . . . 0.0 110.321 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.44 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.73 -44.1 77.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.191 -0.943 . . . . 0.0 110.344 179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.1 mm -65.62 -44.52 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 110.343 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -54.44 -45.4 73.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.26 -0.9 . . . . 0.0 110.443 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 39.4 mm -64.44 -44.2 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.167 -0.958 . . . . 0.0 110.447 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.26 -49.96 57.9 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.413 HD13 ' O ' ' A' ' 57' ' ' LEU . 0.1 OUTLIER -64.25 -38.1 89.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.104 -1.233 . . . . 0.0 110.333 177.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.709 ' O ' HD13 ' A' ' 62' ' ' ILE . 87.3 m -64.71 -50.24 67.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.0 110.462 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 37.9 mm -67.84 -43.85 85.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.277 -0.889 . . . . 0.0 110.875 178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -60.48 -49.48 77.38 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.019 -1.051 . . . . 0.0 109.868 179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.97 -39.92 87.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.336 -0.852 . . . . 0.0 111.047 178.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 58' ' ' THR . 1.1 mp -64.46 -45.63 95.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.212 -0.93 . . . . 0.0 110.87 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.472 ' N ' HG22 ' A' ' 62' ' ' ILE . 49.3 tt0 -62.12 -40.48 96.07 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.114 -0.991 . . . . 0.0 110.294 179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.7 mmt85 -66.05 -51.61 56.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.177 -0.952 . . . . 0.0 110.113 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -56.59 -47.94 78.48 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.286 -0.884 . . . . 0.0 110.143 178.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.446 ' HD3' HD11 ' A' ' 29' ' ' ILE . 65.2 mtm180 -62.19 -35.77 79.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.144 -0.973 . . . . 0.0 109.754 178.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -160.43 134.59 7.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.837 . . . . 0.0 109.815 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -166.19 134.7 2.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.232 -0.917 . . . . 0.0 110.516 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.874 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 24' ' ' THR . 1.5 t . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -84.89 63.03 6.28 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.008 1.531 . . . . 0.0 110.409 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' N ' ' A' ' 27' ' ' LEU . 6.4 p -67.97 -33.89 63.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.312 179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.407 ' N ' ' CG1' ' A' ' 26' ' ' VAL . 28.0 tp -60.29 -34.67 74.09 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 110.209 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.401 ' HB ' ' HE2' ' A' ' 65' ' ' LYS . 78.0 t -59.84 -40.99 84.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 110.496 -178.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.742 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.0 mt -64.59 -37.07 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -0.919 . . . . 0.0 110.374 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.405 ' O ' HD13 ' A' ' 30' ' ' LEU . 0.1 OUTLIER -62.32 -43.31 99.13 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.403 -0.811 . . . . 0.0 110.412 -179.459 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.26 -43.47 97.9 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 0.0 110.389 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' O ' HD13 ' A' ' 36' ' ' LEU . . . -64.41 -38.67 96.11 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.742 HG23 ' O ' ' A' ' 29' ' ' ILE . 59.6 t -57.7 -45.42 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.265 -1.138 . . . . 0.0 110.317 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 75.1 t -58.98 -41.48 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 0.0 110.68 179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.86 -40.66 98.59 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.43 HD13 ' O ' ' A' ' 32' ' ' GLY . 5.6 mp -60.29 -41.52 93.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.102 -1.234 . . . . 0.0 110.572 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 40' ' ' THR . 19.8 t -59.12 -48.72 80.57 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.879 . . . . 0.0 110.741 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.8 -34.13 62.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.16 -0.962 . . . . 0.0 110.352 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.6 tp -108.22 101.7 10.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.212 -0.93 . . . . 0.0 110.535 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.424 HG23 ' O ' ' A' ' 37' ' ' SER . 35.8 p -135.57 36.08 2.92 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.188 -0.945 . . . . 0.0 110.671 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.26 147.73 19.29 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -67.85 174.89 3.33 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -1.123 . . . . 0.0 110.457 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 28.4 tp -175.33 129.51 0.28 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.337 -0.852 . . . . 0.0 109.976 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -81.57 131.89 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.132 -0.98 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 22.3 p90 -60.98 141.41 57.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.149 -0.969 . . . . 0.0 110.133 -179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.585 HG23 ' N ' ' A' ' 47' ' ' LEU . 19.1 m -103.45 -136.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -0.869 . . . . 0.0 110.24 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.585 ' N ' HG23 ' A' ' 46' ' ' VAL . 9.3 tt -62.67 -35.18 78.84 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 110.252 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.502 ' H ' HG23 ' A' ' 46' ' ' VAL . 4.5 tp -130.98 108.28 15.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 0.0 110.685 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 48' ' ' LEU . 49.6 Cg_endo -70.85 62.16 2.37 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.962 1.506 . . . . 0.0 110.126 -179.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.26 -31.0 72.03 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.311 -0.868 . . . . 0.0 110.18 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 31.6 tp -65.25 -50.66 64.93 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.36 -0.838 . . . . 0.0 110.294 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.12 -43.73 78.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.185 -0.947 . . . . 0.0 110.332 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.9 mt -65.57 -44.56 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.907 . . . . 0.0 110.311 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -54.98 -45.44 75.0 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 110.487 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 41.8 mm -63.7 -44.93 98.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.19 -0.944 . . . . 0.0 110.411 179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.07 -50.5 58.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 179.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.6 tt -63.56 -38.66 91.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.158 -1.201 . . . . 0.0 110.454 177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 97.1 m -64.8 -50.13 67.95 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.515 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.4 mm -67.51 -43.46 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.264 -0.898 . . . . 0.0 111.036 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CE2' ' HD2' ' A' ' 64' ' ' ARG . 25.8 t80 -59.23 -48.56 81.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.969 -1.082 . . . . 0.0 109.806 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.4 -39.8 84.57 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 0.0 111.077 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 66.3 mt -63.94 -45.15 97.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.091 -1.006 . . . . 0.0 110.843 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -61.23 -40.93 95.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.02 -1.05 . . . . 0.0 110.241 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.441 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 55.8 mtp180 -66.34 -50.6 63.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 110.027 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.407 ' HD3' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -57.45 -50.16 73.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.268 -0.895 . . . . 0.0 110.139 178.216 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.407 ' N ' ' HD3' ' A' ' 65' ' ' LYS . 98.9 mtt180 -61.88 -35.24 77.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 109.754 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -158.63 137.0 10.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.308 -0.87 . . . . 0.0 109.854 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -96.49 137.38 35.66 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 110.478 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 81.5 m-20 . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.184 -0.948 . . . . 0.0 110.147 179.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.23 66.49 3.49 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 0.0 110.514 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.432 HG13 ' N ' ' A' ' 27' ' ' LEU . 9.6 p -57.18 -35.31 47.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 110.362 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' N ' HG13 ' A' ' 26' ' ' VAL . 26.1 tp -57.07 -41.44 78.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.325 -0.859 . . . . 0.0 110.199 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.408 ' CG1' HG12 ' A' ' 62' ' ' ILE . 58.4 t -61.46 -45.37 98.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.367 -0.833 . . . . 0.0 110.469 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.762 ' O ' HG23 ' A' ' 33' ' ' VAL . 88.5 mt -66.64 -38.17 81.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.1 -1.0 . . . . 0.0 110.32 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.6 tp -63.19 -43.97 96.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.347 -0.846 . . . . 0.0 110.465 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.1 mt -63.13 -43.2 99.05 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.194 -0.941 . . . . 0.0 110.354 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.26 -38.96 95.7 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 29' ' ' ILE . 53.4 t -58.9 -45.59 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.267 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.0 t -60.15 -41.05 85.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.369 -0.832 . . . . 0.0 110.732 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -60.31 -40.41 97.42 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.879 -1.289 . . . . 0.0 109.879 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 83.3 mt -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.096 -1.238 . . . . 0.0 110.545 -179.741 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.7 p -59.42 -48.01 83.29 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.191 -0.943 . . . . 0.0 110.686 -179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.47 -33.1 59.05 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -0.931 . . . . 0.0 110.338 178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.1 tp -107.54 108.51 19.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 110.603 -179.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 40' ' ' THR . 9.9 t -147.05 38.45 0.98 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.242 -0.911 . . . . 0.0 110.731 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.05 -145.25 11.62 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -135.96 145.42 46.16 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.362 -1.081 . . . . 0.0 110.524 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 30.7 tp -176.62 144.71 0.51 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.292 -0.88 . . . . 0.0 109.979 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -106.69 161.94 14.21 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 0.0 110.32 177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -60.13 138.69 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.252 -0.905 . . . . 0.0 110.19 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.4 t -104.74 -134.25 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.893 . . . . 0.0 110.179 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.7 tp -62.25 -33.02 73.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 110.284 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.87 140.5 16.35 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 110.628 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.681 ' HB2' ' HB3' ' A' ' 52' ' ' ALA . 59.8 Cg_endo -77.9 52.46 4.02 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.879 1.463 . . . . 0.0 110.107 -179.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -52.44 -49.77 63.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -0.899 . . . . 0.0 110.154 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.04 -49.26 62.48 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.681 ' HB3' ' HB2' ' A' ' 49' ' ' PRO . . . -55.29 -44.56 75.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.294 -0.879 . . . . 0.0 110.328 179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 19.4 mm -65.25 -43.69 95.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.893 . . . . 0.0 110.269 178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -55.49 -46.06 76.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.219 -0.925 . . . . 0.0 110.471 179.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 89.1 mt -64.15 -44.02 97.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 110.414 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -54.15 -49.86 57.89 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.499 HD23 ' C ' ' A' ' 57' ' ' LEU . 9.7 tt -64.17 -38.47 91.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.136 -1.214 . . . . 0.0 110.427 177.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.2 m -64.2 -50.11 69.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.0 110.555 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.445 ' HA ' HD12 ' A' ' 62' ' ' ILE . 88.4 mt -67.4 -42.27 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.266 -0.896 . . . . 0.0 110.912 178.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -58.6 -48.54 80.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.976 -1.077 . . . . 0.0 109.823 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.65 -39.91 85.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.198 -0.939 . . . . 0.0 110.988 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.445 HD12 ' HA ' ' A' ' 59' ' ' ILE . 78.9 mt -63.65 -45.24 98.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.163 -0.96 . . . . 0.0 110.85 -179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -60.96 -39.46 89.62 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.051 -1.031 . . . . 0.0 110.211 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -65.96 -51.25 60.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.206 -0.934 . . . . 0.0 110.075 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -57.98 -49.41 76.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 110.043 178.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.421 ' O ' ' CG ' ' A' ' 67' ' ' GLN . 39.7 ttm180 -57.93 -39.95 79.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.266 -0.896 . . . . 0.0 109.765 178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.421 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 76.6 mt-30 -155.55 150.01 26.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.356 -0.84 . . . . 0.0 109.85 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.44 148.67 44.11 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.222 -0.924 . . . . 0.0 110.405 -179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 110.152 179.759 . . . . . . . . 0 0 . 1 stop_ save_